data_1whx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1whx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.958 0.409 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.48 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.49 HD21 ' CE1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.431 ' N ' ' CD1' ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.421 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.48 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.403 ' HA ' ' CD1' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.459 ' CG ' HG21 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.472 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 273' ' ' ALA . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 227' ' ' LYS . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.418 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 245' ' ' PHE . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 280' ' ' SER . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.485 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.92 0.391 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.443 ' CG1' ' HB1' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.487 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.451 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.469 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 237' ' ' GLU . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.432 ' N ' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.534 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 243' ' ' SER . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.534 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 283' ' ' HIS . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.469 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.487 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.443 ' HB1' ' CG1' ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.558 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.418 ' N ' HG21 ' A' ' 224' ' ' ILE . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.44 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.428 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.427 HD23 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.427 ' CG1' HD23 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.421 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.433 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 280' ' ' SER . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.466 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.558 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.451 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.433 ' HG ' ' CB ' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.409 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.469 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.412 ' C ' HD22 ' A' ' 253' ' ' LEU . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.421 ' N ' HD22 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 238' ' ' ILE . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 238' ' ' ILE . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.472 ' CD2' ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 235' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.472 ' CG1' ' CD2' ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.422 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.422 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.478 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.662 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 17.2 m-70 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.469 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.471 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 235' ' ' ALA . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.53 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.411 ' CA ' HD23 ' A' ' 265' ' ' LEU . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.474 ' CD2' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.411 HD23 ' CA ' ' A' ' 249' ' ' GLY . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.434 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.733 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.471 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.461 HG11 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.483 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.455 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 260' ' ' ALA . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.488 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 235' ' ' ALA . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.572 HD22 ' CD2' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 263' ' ' GLU . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.442 ' N ' HG11 ' A' ' 262' ' ' VAL . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.572 ' CD2' HD22 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.556 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.556 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.7 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.464 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.483 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.513 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.448 ' CD2' HG12 ' A' ' 261' ' ' ILE . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.438 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.419 ' HB2' ' CD1' ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 245' ' ' PHE . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.441 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.691 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.438 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.513 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.954 0.407 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.536 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG23 ' A' ' 224' ' ' ILE . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 287' ' ' LEU . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.428 ' N ' HG23 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD21 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 238' ' ' ILE . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.419 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 264' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 235' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 256' ' ' GLY . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 255' ' ' GLU . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.569 ' CD2' HD21 ' A' ' 248' ' ' LEU . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.42 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.42 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.408 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.419 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.473 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.458 ' CD2' HD21 ' A' ' 229' ' ' LEU . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.536 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.483 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.46 ' CE ' HG21 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 260' ' ' ALA . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.57 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.568 ' CD2' ' CE1' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.46 HG21 ' CE ' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.457 ' CG1' HD23 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.568 ' CE1' ' CD2' ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.406 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.479 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.483 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.945 0.402 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.501 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 224' ' ' ILE . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 2.0 t30 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.49 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 248' ' ' LEU . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 248' ' ' LEU . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.403 ' N ' HG11 ' A' ' 262' ' ' VAL . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.47 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.53 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.53 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 32.3 m-70 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.99 0.424 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.412 HG12 ' CB ' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 274' ' ' PHE . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.403 ' CG ' HG23 ' A' ' 259' ' ' THR . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.457 ' CD1' ' HB1' ' A' ' 260' ' ' ALA . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.403 HG23 ' CG ' ' A' ' 227' ' ' LYS . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 229' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.418 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.554 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.554 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.712 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.473 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.412 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.464 ' CG1' ' HB1' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.534 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' A' ' 287' ' ' LEU . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.458 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.442 ' CG2' HG12 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.407 ' N ' HG21 ' A' ' 233' ' ' THR . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.417 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.403 ' N ' HD11 ' A' ' 248' ' ' LEU . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 262' ' ' VAL . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 235' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.413 ' N ' HG12 ' A' ' 258' ' ' ILE . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.431 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.471 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.606 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 18.5 m-70 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.458 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.471 ' CD2' HD23 ' A' ' 229' ' ' LEU . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.534 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.464 ' HB1' ' CG1' ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 292' ' ' ALA . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.563 HG21 ' CE2' ' A' ' 274' ' ' PHE . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.459 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.542 ' CD2' ' CD2' ' A' ' 287' ' ' LEU . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.439 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HD13 ' A' ' 248' ' ' LEU . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 243' ' ' SER . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 235' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 259' ' ' THR . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.439 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.445 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.746 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . 0.459 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.542 ' CD2' ' CD2' ' A' ' 229' ' ' LEU . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 274' ' ' PHE . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.522 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.887 0.375 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' HG23 ' A' ' 259' ' ' THR . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.51 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.565 HD23 ' CZ ' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.467 HG23 ' CG ' ' A' ' 227' ' ' LYS . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 248' ' ' LEU . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.565 ' CZ ' HD23 ' A' ' 248' ' ' LEU . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.574 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.574 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 9.9 m-70 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.562 ' CE2' ' CE1' ' A' ' 283' ' ' HIS . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.454 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.499 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.443 ' HG2' ' CG2' ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.506 ' CZ ' HD23 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.47 ' HB2' ' CD1' ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.535 HD23 ' CE2' ' A' ' 264' ' ' PHE . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.443 ' CG2' ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 263' ' ' GLU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 262' ' ' VAL . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.535 ' CE2' HD23 ' A' ' 248' ' ' LEU . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.483 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' CZ ' ' A' ' 245' ' ' PHE . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.464 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.499 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.89 0.376 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.546 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.42 ' CD2' HG12 ' A' ' 261' ' ' ILE . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 287' ' ' LEU . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 234' ' ' LEU . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.419 ' N ' HG21 ' A' ' 233' ' ' THR . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.569 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.494 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 264' ' ' PHE . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.401 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 229' ' ' LEU . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.546 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.955 0.407 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.594 ' CG1' ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.494 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 260' ' ' ALA . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.554 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 264' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 229' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.417 ' CG1' HD23 ' A' ' 248' ' ' LEU . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 248' ' ' LEU . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.563 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 276' ' ' HIS . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.563 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.554 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.671 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . 0.497 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 22.6 m-70 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.494 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.594 ' CB ' ' CG1' ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.939 0.399 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 225' ' ' LEU . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.476 ' CD2' HG12 ' A' ' 261' ' ' ILE . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.472 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 248' ' ' LEU . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.453 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 263' ' ' GLU . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 262' ' ' VAL . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.525 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.469 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.479 ' CD2' HD21 ' A' ' 229' ' ' LEU . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.908 0.385 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.457 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . 0.462 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.451 ' N ' HD13 ' A' ' 248' ' ' LEU . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.549 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 243' ' ' SER . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 235' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.426 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 268' ' ' LEU . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.549 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.599 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.44 ' CB ' ' CG1' ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.1 t -105.62 -43.9 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 3.2 m -63.25 -38.32 90.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.06 -40.55 3.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 t -41.14 -46.84 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 43.2 p -75.96 -57.0 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.4 -48.18 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 293' ' ' PRO . 28.1 mtp85 -144.04 165.1 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m -65.17 141.61 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.48 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.49 HD21 ' CE1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.431 ' N ' ' CD1' ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.49 ' CE1' HD21 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.421 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.583 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.48 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.403 ' HA ' ' CD1' ' A' ' 225' ' ' LEU . . . -84.69 142.72 39.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.401 ' HB3' ' NH2' ' A' ' 219' ' ' ARG . 53.6 Cg_endo -69.77 154.79 67.28 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.679 2.253 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 15.5 pt -62.56 -23.94 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -89.63 -10.97 64.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 297' ' ' PHE . 12.7 p -39.18 -48.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.442 ' N ' ' CG1' ' A' ' 296' ' ' VAL . 15.8 m-85 -91.56 -38.38 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 98.14 -163.73 21.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 149.46 46.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -110.47 157.65 37.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.81 64.95 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -107.87 -175.09 2.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -62.67 -48.57 78.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.69 -42.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.16 -49.4 2.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.2 t -47.97 -45.86 31.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -44.64 -44.14 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -37.65 -46.98 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -44.12 151.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -111.71 153.07 44.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 179.79 3.43 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.323 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.47 -27.41 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.76 -42.28 75.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -44.15 -23.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.75 71.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.107 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.41 -47.48 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 15.3 t -38.55 120.61 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.06 174.42 31.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -178.86 2.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.01 -45.44 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.9 p -149.67 176.07 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.521 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.1 t -101.7 -60.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.0 m -70.19 -46.31 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.25 -41.66 3.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 m -54.59 -48.74 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.7 p -72.83 -47.64 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.98 128.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -135.92 122.63 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m -51.0 150.98 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.459 ' CG ' HG21 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.472 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 273' ' ' ALA . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 227' ' ' LYS . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.418 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 245' ' ' PHE . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 280' ' ' SER . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.485 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -100.29 142.76 25.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 178.8 4.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 0.0 112.353 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.412 ' H ' ' CD1' ' A' ' 294' ' ' ILE . 0.2 OUTLIER -85.51 -14.33 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.94 -36.94 45.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 297' ' ' PHE . 12.5 p -39.14 -50.08 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.434 ' N ' ' CG1' ' A' ' 296' ' ' VAL . 31.0 m-85 -96.06 -62.72 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.32 161.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.3 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -50.64 138.17 23.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.572 0.701 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -175.59 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -109.68 45.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -57.86 -41.54 82.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -40.25 -37.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.23 -46.42 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 35.1 t -47.54 -38.46 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 1.1 tm0? -40.7 -40.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 309' ' ' GLU . 6.8 t-80 -37.32 -44.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 308' ' ' HIS . 41.9 tt0 -34.69 119.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -101.99 142.87 25.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.55 34.13 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.282 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.03 -39.99 9.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -40.51 -49.37 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.51 -42.16 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.16 2.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -47.16 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t 55.58 42.2 29.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -40.74 148.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -174.71 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.6 t -103.0 -56.85 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.3 m -133.61 175.76 9.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.4 p -98.73 -30.12 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.5 m -95.79 -66.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.79 4.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 75.5 p -52.53 -48.05 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.81 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.7 t -54.11 -55.25 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.5 82.48 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.35 144.92 51.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m -63.78 147.76 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.443 ' CG1' ' HB1' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.487 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.451 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.469 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 237' ' ' GLU . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.432 ' N ' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.534 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 243' ' ' SER . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.469 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.534 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 283' ' ' HIS . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.469 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.487 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.443 ' HB1' ' CG1' ' A' ' 223' ' ' VAL . . . -100.76 142.35 24.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -174.87 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 25.2 pt -91.41 -14.62 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.47 -22.67 28.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 4.0 p -40.61 -36.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 111.17 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.93 -49.09 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 49.66 -167.89 0.27 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.49 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -151.63 178.63 9.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -158.28 147.28 14.57 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -172.43 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.304 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -115.22 74.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 -19.52 18.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -62.1 -29.19 70.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -49.04 -33.7 11.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 34.5 m -89.18 -65.79 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -38.89 -31.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -42.28 -67.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -146.01 163.05 36.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -150.56 157.6 36.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.557 0.694 . . . . 0.0 110.954 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.74 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -26.37 14.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -51.07 -38.64 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 3.2 ptmm? -57.26 -39.84 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.71 -44.41 96.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 10.7 mt-10 -47.1 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 63.1 p 34.49 43.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -46.61 139.56 7.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.03 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 46.2 m -99.66 -57.11 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 m -91.91 177.74 6.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 97.3 p -107.2 -49.55 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 94.7 p -88.06 -43.99 11.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.22 -56.15 25.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -42.24 -46.59 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.838 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.1 t -47.96 -57.42 5.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.93 117.41 4.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.437 ' NH2' ' O ' ' A' ' 291' ' ' TRP . 35.7 mtp180 -143.77 169.95 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t -64.88 156.18 31.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.558 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.418 ' N ' HG21 ' A' ' 224' ' ' ILE . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.44 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.428 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.427 HD23 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.427 ' CG1' HD23 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.498 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.421 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.433 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 280' ' ' SER . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.466 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.558 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -113.03 143.42 29.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 158.11 58.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.646 2.23 . . . . 0.0 112.343 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.409 HD11 ' C ' ' A' ' 294' ' ' ILE . 2.8 pp -66.89 -18.02 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.78 -21.76 70.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.4 p -43.29 -45.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.498 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 8.4 m-85 -92.21 -37.63 12.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.96 175.76 47.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.517 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.35 176.84 9.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.331 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -127.12 144.57 50.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.567 0.699 . . . . 0.0 111.08 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 124.37 11.03 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -73.61 136.43 43.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -79.8 -43.21 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -48.37 -41.03 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -44.63 -37.68 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 m -69.32 -41.84 76.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -48.85 -50.03 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 309' ' ' GLU . 14.8 t60 -43.93 -32.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 21.8 tp10 -36.03 127.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.49 122.35 43.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 145.42 57.11 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.658 2.239 . . . . 0.0 112.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.9 -19.85 19.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -48.21 -40.87 25.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -51.4 -46.17 62.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.45 -46.82 73.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.66 -43.23 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.1 t -44.04 103.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -151.98 -164.09 12.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 152.88 69.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.627 2.218 . . . . 0.0 112.342 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 321' ' ' SER . 3.4 m -103.08 -56.73 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 320' ' ' SER . 32.2 t -34.91 147.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -107.52 -50.71 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.2 m -44.8 -46.9 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.65 -70.81 0.86 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 74.4 p -42.87 -53.3 4.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -49.28 -39.47 30.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.815 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -63.78 -112.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -99.9 171.72 7.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t -85.62 149.48 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.451 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.433 ' HG ' ' CB ' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.409 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.469 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.412 ' C ' HD22 ' A' ' 253' ' ' LEU . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.421 ' N ' HD22 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 238' ' ' ILE . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 238' ' ' ILE . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.472 ' CD2' ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 235' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.472 ' CG1' ' CD2' ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.596 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.422 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.422 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.478 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.662 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 17.2 m-70 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.469 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.451 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' A' ' 225' ' ' LEU . . . -90.63 140.52 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 146.41 60.53 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.86 -15.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -73.42 -26.86 69.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 297' ' ' PHE . 7.0 p -49.33 -44.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.596 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 6.4 m-85 -96.41 -45.09 6.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.69 24.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.56 156.36 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.34 . . . . 0.0 111.137 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -48.6 143.86 7.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.574 0.702 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -169.19 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -123.82 43.92 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.98 -54.03 4.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -46.63 -31.56 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.65 -39.75 51.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.7 m -45.98 -33.24 3.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -83.21 -47.58 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -39.92 -32.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 310' ' ' GLN . 18.8 mm-40 -38.63 123.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 309' ' ' GLU . 8.5 pt20 -33.96 96.96 0.11 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.429 ' N ' ' O ' ' A' ' 309' ' ' GLU . 54.0 Cg_endo -69.71 165.42 30.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.59 -45.35 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -53.07 -50.54 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -41.13 -52.81 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.2 -43.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 317' ' ' SER . 19.6 tt0 -51.68 -46.81 63.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 316' ' ' GLU . 28.3 t -34.88 124.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.24 178.97 36.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 164.06 35.97 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.66 2.24 . . . . 0.0 112.329 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 53.2 p -101.66 -44.21 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.0 m 49.48 46.19 23.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 217' ' ' SER . 23.3 m -65.4 -46.54 79.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.7 p -81.02 -48.47 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -55.55 -64.65 4.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.5 m -55.48 -52.73 62.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 213' ' ' SER . 28.9 t -47.82 -56.94 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -42.4 -64.74 1.48 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -53.78 156.6 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m -44.57 154.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.471 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 235' ' ' ALA . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.53 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.411 ' CA ' HD23 ' A' ' 265' ' ' LEU . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.474 ' CD2' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.411 HD23 ' CA ' ' A' ' 249' ' ' GLY . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.425 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.434 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.733 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.471 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -96.91 143.52 26.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 12.0 pt -91.17 -16.5 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -84.25 -16.99 65.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.0 -53.98 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 263' ' ' GLU . 12.9 m-85 -93.88 -40.66 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.88 132.98 0.91 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -174.59 149.54 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.063 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -131.79 143.87 50.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 175.54 7.99 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.93 67.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -87.5 -43.04 12.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -40.38 -41.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -40.55 -42.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 23.6 t -50.17 -49.18 53.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -45.69 -38.74 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 309' ' ' GLU . 59.1 t-80 -39.16 -39.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.814 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 308' ' ' HIS . 16.2 tt0 -35.09 100.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -96.72 135.92 21.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.587 0.708 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.9 32.81 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.73 -19.37 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -59.53 -39.74 84.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 6.9 ptmt -47.93 -33.58 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.447 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.65 -38.53 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 317' ' ' SER . 6.3 tp10 -49.04 -45.82 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' GLU . 83.2 p -38.0 132.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -174.31 106.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -179.19 2.75 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.7 m -100.97 -58.49 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.6 m 57.42 41.79 25.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.5 p -97.66 -57.11 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 215' ' ' GLY . 2.5 m -59.52 -55.13 38.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.23 -45.43 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.0 t -44.03 -62.26 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.809 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.7 p -51.08 -48.27 61.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.38 73.72 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -68.87 144.94 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m -45.25 156.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.461 HG11 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.483 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.455 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 260' ' ' ALA . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.488 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 235' ' ' ALA . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.572 HD22 ' CD2' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 263' ' ' GLU . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.588 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.572 ' CD2' HD22 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.556 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.556 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.7 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.464 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.483 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -97.77 142.75 25.05 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -176.74 1.57 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.4 pt -91.23 -14.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.7 -18.45 44.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 5.6 p -48.62 -43.18 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 111.114 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.588 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 10.6 m-85 -94.46 -54.78 3.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.93 -174.65 19.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -158.15 168.82 26.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -151.71 138.3 11.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.551 0.691 . . . . 0.0 111.087 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.61 37.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -123.19 82.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.72 -27.37 14.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -57.94 -42.3 84.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -42.36 -44.85 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.0 t -67.61 -46.19 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 308' ' ' HIS . 14.5 mm100 -39.58 -43.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.3 t-160 -36.94 -42.93 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -39.21 158.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.13 151.23 68.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 112.65 3.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.744 2.296 . . . . 0.0 112.333 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -97.89 -39.53 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 312' ' ' ALA . 14.1 pt-20 -37.86 -43.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -39.43 -56.45 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.66 52.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.5 tt0 -45.27 -47.72 12.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 316' ' ' GLU . 10.5 t -35.56 129.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.35 144.97 9.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 321' ' ' SER . 26.5 p -103.21 -57.94 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 320' ' ' SER . 1.7 t -35.11 146.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.447 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.3 p -87.3 -47.18 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 110.888 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 215' ' ' GLY . 61.7 m -79.39 -42.29 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.63 -55.24 1.05 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 88.1 p -42.2 -47.98 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -81.83 -59.63 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 45.16 50.78 9.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -153.65 135.22 14.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.842 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m -66.88 143.33 56.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.513 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.448 ' CD2' HG12 ' A' ' 261' ' ' ILE . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.438 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.419 ' HB2' ' CD1' ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 245' ' ' PHE . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.441 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.691 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.438 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.513 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -99.33 151.8 37.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -179.52 2.97 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.367 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.37 -14.78 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.63 -28.34 22.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.527 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.6 p -40.02 -39.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.66 -62.15 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -56.67 -176.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.7 147.4 11.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -38.73 143.68 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 111.085 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 127.34 14.45 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.242 . . . . 0.0 112.353 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.27 41.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.82 -60.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -42.42 -38.41 1.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -52.15 -43.48 64.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 36.0 m -45.58 -28.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -95.72 -33.8 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 310' ' ' GLN . 7.2 m170 -39.61 -51.89 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 3.5 pt-20 -34.49 94.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 308' ' ' HIS . 4.5 tt0 -130.53 124.77 21.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.948 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 106.05 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -87.35 -26.43 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -44.12 -41.23 5.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -67.63 -49.01 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.7 -41.92 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.37 -53.98 9.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.4 t -38.06 122.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.96 91.81 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 133.09 24.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.694 2.263 . . . . 0.0 112.346 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 31.9 m -100.59 -48.36 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 40.8 t -44.25 106.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.503 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -47.6 82.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 215' ' ' GLY . 14.7 m -72.67 -52.9 13.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -37.71 -48.65 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 t -47.41 -62.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.7 m -64.51 -59.71 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.18 110.77 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 51.3 mmt-85 -78.47 128.01 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m -42.26 162.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.844 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.536 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG23 ' A' ' 224' ' ' ILE . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 287' ' ' LEU . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.428 ' N ' HG23 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD21 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 238' ' ' ILE . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.419 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 264' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 235' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 256' ' ' GLY . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 255' ' ' GLU . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.569 ' CD2' HD21 ' A' ' 248' ' ' LEU . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.42 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.42 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.408 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.408 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.419 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.473 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.458 ' CD2' HD21 ' A' ' 229' ' ' LEU . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.536 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -105.83 144.82 29.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -172.48 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 2.6 pp -91.63 -22.79 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.56 92.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -39.77 -55.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.59 -29.28 14.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -69.21 -0.52 22.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -84.19 114.46 21.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -163.62 149.41 9.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 173.88 10.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -126.95 96.71 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.83 -40.84 7.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -41.11 -35.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.38 -58.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 56.5 p -64.72 -36.88 85.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.455 ' HA ' ' NE2' ' A' ' 307' ' ' GLN . 5.6 tp60 -55.62 -27.89 52.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.1 m170 -36.83 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -163.4 -179.34 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -131.57 151.52 78.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.604 0.716 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 105.02 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.03 -20.66 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -49.0 -38.6 23.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 13.7 ptmt -43.33 -31.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.31 -44.97 95.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.082 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' SER . 21.9 tt0 -45.29 -46.74 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 316' ' ' GLU . 14.8 m -34.97 122.98 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.49 145.52 9.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.03 39.41 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 32.4 m -101.74 -57.81 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.5 t -165.61 176.74 7.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.7 t -69.82 -44.07 70.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.0 m -58.65 -43.21 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -40.93 -47.21 4.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 m -60.16 -49.91 75.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 44.2 t -54.33 -44.85 72.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.02 127.53 5.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -169.51 152.58 4.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t -50.67 150.76 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.483 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.46 ' CE ' HG21 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 260' ' ' ALA . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.57 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.568 ' CD2' ' CE1' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.46 HG21 ' CE ' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.457 ' CG1' HD23 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.568 ' CE1' ' CD2' ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.406 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.479 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.483 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -100.97 143.47 26.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 13.3 pt -91.71 -26.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -76.98 -27.15 60.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 297' ' ' PHE . 11.7 p -39.44 -46.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.412 ' N ' HG12 ' A' ' 296' ' ' VAL . 12.6 m-85 -96.1 -58.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 46.36 -173.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.0 172.38 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -142.73 128.48 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.05 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.708 2.272 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.68 43.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -91.32 -56.55 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -46.88 -35.07 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.68 -40.73 2.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.9 t -39.33 -40.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 309' ' ' GLU . 3.8 tp-100 -71.71 -45.6 61.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 30.1 t60 -37.09 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 307' ' ' GLN . 7.0 tp10 -35.03 105.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -99.72 131.95 23.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.55 40.59 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -94.94 -30.28 14.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -39.73 -42.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.54 -46.64 70.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -49.32 -40.64 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.448 ' C ' ' OE1' ' A' ' 316' ' ' GLU . 9.9 tm-20 -45.38 -43.0 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 89.7 p -40.33 103.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.7 166.24 36.64 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 162.05 43.57 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 24.3 m -103.18 -58.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.819 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.1 t -167.83 177.99 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -59.43 -57.44 12.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.5 m -45.95 -41.65 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -48.18 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 20.9 t -54.25 -55.38 28.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.5 t -43.42 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -89.79 81.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -74.11 176.5 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t -93.88 141.22 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.501 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 224' ' ' ILE . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 2.0 t30 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.49 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.418 ' N ' HD12 ' A' ' 248' ' ' LEU . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 248' ' ' LEU . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.403 ' N ' HG11 ' A' ' 262' ' ' VAL . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.47 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.53 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.53 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 32.3 m-70 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -93.64 140.7 23.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -172.11 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.97 -14.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.31 -31.86 50.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.8 m -41.13 -53.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.132 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -93.54 -36.56 12.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.95 0.01 40.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.07 162.2 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -159.75 148.85 14.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.575 0.702 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.55 54.69 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.72 2.28 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -133.63 85.98 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -98.22 -37.97 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -42.13 -42.9 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -40.12 -52.15 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 37.4 t -55.21 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.07 -44.37 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -40.37 -65.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -69.23 117.67 11.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -142.7 143.8 27.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.7 2.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.369 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.22 -35.63 13.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 312' ' ' ALA . 15.9 tt0 -38.26 -47.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -41.35 -45.26 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -38.64 -60.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.2 -50.47 72.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t 71.69 41.45 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 60.08 146.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 162.23 42.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 22.3 m -61.86 -56.05 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 80.2 p -174.05 171.25 3.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.456 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.3 m -51.61 -57.59 8.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.3 m -55.14 -43.54 74.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -59.93 -52.36 53.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 33.1 m -42.22 -53.25 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.8 t -48.09 -40.86 24.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 62.09 91.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -136.58 162.56 32.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m -86.89 153.94 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.798 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.412 HG12 ' CB ' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 274' ' ' PHE . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.403 ' CG ' HG23 ' A' ' 259' ' ' THR . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.457 ' CD1' ' HB1' ' A' ' 260' ' ' ALA . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.403 HG23 ' CG ' ' A' ' 227' ' ' LYS . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 229' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.418 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.554 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.554 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.712 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.473 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.478 ' CD2' ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.412 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -90.93 145.8 32.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -174.76 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.27 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 21.8 pt -90.58 -16.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.59 -35.33 51.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 297' ' ' PHE . 2.7 m -39.9 -61.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.412 ' H ' ' CG2' ' A' ' 296' ' ' VAL . 26.8 m-85 -96.75 -30.36 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -67.85 -0.82 15.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -81.32 112.37 18.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.344 . . . . 0.0 111.053 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -174.95 143.89 0.8 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.563 0.697 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 85.96 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.381 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -124.66 95.41 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -96.86 -39.66 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -42.93 -46.67 5.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.33 -39.34 4.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.4 t -51.45 -37.69 50.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.3 mm-40 -72.13 -49.95 31.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 307' ' ' GLN . 14.3 m170 -36.97 -38.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -40.03 110.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -98.2 135.47 21.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 115.62 4.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -36.29 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -39.12 -42.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.94 -55.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.67 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.6 tt0 -46.7 -46.67 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.66 110.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.9 -173.94 33.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 135.96 31.93 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 59.5 p -101.41 -58.23 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.2 t -80.6 165.89 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.6 m -49.2 -47.48 46.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.1 m -56.76 -49.88 73.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.71 -40.13 6.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.8 t -62.33 -49.67 74.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.814 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.2 m -45.11 -51.73 9.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.75 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -156.07 155.86 33.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t -66.37 141.74 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.464 ' CG1' ' HB1' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.534 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' A' ' 287' ' ' LEU . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.458 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.442 ' CG2' HG12 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.407 ' N ' HG21 ' A' ' 233' ' ' THR . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.417 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.403 ' N ' HD11 ' A' ' 248' ' ' LEU . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.464 HD23 ' CG1' ' A' ' 262' ' ' VAL . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 235' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.413 ' N ' HG12 ' A' ' 258' ' ' ILE . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 229' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.464 ' CG1' HD23 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.434 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.431 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.471 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.606 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 18.5 m-70 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.458 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.471 ' CD2' HD23 ' A' ' 229' ' ' LEU . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.534 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.464 ' HB1' ' CG1' ' A' ' 223' ' ' VAL . . . -85.08 140.34 36.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -176.32 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.28 . . . . 0.0 112.344 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 21.0 pt -86.39 -27.13 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.9 -25.34 67.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 12.0 p -40.95 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 111.1 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.434 ' CZ ' ' OE1' ' A' ' 263' ' ' GLU . 9.9 m-85 -96.85 -49.76 4.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 58.96 -176.8 2.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -141.36 153.7 45.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.02 154.62 1.74 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . 0.445 ' OE1' ' CG ' ' A' ' 305' ' ' ASP . 1.0 OUTLIER -122.85 86.65 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -88.77 -34.43 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.07 -38.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.445 ' CG ' ' OE1' ' A' ' 302' ' ' GLN . 7.8 m-20 -39.34 -47.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.3 t -48.77 -45.09 39.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -39.43 -38.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' A' ' 309' ' ' GLU . 29.6 m170 -36.83 -41.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 18.4 pt-20 -34.54 139.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -123.91 149.77 60.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.49 40.54 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.3 -42.48 7.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 314' ' ' LYS . 10.1 pt-20 -42.3 -40.42 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 313' ' ' GLU . 0.1 OUTLIER -42.34 -45.63 4.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.49 -41.52 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 317' ' ' SER . 25.0 mm-40 -47.22 -45.48 23.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.53 123.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.49 20.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 162.82 40.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.718 2.279 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 26.1 p -102.78 -41.73 6.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.6 m -55.29 157.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 89.1 p -77.23 -50.28 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 -45.88 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -48.3 7.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 27.7 m -49.8 -54.97 15.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.2 m -58.76 -47.7 83.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 60.62 56.97 21.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -95.08 146.96 23.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t -52.6 149.26 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 292' ' ' ALA . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.563 HG21 ' CE2' ' A' ' 274' ' ' PHE . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.459 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.542 ' CD2' ' CD2' ' A' ' 287' ' ' LEU . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.439 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HD13 ' A' ' 248' ' ' LEU . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 243' ' ' SER . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 235' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 259' ' ' THR . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.439 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.445 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.563 ' CE2' HG21 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.746 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . 0.459 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.542 ' CD2' ' CD2' ' A' ' 229' ' ' LEU . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 274' ' ' PHE . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.522 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -104.22 137.23 19.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.469 ' HD2' ' CG1' ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.78 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 8.9 pt -92.01 -22.72 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.75 70.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.469 ' CG1' ' HD2' ' A' ' 293' ' ' PRO . 35.0 m -39.01 -52.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.466 ' N ' HG22 ' A' ' 296' ' ' VAL . 18.5 m-85 -97.0 -42.75 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 91.37 150.25 24.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.2 23.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -164.65 135.29 3.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.555 0.693 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 118.64 5.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -106.34 40.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -99.19 -54.43 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 6.2 ptmt -54.69 -31.89 58.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 9.9 t70 -45.06 -48.53 11.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.4 t -76.73 -51.31 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 308' ' ' HIS . 47.1 tt0 -39.73 -33.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.3 p-80 -36.8 -35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 308' ' ' HIS . 4.1 pt-20 -34.45 102.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . 0.457 ' NE2' ' HE3' ' A' ' 314' ' ' LYS . 34.3 tt0 -108.88 135.17 20.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.47 69.15 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.728 2.285 . . . . 0.0 112.289 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.76 -30.83 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -45.86 -29.92 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.457 ' HE3' ' NE2' ' A' ' 310' ' ' GLN . 0.1 OUTLIER -49.25 -36.96 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.87 -40.12 13.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 317' ' ' SER . 48.3 mt-10 -46.09 -52.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 316' ' ' GLU . 24.8 p -38.14 123.15 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 165.94 145.28 4.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.31 8.28 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.6 p -101.42 -44.59 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 m -174.79 175.25 2.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.0 p -82.27 -56.82 3.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.0 p -47.22 -29.38 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.44 -63.2 4.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.6 p -69.86 -55.06 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.827 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.3 m -44.5 -61.18 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.01 121.8 3.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -136.97 127.71 27.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m -44.62 158.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' CG ' HG23 ' A' ' 259' ' ' THR . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 260' ' ' ALA . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.51 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.565 HD23 ' CZ ' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.467 HG23 ' CG ' ' A' ' 227' ' ' LYS . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 229' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 248' ' ' LEU . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.565 ' CZ ' HD23 ' A' ' 248' ' ' LEU . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.574 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.574 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 9.9 m-70 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.562 ' CE2' ' CE1' ' A' ' 283' ' ' HIS . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.454 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.469 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -90.6 148.06 37.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.4 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 53.1 Cg_endo -69.83 -174.15 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.298 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 2.6 pp -90.92 -22.77 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -83.45 -29.59 32.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 293' ' ' PRO . 1.5 p -39.45 -49.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -95.98 -62.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -50.11 153.29 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.48 -179.93 5.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -73.49 127.9 88.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.561 0.696 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.84 6.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.309 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -124.95 34.57 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -38.44 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -53.56 -39.28 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.96 -56.15 2.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 t -42.34 -42.25 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 308' ' ' HIS . 8.7 tm0? -50.91 -39.73 55.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.5 p-80 -36.9 -35.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 308' ' ' HIS . 9.3 mt-10 -34.47 102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -103.05 133.19 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.26 38.95 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -96.52 -32.19 12.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -41.0 -45.0 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -45.05 -45.68 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.8 -41.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 317' ' ' SER . 7.3 tp10 -46.1 -44.28 15.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 316' ' ' GLU . 79.9 p -34.52 121.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -93.1 151.15 20.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -173.0 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.8 m -95.34 -57.46 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.1 p -140.69 177.86 7.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.1 m -102.71 -47.01 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 83.3 p -52.76 -44.12 66.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.1 -46.79 49.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.0 t -54.98 -59.46 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 79.3 p -53.95 -45.24 71.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 294' ' ' ILE . . . -52.61 -74.31 0.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -57.13 156.55 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t -45.82 151.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.499 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.443 ' HG2' ' CG2' ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.506 ' CZ ' HD23 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.47 ' HB2' ' CD1' ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.535 HD23 ' CE2' ' A' ' 264' ' ' PHE . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.443 ' CG2' ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 263' ' ' GLU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 262' ' ' VAL . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.535 ' CE2' HD23 ' A' ' 248' ' ' LEU . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.47 ' CD1' ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.483 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' CZ ' ' A' ' 245' ' ' PHE . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.464 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.499 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -98.48 142.73 25.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -175.45 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.67 2.246 . . . . 0.0 112.348 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 218' ' ' GLY . 29.2 pt -89.62 -24.03 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -80.86 -21.4 63.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 297' ' ' PHE . 11.2 p -42.76 -48.79 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.407 ' N ' ' CG1' ' A' ' 296' ' ' VAL . 17.4 m-85 -94.37 -40.82 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.37 124.72 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.01 138.87 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -173.78 140.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -172.41 108.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -37.56 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 306' ' ' SER . 12.1 mptt -46.16 -37.98 7.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.498 ' O ' ' NE2' ' A' ' 307' ' ' GLN . 5.6 m-20 -39.21 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 304' ' ' LYS . 38.6 t -47.25 -42.68 20.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 308' ' ' HIS . 1.4 pm0 -39.48 -30.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.601 ' N ' ' NE2' ' A' ' 307' ' ' GLN . 64.0 t-80 -39.42 -38.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 54.1 tt0 -36.31 103.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -73.62 130.97 82.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 172.63 12.33 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.84 -33.4 14.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -43.07 -41.02 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -41.83 -41.03 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.24 -40.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 317' ' ' SER . 56.8 mm-40 -46.37 -46.27 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 316' ' ' GLU . 11.1 t -37.55 122.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.83 16.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -173.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.701 2.267 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 11.0 t -100.28 -57.95 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 m -174.12 177.39 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.1 t -77.37 -43.64 32.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 56.2 p -52.4 -47.67 66.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.88 -43.71 64.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 m -47.98 -54.76 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 56.9 m -71.99 -45.64 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.848 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.85 130.95 7.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -141.02 138.75 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t -50.74 153.98 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.546 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.42 ' CD2' HG12 ' A' ' 261' ' ' ILE . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 287' ' ' LEU . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 234' ' ' LEU . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.419 ' N ' HG21 ' A' ' 233' ' ' THR . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.569 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.494 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 264' ' ' PHE . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.401 ' O ' ' CB ' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 229' ' ' LEU . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.546 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 220' ' ' SER . . . -98.91 130.06 28.4 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 141.67 45.94 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 36.7 pt -48.5 -19.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.119 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.43 56.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.473 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 297' ' ' PHE . 7.7 p -39.03 -34.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.464 ' N ' HG12 ' A' ' 296' ' ' VAL . 11.9 m-85 -96.88 -40.76 8.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 63.2 135.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.74 157.23 19.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -172.65 134.83 0.75 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.89 61.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -93.07 81.36 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -82.63 -42.18 18.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -40.22 -41.53 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.421 ' OD1' ' C ' ' A' ' 305' ' ' ASP . 1.6 t0 -39.39 -58.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 92.8 p -41.95 -42.81 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 308' ' ' HIS . 38.1 tp60 -38.35 -40.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 309' ' ' GLU . 22.4 p-80 -36.8 -44.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 308' ' ' HIS . 2.2 pp20? -45.27 142.07 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.89 141.18 14.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.638 0.732 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.82 4.27 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.93 -36.42 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -46.54 -40.64 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -42.37 -32.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -45.68 -41.08 9.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 317' ' ' SER . 17.3 pt-20 -45.16 -35.62 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.444 ' N ' ' HG3' ' A' ' 316' ' ' GLU . 13.7 m -42.47 120.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 167.83 82.6 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 147.99 64.26 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.74 2.294 . . . . 0.0 112.328 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.1 p -99.15 -58.52 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 7.0 t -144.79 174.82 10.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.5 p -77.29 -44.21 30.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -88.52 -49.83 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -42.94 6.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 40.2 t -45.47 -48.96 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.1 m -62.1 -55.09 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.26 4.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -75.25 172.12 12.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t -51.57 153.51 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.594 ' CG1' ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.494 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 260' ' ' ALA . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.554 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 264' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 229' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.417 ' CG1' HD23 ' A' ' 248' ' ' LEU . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.466 ' CE2' HD21 ' A' ' 248' ' ' LEU . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.563 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 276' ' ' HIS . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.563 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.554 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 277' ' ' LEU . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.671 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . 0.497 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 22.6 m-70 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.494 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.594 ' CB ' ' CG1' ' A' ' 223' ' ' VAL . . . -95.81 140.98 22.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 177.52 5.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.69 2.26 . . . . 0.0 112.346 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.0 pt -85.35 -20.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.35 -12.0 65.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 p -46.76 -52.26 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 111.124 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 298' ' ' GLY . 6.2 m-85 -96.21 -58.6 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.5 154.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.49 177.83 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 129.23 87.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.56 0.695 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 148.22 64.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.49 43.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -96.01 -42.4 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 19.9 pttt -40.9 -42.25 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 t70 -39.04 -53.18 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.9 t -50.73 -62.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.4 mm100 -51.99 -43.21 63.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 309' ' ' GLU . 2.3 t60 -36.99 -40.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 308' ' ' HIS . 6.9 tm-20 -34.55 107.24 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -107.41 151.72 41.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -177.88 2.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.66 -40.34 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 312' ' ' ALA . 31.6 mt-10 -38.34 -45.69 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -53.08 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -42.64 -45.38 4.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 14.8 tt0 -45.55 -47.13 14.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 48.0 t -34.93 114.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -133.8 174.54 20.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 178.69 4.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 18.2 t -97.34 -58.13 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 5.0 m -146.02 172.63 13.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 99.9 p -90.55 -43.85 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 91.9 p -51.19 -43.61 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.26 -51.21 28.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.5 p -55.55 -48.68 74.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.0 m -72.93 -60.4 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.59 58.07 3.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -55.13 164.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t -65.82 157.16 31.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 225' ' ' LEU . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.476 ' CD2' HG12 ' A' ' 261' ' ' ILE . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.472 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 248' ' ' LEU . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.453 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 263' ' ' GLU . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 262' ' ' VAL . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.525 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.469 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.479 ' CD2' HD21 ' A' ' 229' ' ' LEU . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 220' ' ' SER . . . -86.59 130.74 47.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 139.92 41.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 17.7 pt -48.31 -26.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.76 -37.04 92.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 297' ' ' PHE . 11.5 p -39.38 -48.24 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.104 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.445 ' N ' ' CG1' ' A' ' 296' ' ' VAL . 10.3 m-85 -94.84 -50.67 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -41.78 141.41 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -126.15 167.68 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -41.13 131.44 2.0 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.582 0.706 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 88.39 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -98.8 42.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -99.43 -39.44 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -52.82 -43.74 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.11 -54.61 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.7 t -45.12 -46.22 11.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 18.2 tm0? -41.33 -41.38 1.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 309' ' ' GLU . 7.3 p-80 -36.96 -39.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 308' ' ' HIS . 26.5 tt0 -34.45 100.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.63 150.3 19.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.573 0.702 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.99 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.621 2.214 . . . . 0.0 112.352 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -80.96 -39.27 26.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -44.8 -46.12 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -38.03 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.7 -39.07 1.0 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.23 -45.27 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.1 t -39.53 123.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.95 94.37 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.39 68.8 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.295 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 t -102.22 -57.51 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 t -171.15 147.84 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.9 p -87.23 -44.19 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.4 t -45.57 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.29 -53.05 36.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 13.5 t -44.55 -54.48 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.1 m -60.29 -55.78 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 84.85 -39.88 2.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 164.62 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t -52.82 160.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.44 ' CG1' ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.457 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.462 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.451 ' N ' HD13 ' A' ' 248' ' ' LEU . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.549 ' CZ ' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 243' ' ' SER . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 235' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.426 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.426 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 268' ' ' LEU . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.549 HD21 ' CZ ' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.599 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.44 ' CB ' ' CG1' ' A' ' 223' ' ' VAL . . . -86.62 142.21 34.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -176.24 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.648 2.232 . . . . 0.0 112.314 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 2.5 pp -90.39 -18.05 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -85.82 -24.8 40.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.522 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 297' ' ' PHE . 13.7 p -38.91 -42.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 296' ' ' VAL . 11.9 m-85 -96.96 -48.04 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.22 -176.53 54.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -136.35 167.42 21.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -111.67 141.37 24.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.601 0.715 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -172.6 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.326 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -126.48 42.19 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -50.58 -41.56 54.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -40.22 -43.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.3 -43.49 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 67.8 m -44.03 -40.53 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.9 mm-40 -39.03 -42.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 307' ' ' GLN . 1.5 t-80 -36.86 -43.27 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 310' ' ' GLN . 14.4 tp10 -39.63 150.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' A' ' 309' ' ' GLU . 43.1 mt-30 -107.2 156.2 37.99 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.19 22.87 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.243 . . . . 0.0 112.388 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.72 -43.84 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.076 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -38.75 -43.7 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -39.77 -46.85 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.6 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 44.2 tp10 -45.88 -41.66 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 3.8 t -34.57 -63.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 317' ' ' SER . . . 35.22 87.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 140.93 43.96 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 91.0 p -102.95 -55.49 2.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 77.8 p -72.96 161.38 30.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.958 0.409 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.489 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 248' ' ' LEU . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.434 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.55 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.75 ' HB2' HD21 ' A' ' 287' ' ' LEU . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 277' ' ' LEU . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 259' ' ' THR . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 258' ' ' ILE . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.482 HG21 HD11 ' A' ' 238' ' ' ILE . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 233' ' ' THR . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.489 ' O ' HD12 ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.543 ' CE1' HD21 ' A' ' 277' ' ' LEU . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.4 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 226' ' ' ALA . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.603 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.603 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.403 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.543 HD21 ' CE1' ' A' ' 245' ' ' PHE . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.887 ' HB2' HD21 ' A' ' 287' ' ' LEU . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.92 0.391 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.508 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 234' ' ' LEU . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.452 ' N ' HG22 ' A' ' 233' ' ' THR . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.529 ' HB2' HG11 ' A' ' 251' ' ' VAL . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.402 ' HB2' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.722 ' HB2' HD12 ' A' ' 265' ' ' LEU . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.436 HD22 ' CG1' ' A' ' 262' ' ' VAL . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 239' ' ' GLN . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 227' ' ' LYS . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.47 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 248' ' ' LEU . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 247' ' ' SER . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.582 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 277' ' ' LEU . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.508 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.571 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 259' ' ' THR . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 233' ' ' THR . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.403 HG23 ' CE1' ' A' ' 242' ' ' PHE . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 251' ' ' VAL . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 238' ' ' ILE . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.407 HD22 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 239' ' ' GLN . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 227' ' ' LYS . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.538 ' HG2' HD12 ' A' ' 268' ' ' LEU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 267' ' ' PRO . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.767 ' HB2' HD21 ' A' ' 287' ' ' LEU . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.436 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 277' ' ' LEU . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.571 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.607 HG12 ' HB3' ' A' ' 292' ' ' ALA . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.468 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.902 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 258' ' ' ILE . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 238' ' ' ILE . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.691 ' HG3' HG21 ' A' ' 251' ' ' VAL . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' A' ' 277' ' ' LEU . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.677 HD22 ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 239' ' ' GLN . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 259' ' ' THR . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.576 ' N ' HD12 ' A' ' 258' ' ' ILE . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 261' ' ' ILE . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.677 ' CG1' HD22 ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.492 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.443 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.757 ' HB2' HD11 ' A' ' 287' ' ' LEU . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.468 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.902 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.581 HG12 ' CB ' ' A' ' 292' ' ' ALA . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.485 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 259' ' ' THR . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.501 ' N ' HG22 ' A' ' 233' ' ' THR . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.687 ' HG3' HG21 ' A' ' 251' ' ' VAL . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.794 ' CE1' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 239' ' ' GLN . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 227' ' ' LYS . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.435 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.619 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.794 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.881 ' HB2' HD21 ' A' ' 287' ' ' LEU . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.881 HD21 ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 277' ' ' LEU . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.485 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.581 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.551 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.495 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 258' ' ' ILE . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 233' ' ' THR . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 242' ' ' PHE . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.698 ' HG3' HG21 ' A' ' 251' ' ' VAL . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 248' ' ' LEU . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.693 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.698 HG21 ' HG3' ' A' ' 239' ' ' GLN . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 267' ' ' PRO . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 287' ' ' LEU . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' HIS . . . . . 0.618 ' ND1' HG13 ' A' ' 285' ' ' VAL . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.618 HG13 ' ND1' ' A' ' 284' ' ' HIS . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 282' ' ' PHE . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.495 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 233' ' ' THR . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.47 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 233' ' ' THR . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' A' ' 251' ' ' VAL . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.803 ' HB2' HD12 ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.559 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 239' ' ' GLN . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 227' ' ' LYS . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 248' ' ' LEU . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.458 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.699 ' HB2' HD11 ' A' ' 289' ' ' LEU . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.71 ' HB2' HD21 ' A' ' 287' ' ' LEU . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 277' ' ' LEU . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.511 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.954 0.407 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.678 ' HG2' HG22 ' A' ' 259' ' ' THR . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 258' ' ' ILE . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.549 ' N ' HG22 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.43 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 251' ' ' VAL . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 248' ' ' LEU . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 248' ' ' LEU . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.511 HH21 HD21 ' A' ' 252' ' ' LEU . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 239' ' ' GLN . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.511 HD21 HH21 ' A' ' 250' ' ' ARG . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 255' ' ' GLU . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.758 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.678 HG22 ' HG2' ' A' ' 227' ' ' LYS . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' HIS . . . . . 0.432 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 282' ' ' PHE . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.504 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.775 ' HD3' HG22 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 258' ' ' ILE . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.594 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 238' ' ' ILE . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 233' ' ' THR . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 233' ' ' THR . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.592 ' HG3' HG21 ' A' ' 251' ' ' VAL . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 260' ' ' ALA . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.775 HG22 ' HD3' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.664 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.77 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.444 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' HIS . . . . . 0.594 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 277' ' ' LEU . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.504 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.945 0.402 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 292' ' ' ALA . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.512 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 259' ' ' THR . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 233' ' ' THR . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' ' 242' ' ' PHE . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.554 ' O ' HD12 ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.504 ' CE1' HD21 ' A' ' 277' ' ' LEU . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 227' ' ' LYS . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 261' ' ' ILE . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.539 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.546 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 282' ' ' PHE . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.99 0.424 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HB3' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.502 ' N ' HG22 ' A' ' 233' ' ' THR . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 248' ' ' LEU . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.663 ' CE1' HD21 ' A' ' 277' ' ' LEU . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.739 ' HB3' HD12 ' A' ' 265' ' ' LEU . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.672 HD22 ' CG1' ' A' ' 262' ' ' VAL . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.534 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.609 HD12 ' H ' ' A' ' 229' ' ' LEU . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.739 HD12 ' HB3' ' A' ' 247' ' ' SER . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.432 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 245' ' ' PHE . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.902 ' HB2' HD21 ' A' ' 287' ' ' LEU . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.602 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 259' ' ' THR . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.455 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.49 HG21 HD11 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.452 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' A' ' 251' ' ' VAL . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.69 ' HB2' HD11 ' A' ' 248' ' ' LEU . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 242' ' ' PHE . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' A' ' 239' ' ' GLN . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 227' ' ' LYS . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.439 HG23 ' CD2' ' A' ' 225' ' ' LEU . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.456 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.411 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.494 HD21 ' CE1' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HB2' HD21 ' A' ' 287' ' ' LEU . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.455 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.506 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.531 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 224' ' ' ILE . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.456 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.774 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 233' ' ' THR . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 242' ' ' PHE . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.614 ' O ' HD12 ' A' ' 248' ' ' LEU . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.606 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.774 HD12 ' H ' ' A' ' 229' ' ' LEU . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.457 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.609 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 289' ' ' LEU . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.606 HD21 ' CE1' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 287' ' ' LEU . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' HIS . . . . . 0.631 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.631 HG13 ' ND1' ' A' ' 284' ' ' HIS . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 282' ' ' PHE . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 277' ' ' LEU . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.531 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.887 0.375 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 287' ' ' LEU . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 234' ' ' LEU . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 233' ' ' THR . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.432 ' HG3' HG21 ' A' ' 251' ' ' VAL . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 239' ' ' GLN . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 260' ' ' ALA . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.754 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.509 ' HG2' ' CE1' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.509 ' CE1' ' HG2' ' A' ' 272' ' ' LYS . 45.9 m170 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 287' ' ' LEU . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' HIS . . . . . 0.64 ' ND1' HG13 ' A' ' 285' ' ' VAL . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.64 HG13 ' ND1' ' A' ' 284' ' ' HIS . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.509 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.785 ' HG2' HG22 ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 233' ' ' THR . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.403 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 239' ' ' GLN . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 260' ' ' ALA . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.785 HG22 ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.487 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.957 HD12 ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.522 ' HB2' HD11 ' A' ' 289' ' ' LEU . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 282' ' ' PHE . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 277' ' ' LEU . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.89 0.376 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.578 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.557 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.69 ' CE1' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.601 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.557 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.578 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.955 0.407 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.791 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.514 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' HD12 ' A' ' 248' ' ' LEU . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.688 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 265' ' ' LEU . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 242' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 239' ' ' GLN . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 260' ' ' ALA . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 247' ' ' SER . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 224' ' ' ILE . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.688 HD21 ' CE1' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 287' ' ' LEU . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.462 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.514 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.791 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.939 0.399 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.401 ' CG ' HG23 ' A' ' 222' ' ' THR . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.401 HG23 ' CG ' ' A' ' 221' ' ' LYS . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.555 HG12 ' CB ' ' A' ' 292' ' ' ALA . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.622 ' HG2' HG22 ' A' ' 259' ' ' THR . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 258' ' ' ILE . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 238' ' ' ILE . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 233' ' ' THR . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.64 ' HG3' HG21 ' A' ' 251' ' ' VAL . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' A' ' 248' ' ' LEU . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.785 ' CE1' HD21 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 242' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 260' ' ' ALA . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.629 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 227' ' ' LYS . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.497 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.478 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.762 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.908 0.385 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.445 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 248' ' ' LEU . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 242' ' ' PHE . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.791 HD12 ' H ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.524 HD21 ' CE1' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.735 ' HB2' HD11 ' A' ' 287' ' ' LEU . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.1 t -105.62 -43.9 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' ILE . 3.2 m -63.25 -38.32 90.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.06 -40.55 3.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 t -41.14 -46.84 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 43.2 p -75.96 -57.0 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.4 -48.18 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -144.04 165.1 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m -65.17 141.61 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.565 HG21 ' HE2' ' A' ' 297' ' ' PHE . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.489 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 248' ' ' LEU . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.434 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.55 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.75 ' HB2' HD21 ' A' ' 287' ' ' LEU . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 277' ' ' LEU . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 225' ' ' LEU . . . -84.69 142.72 39.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.512 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.6 Cg_endo -69.77 154.79 67.28 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.679 2.253 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 214' ' ' SER . 15.5 pt -62.56 -23.94 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -89.63 -10.97 64.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 297' ' ' PHE . 12.7 p -39.18 -48.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.573 ' N ' HG13 ' A' ' 296' ' ' VAL . 15.8 m-85 -91.56 -38.38 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 98.14 -163.73 21.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 149.46 46.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 301' ' ' PRO . . . -110.47 157.65 37.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 300' ' ' ALA . 53.3 Cg_endo -69.77 155.81 64.95 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.346 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -107.87 -175.09 2.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -62.67 -48.57 78.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.69 -42.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.16 -49.4 2.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.2 t -47.97 -45.86 31.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -44.64 -44.14 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -37.65 -46.98 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -44.12 151.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -111.71 153.07 44.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 179.79 3.43 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.323 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.47 -27.41 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.76 -42.28 75.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -44.15 -23.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.75 71.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.107 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.41 -47.48 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 15.3 t -38.55 120.61 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.06 174.42 31.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -178.86 2.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.01 -45.44 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.9 p -149.67 176.07 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.521 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.1 t -101.7 -60.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.0 m -70.19 -46.31 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.25 -41.66 3.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 m -54.59 -48.74 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.7 p -72.83 -47.64 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.98 128.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -135.92 122.63 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m -51.0 150.98 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 259' ' ' THR . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 258' ' ' ILE . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.482 HG21 HD11 ' A' ' 238' ' ' ILE . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 233' ' ' THR . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.489 ' O ' HD12 ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.543 ' CE1' HD21 ' A' ' 277' ' ' LEU . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.4 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 226' ' ' ALA . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.603 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.603 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.403 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.543 HD21 ' CE1' ' A' ' 245' ' ' PHE . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.887 ' HB2' HD21 ' A' ' 287' ' ' LEU . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -100.29 142.76 25.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.74 178.8 4.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 0.0 112.353 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 294' ' ' ILE . 0.2 OUTLIER -85.51 -14.33 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.94 -36.94 45.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 297' ' ' PHE . 12.5 p -39.14 -50.08 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.591 ' N ' HG13 ' A' ' 296' ' ' VAL . 31.0 m-85 -96.06 -62.72 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.32 161.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.3 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -50.64 138.17 23.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.572 0.701 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -175.59 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -109.68 45.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -57.86 -41.54 82.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -40.25 -37.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.23 -46.42 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 35.1 t -47.54 -38.46 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 1.1 tm0? -40.7 -40.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 309' ' ' GLU . 6.8 t-80 -37.32 -44.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 308' ' ' HIS . 41.9 tt0 -34.69 119.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -101.99 142.87 25.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.55 34.13 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.282 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.03 -39.99 9.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -40.51 -49.37 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.51 -42.16 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.16 2.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -47.16 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t 55.58 42.2 29.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -40.74 148.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -174.71 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.6 t -103.0 -56.85 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.3 m -133.61 175.76 9.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.4 p -98.73 -30.12 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.5 m -95.79 -66.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.79 4.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 75.5 p -52.53 -48.05 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.81 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.7 t -54.11 -55.25 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.5 82.48 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.35 144.92 51.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m -63.78 147.76 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.508 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 234' ' ' LEU . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.452 ' N ' HG22 ' A' ' 233' ' ' THR . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.529 ' HB2' HG11 ' A' ' 251' ' ' VAL . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.402 ' HB2' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.722 ' HB2' HD12 ' A' ' 265' ' ' LEU . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.436 HD22 ' CG1' ' A' ' 262' ' ' VAL . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 239' ' ' GLN . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 227' ' ' LYS . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.47 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 248' ' ' LEU . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 247' ' ' SER . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.582 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 277' ' ' LEU . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.508 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -100.76 142.35 24.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.2 Cg_endo -69.71 -174.87 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.383 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 25.2 pt -91.41 -14.62 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.47 -22.67 28.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 293' ' ' PRO . 4.0 p -40.61 -36.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.93 -49.09 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 49.66 -167.89 0.27 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.49 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -151.63 178.63 9.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -158.28 147.28 14.57 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -172.43 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.304 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -115.22 74.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 -19.52 18.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -62.1 -29.19 70.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -49.04 -33.7 11.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 34.5 m -89.18 -65.79 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -38.89 -31.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -42.28 -67.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -146.01 163.05 36.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -150.56 157.6 36.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.557 0.694 . . . . 0.0 110.954 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.74 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -26.37 14.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -51.07 -38.64 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 3.2 ptmm? -57.26 -39.84 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.71 -44.41 96.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 10.7 mt-10 -47.1 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 63.1 p 34.49 43.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -46.61 139.56 7.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.03 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 46.2 m -99.66 -57.11 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 m -91.91 177.74 6.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 97.3 p -107.2 -49.55 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 94.7 p -88.06 -43.99 11.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.22 -56.15 25.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -42.24 -46.59 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.838 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.1 t -47.96 -57.42 5.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.93 117.41 4.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.437 ' NH2' ' O ' ' A' ' 291' ' ' TRP . 35.7 mtp180 -143.77 169.95 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t -64.88 156.18 31.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.571 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 259' ' ' THR . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 233' ' ' THR . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.403 HG23 ' CE1' ' A' ' 242' ' ' PHE . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 251' ' ' VAL . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 238' ' ' ILE . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.407 HD22 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 239' ' ' GLN . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 227' ' ' LYS . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.498 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.538 ' HG2' HD12 ' A' ' 268' ' ' LEU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 267' ' ' PRO . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.767 ' HB2' HD21 ' A' ' 287' ' ' LEU . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.436 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 277' ' ' LEU . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.571 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -113.03 143.42 29.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.69 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.79 158.11 58.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.646 2.23 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.89 -18.02 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.78 -21.76 70.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 293' ' ' PRO . 9.4 p -43.29 -45.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.512 ' N ' HG13 ' A' ' 296' ' ' VAL . 8.4 m-85 -92.21 -37.63 12.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.96 175.76 47.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.517 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.35 176.84 9.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.331 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -127.12 144.57 50.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.567 0.699 . . . . 0.0 111.08 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 124.37 11.03 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -73.61 136.43 43.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -79.8 -43.21 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -48.37 -41.03 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -44.63 -37.68 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 m -69.32 -41.84 76.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -48.85 -50.03 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 309' ' ' GLU . 12.5 t-80 -43.93 -32.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 21.8 tp10 -36.03 127.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.49 122.35 43.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 145.42 57.11 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.658 2.239 . . . . 0.0 112.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.9 -19.85 19.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -48.21 -40.87 25.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -51.4 -46.17 62.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.45 -46.82 73.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.66 -43.23 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.1 t -44.04 103.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -151.98 -164.09 12.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 152.88 69.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.627 2.218 . . . . 0.0 112.342 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 321' ' ' SER . 3.4 m -103.08 -56.73 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 320' ' ' SER . 32.2 t -34.91 147.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -107.52 -50.71 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.2 m -44.8 -46.9 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.65 -70.81 0.86 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 74.4 p -42.87 -53.3 4.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -49.28 -39.47 30.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.815 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -63.78 -112.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -99.9 171.72 7.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t -85.62 149.48 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.607 HG12 ' HB3' ' A' ' 292' ' ' ALA . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.468 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.902 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 258' ' ' ILE . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 238' ' ' ILE . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.691 ' HG3' HG21 ' A' ' 251' ' ' VAL . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' A' ' 277' ' ' LEU . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.677 HD22 ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 239' ' ' GLN . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 259' ' ' THR . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.576 ' N ' HD12 ' A' ' 258' ' ' ILE . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 261' ' ' ILE . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.677 ' CG1' HD22 ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.596 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.492 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.443 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.757 ' HB2' HD11 ' A' ' 287' ' ' LEU . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.468 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.902 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -90.63 140.52 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.6 Cg_endo -69.69 146.41 60.53 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.86 -15.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -73.42 -26.86 69.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 297' ' ' PHE . 7.0 p -49.33 -44.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.596 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 6.4 m-85 -96.41 -45.09 6.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.69 24.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.56 156.36 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.34 . . . . 0.0 111.137 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -48.6 143.86 7.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.574 0.702 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -169.19 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -123.82 43.92 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.98 -54.03 4.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -46.63 -31.56 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.65 -39.75 51.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.7 m -45.98 -33.24 3.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -83.21 -47.58 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -39.92 -32.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 310' ' ' GLN . 18.8 mm-40 -38.63 123.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 309' ' ' GLU . 8.5 pt20 -33.96 96.96 0.11 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.429 ' N ' ' O ' ' A' ' 309' ' ' GLU . 54.0 Cg_endo -69.71 165.42 30.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.59 -45.35 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -53.07 -50.54 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -41.13 -52.81 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.2 -43.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 317' ' ' SER . 19.6 tt0 -51.68 -46.81 63.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 316' ' ' GLU . 28.3 t -34.88 124.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.24 178.97 36.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 164.06 35.97 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.66 2.24 . . . . 0.0 112.329 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 53.2 p -101.66 -44.21 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.0 m 49.48 46.19 23.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 217' ' ' SER . 23.3 m -65.4 -46.54 79.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.7 p -81.02 -48.47 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -55.55 -64.65 4.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.5 m -55.48 -52.73 62.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 213' ' ' SER . 28.9 t -47.82 -56.94 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -42.4 -64.74 1.48 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -53.78 156.6 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m -44.57 154.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.581 HG12 ' CB ' ' A' ' 292' ' ' ALA . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.485 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 259' ' ' THR . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.501 ' N ' HG22 ' A' ' 233' ' ' THR . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.687 ' HG3' HG21 ' A' ' 251' ' ' VAL . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.794 ' CE1' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 239' ' ' GLN . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 227' ' ' LYS . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.435 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.619 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.794 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.881 ' HB2' HD21 ' A' ' 287' ' ' LEU . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.881 HD21 ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 277' ' ' LEU . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.485 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.581 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -96.91 143.52 26.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.616 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.75 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 12.0 pt -91.17 -16.5 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -84.25 -16.99 65.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 293' ' ' PRO . 2.7 p -51.0 -53.98 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 263' ' ' GLU . 12.9 m-85 -93.88 -40.66 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.88 132.98 0.91 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -174.59 149.54 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.063 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -131.79 143.87 50.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 175.54 7.99 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.93 67.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -87.5 -43.04 12.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -40.38 -41.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -40.55 -42.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 23.6 t -50.17 -49.18 53.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -45.69 -38.74 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 309' ' ' GLU . 59.1 t-80 -39.16 -39.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.814 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 308' ' ' HIS . 16.2 tt0 -35.09 100.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -96.72 135.92 21.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.587 0.708 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.9 32.81 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.73 -19.37 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -59.53 -39.74 84.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 6.9 ptmt -47.93 -33.58 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.65 -38.53 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 317' ' ' SER . 6.3 tp10 -49.04 -45.82 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' GLU . 83.2 p -38.0 132.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.412 ' HA2' ' HD2' ' A' ' 319' ' ' PRO . . . -174.31 106.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HD2' ' HA2' ' A' ' 318' ' ' GLY . 53.6 Cg_endo -69.79 -179.19 2.75 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.7 m -100.97 -58.49 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.6 m 57.42 41.79 25.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.5 p -97.66 -57.11 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 215' ' ' GLY . 2.5 m -59.52 -55.13 38.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.23 -45.43 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.0 t -44.03 -62.26 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.809 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.7 p -51.08 -48.27 61.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.38 73.72 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -68.87 144.94 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m -45.25 156.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.551 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.495 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 258' ' ' ILE . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 233' ' ' THR . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 242' ' ' PHE . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.698 ' HG3' HG21 ' A' ' 251' ' ' VAL . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 248' ' ' LEU . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.693 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.698 HG21 ' HG3' ' A' ' 239' ' ' GLN . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.588 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 267' ' ' PRO . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 287' ' ' LEU . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' HIS . . . . . 0.618 ' ND1' HG13 ' A' ' 285' ' ' VAL . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.618 HG13 ' ND1' ' A' ' 284' ' ' HIS . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 282' ' ' PHE . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.495 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -97.77 142.75 25.05 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.559 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.72 -176.74 1.57 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.4 pt -91.23 -14.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.7 -18.45 44.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 293' ' ' PRO . 5.6 p -48.62 -43.18 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 111.114 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.588 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 10.6 m-85 -94.46 -54.78 3.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.93 -174.65 19.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -158.15 168.82 26.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -151.71 138.3 11.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.551 0.691 . . . . 0.0 111.087 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.61 37.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -123.19 82.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.72 -27.37 14.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -57.94 -42.3 84.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -42.36 -44.85 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.0 t -67.61 -46.19 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 308' ' ' HIS . 14.5 mm100 -39.58 -43.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.3 t-160 -36.94 -42.93 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -39.21 158.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.13 151.23 68.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 112.65 3.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.744 2.296 . . . . 0.0 112.333 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -97.89 -39.53 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 312' ' ' ALA . 14.1 pt-20 -37.86 -43.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -39.43 -56.45 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.66 52.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.5 tt0 -45.27 -47.72 12.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 316' ' ' GLU . 10.5 t -35.56 129.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.35 144.97 9.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 321' ' ' SER . 26.5 p -103.21 -57.94 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 320' ' ' SER . 1.7 t -35.11 146.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.447 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.3 p -87.3 -47.18 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 110.888 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 215' ' ' GLY . 61.7 m -79.39 -42.29 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.63 -55.24 1.05 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 88.1 p -42.2 -47.98 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -81.83 -59.63 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 45.16 50.78 9.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -153.65 135.22 14.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.842 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m -66.88 143.33 56.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 297' ' ' PHE . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 233' ' ' THR . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.47 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 233' ' ' THR . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' A' ' 251' ' ' VAL . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.803 ' HB2' HD12 ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.559 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 239' ' ' GLN . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 227' ' ' LYS . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 248' ' ' LEU . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.458 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.699 ' HB2' HD11 ' A' ' 289' ' ' LEU . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.71 ' HB2' HD21 ' A' ' 287' ' ' LEU . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 277' ' ' LEU . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.511 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -99.33 151.8 37.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.555 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.78 -179.52 2.97 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.367 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.37 -14.78 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.63 -28.34 22.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.527 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 293' ' ' PRO . 2.6 p -40.02 -39.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 223' ' ' VAL . 10.3 m-85 -96.66 -62.15 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -56.67 -176.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.7 147.4 11.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -38.73 143.68 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 111.085 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 127.34 14.45 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.242 . . . . 0.0 112.353 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.27 41.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.82 -60.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -42.42 -38.41 1.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -52.15 -43.48 64.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 36.0 m -45.58 -28.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -95.72 -33.8 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 310' ' ' GLN . 7.2 m170 -39.61 -51.89 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 3.5 pt-20 -34.49 94.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 308' ' ' HIS . 4.5 tt0 -130.53 124.77 21.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.948 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 106.05 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -87.35 -26.43 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -44.12 -41.23 5.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -67.63 -49.01 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.7 -41.92 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.37 -53.98 9.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.4 t -38.06 122.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.96 91.81 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 133.09 24.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.694 2.263 . . . . 0.0 112.346 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 31.9 m -100.59 -48.36 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 40.8 t -44.25 106.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.503 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -47.6 82.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 215' ' ' GLY . 14.7 m -72.67 -52.9 13.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -37.71 -48.65 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 t -47.41 -62.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.7 m -64.51 -59.71 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.18 110.77 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 51.3 mmt-85 -78.47 128.01 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m -42.26 162.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.844 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.678 ' HG2' HG22 ' A' ' 259' ' ' THR . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 258' ' ' ILE . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.549 ' N ' HG22 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.43 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 251' ' ' VAL . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 248' ' ' LEU . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 248' ' ' LEU . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.511 HH21 HD21 ' A' ' 252' ' ' LEU . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 239' ' ' GLN . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.511 HD21 HH21 ' A' ' 250' ' ' ARG . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 255' ' ' GLU . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.758 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.678 HG22 ' HG2' ' A' ' 227' ' ' LYS . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' HIS . . . . . 0.432 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 282' ' ' PHE . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -105.83 144.82 29.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.533 ' HG2' HG13 ' A' ' 296' ' ' VAL . 54.2 Cg_endo -69.78 -172.48 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.6 pp -91.63 -22.79 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.56 92.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 297' ' ' PHE . 3.0 m -39.77 -55.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.549 ' H ' HG23 ' A' ' 296' ' ' VAL . 20.4 m-85 -95.59 -29.28 14.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -69.21 -0.52 22.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -84.19 114.46 21.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -163.62 149.41 9.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 173.88 10.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -126.95 96.71 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.83 -40.84 7.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -41.11 -35.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.38 -58.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 56.5 p -64.72 -36.88 85.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 308' ' ' HIS . 4.4 tp-100 -55.62 -27.89 52.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.1 m170 -36.83 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -163.4 -179.34 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -131.57 151.52 78.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.604 0.716 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 105.02 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.03 -20.66 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -49.0 -38.6 23.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 13.7 ptmt -43.33 -31.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.31 -44.97 95.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.082 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' SER . 21.9 tt0 -45.29 -46.74 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 316' ' ' GLU . 14.8 m -34.97 122.98 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.49 145.52 9.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.03 39.41 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 32.4 m -101.74 -57.81 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.5 t -165.61 176.74 7.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.7 t -69.82 -44.07 70.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.0 m -58.65 -43.21 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -40.93 -47.21 4.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 m -60.16 -49.91 75.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 44.2 t -54.33 -44.85 72.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.02 127.53 5.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -169.51 152.58 4.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t -50.67 150.76 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.504 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.775 ' HD3' HG22 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 258' ' ' ILE . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.594 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 238' ' ' ILE . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 233' ' ' THR . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 233' ' ' THR . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.592 ' HG3' HG21 ' A' ' 251' ' ' VAL . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 260' ' ' ALA . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.775 HG22 ' HD3' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.664 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.77 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.444 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' HIS . . . . . 0.594 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.472 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 277' ' ' LEU . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.504 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -100.97 143.47 26.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 13.3 pt -91.71 -26.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -76.98 -27.15 60.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.531 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.7 p -39.44 -46.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.531 ' N ' HG13 ' A' ' 296' ' ' VAL . 12.6 m-85 -96.1 -58.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 46.36 -173.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.0 172.38 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -142.73 128.48 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.05 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.708 2.272 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.68 43.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -91.32 -56.55 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -46.88 -35.07 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.68 -40.73 2.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.9 t -39.33 -40.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 309' ' ' GLU . 3.8 tp-100 -71.71 -45.6 61.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 30.1 t60 -37.09 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 307' ' ' GLN . 7.0 tp10 -35.03 105.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -99.72 131.95 23.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.55 40.59 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -94.94 -30.28 14.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -39.73 -42.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.54 -46.64 70.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -49.32 -40.64 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.448 ' C ' ' OE1' ' A' ' 316' ' ' GLU . 9.9 tm-20 -45.38 -43.0 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 89.7 p -40.33 103.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.7 166.24 36.64 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 162.05 43.57 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 24.3 m -103.18 -58.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.819 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.1 t -167.83 177.99 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -59.43 -57.44 12.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.5 m -45.95 -41.65 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -48.18 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 20.9 t -54.25 -55.38 28.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.5 t -43.42 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -89.79 81.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -74.11 176.5 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t -93.88 141.22 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 292' ' ' ALA . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.512 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 259' ' ' THR . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 233' ' ' THR . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' ' 242' ' ' PHE . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.554 ' O ' HD12 ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.504 ' CE1' HD21 ' A' ' 277' ' ' LEU . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 227' ' ' LYS . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 261' ' ' ILE . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.539 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.546 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 282' ' ' PHE . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -93.64 140.7 23.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.554 ' O ' HG22 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.74 -172.11 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.97 -14.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.31 -31.86 50.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 293' ' ' PRO . 2.8 m -41.13 -53.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.132 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.526 ' H ' HG23 ' A' ' 296' ' ' VAL . 32.3 m-85 -93.54 -36.56 12.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.95 0.01 40.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.07 162.2 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -159.75 148.85 14.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.575 0.702 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.55 54.69 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.72 2.28 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -133.63 85.98 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -98.22 -37.97 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -42.13 -42.9 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -40.12 -52.15 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 37.4 t -55.21 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.07 -44.37 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -40.37 -65.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -69.23 117.67 11.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -142.7 143.8 27.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.7 2.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.369 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.22 -35.63 13.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 312' ' ' ALA . 15.9 tt0 -38.26 -47.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -41.35 -45.26 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -38.64 -60.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.2 -50.47 72.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t 71.69 41.45 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 60.08 146.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 162.23 42.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 22.3 m -61.86 -56.05 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 80.2 p -174.05 171.25 3.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.456 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.3 m -51.61 -57.59 8.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.3 m -55.14 -43.54 74.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -59.93 -52.36 53.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 33.1 m -42.22 -53.25 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.8 t -48.09 -40.86 24.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 62.09 91.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -136.58 162.56 32.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m -86.89 153.94 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.798 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HB3' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.502 ' N ' HG22 ' A' ' 233' ' ' THR . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 248' ' ' LEU . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.663 ' CE1' HD21 ' A' ' 277' ' ' LEU . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.739 ' HB3' HD12 ' A' ' 265' ' ' LEU . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.672 HD22 ' CG1' ' A' ' 262' ' ' VAL . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.534 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.609 HD12 ' H ' ' A' ' 229' ' ' LEU . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.739 HD12 ' HB3' ' A' ' 247' ' ' SER . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.432 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 245' ' ' PHE . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.902 ' HB2' HD21 ' A' ' 287' ' ' LEU . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.602 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -90.93 145.8 32.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.583 ' HG2' HG13 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.77 -174.76 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.27 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 21.8 pt -90.58 -16.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.59 -35.33 51.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.715 HG23 ' H ' ' A' ' 297' ' ' PHE . 2.7 m -39.9 -61.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.715 ' H ' HG23 ' A' ' 296' ' ' VAL . 26.8 m-85 -96.75 -30.36 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -67.85 -0.82 15.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -81.32 112.37 18.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.344 . . . . 0.0 111.053 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -174.95 143.89 0.8 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.563 0.697 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 85.96 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.381 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -124.66 95.41 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -96.86 -39.66 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -42.93 -46.67 5.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.33 -39.34 4.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.4 t -51.45 -37.69 50.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.3 mm-40 -72.13 -49.95 31.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 307' ' ' GLN . 14.3 m170 -36.97 -38.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -40.03 110.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -98.2 135.47 21.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 115.62 4.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -36.29 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -39.12 -42.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.94 -55.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.67 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.6 tt0 -46.7 -46.67 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.66 110.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.9 -173.94 33.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 135.96 31.93 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 59.5 p -101.41 -58.23 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.2 t -80.6 165.89 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.6 m -49.2 -47.48 46.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.1 m -56.76 -49.88 73.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.71 -40.13 6.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.8 t -62.33 -49.67 74.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.814 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.2 m -45.11 -51.73 9.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.75 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -156.07 155.86 33.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t -66.37 141.74 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 259' ' ' THR . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.455 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.49 HG21 HD11 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.452 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' A' ' 251' ' ' VAL . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.69 ' HB2' HD11 ' A' ' 248' ' ' LEU . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 242' ' ' PHE . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' A' ' 239' ' ' GLN . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 227' ' ' LYS . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.439 HG23 ' CD2' ' A' ' 225' ' ' LEU . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.434 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.456 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.411 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.494 HD21 ' CE1' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HB2' HD21 ' A' ' 287' ' ' LEU . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.455 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.506 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -85.08 140.34 36.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.5 Cg_endo -69.74 -176.32 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.28 . . . . 0.0 112.344 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 295' ' ' GLY . 21.0 pt -86.39 -27.13 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 294' ' ' ILE . . . -75.9 -25.34 67.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 293' ' ' PRO . 12.0 p -40.95 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 111.1 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.483 ' N ' HG13 ' A' ' 296' ' ' VAL . 9.9 m-85 -96.85 -49.76 4.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 58.96 -176.8 2.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -141.36 153.7 45.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.02 154.62 1.74 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLN . . . . . 0.445 ' OE1' ' CG ' ' A' ' 305' ' ' ASP . 1.0 OUTLIER -122.85 86.65 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -88.77 -34.43 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.07 -38.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.445 ' CG ' ' OE1' ' A' ' 302' ' ' GLN . 7.8 m-20 -39.34 -47.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.3 t -48.77 -45.09 39.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -39.43 -38.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' A' ' 309' ' ' GLU . 29.6 m170 -36.83 -41.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 18.4 pt-20 -34.54 139.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -123.91 149.77 60.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.49 40.54 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.3 -42.48 7.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 314' ' ' LYS . 10.1 pt-20 -42.3 -40.42 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 313' ' ' GLU . 0.1 OUTLIER -42.34 -45.63 4.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.49 -41.52 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 317' ' ' SER . 25.0 mm-40 -47.22 -45.48 23.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.53 123.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.49 20.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 162.82 40.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.718 2.279 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 26.1 p -102.78 -41.73 6.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.6 m -55.29 157.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 89.1 p -77.23 -50.28 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 -45.88 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -48.3 7.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 27.7 m -49.8 -54.97 15.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.2 m -58.76 -47.7 83.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 60.62 56.97 21.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -95.08 146.96 23.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t -52.6 149.26 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.531 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 224' ' ' ILE . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.456 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.774 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 233' ' ' THR . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 242' ' ' PHE . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.614 ' O ' HD12 ' A' ' 248' ' ' LEU . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.606 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.774 HD12 ' H ' ' A' ' 229' ' ' LEU . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.457 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.609 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 289' ' ' LEU . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.606 HD21 ' CE1' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 287' ' ' LEU . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' HIS . . . . . 0.631 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.631 HG13 ' ND1' ' A' ' 284' ' ' HIS . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 282' ' ' PHE . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 277' ' ' LEU . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.531 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 296' ' ' VAL . . . -104.22 137.23 19.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.765 ' HG2' HG13 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.78 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 8.9 pt -92.01 -22.72 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.75 70.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 293' ' ' PRO . 35.0 m -39.01 -52.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.614 ' N ' HG23 ' A' ' 296' ' ' VAL . 18.5 m-85 -97.0 -42.75 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 91.37 150.25 24.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.2 23.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -164.65 135.29 3.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.555 0.693 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 118.64 5.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -106.34 40.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -99.19 -54.43 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 6.2 ptmt -54.69 -31.89 58.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 9.9 t70 -45.06 -48.53 11.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.4 t -76.73 -51.31 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 308' ' ' HIS . 47.1 tt0 -39.73 -33.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.3 p-80 -36.8 -35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 308' ' ' HIS . 4.1 pt-20 -34.45 102.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -108.88 135.17 20.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.47 69.15 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.728 2.285 . . . . 0.0 112.289 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.76 -30.83 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -45.86 -29.92 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 0.1 OUTLIER -49.25 -36.96 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.87 -40.12 13.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 317' ' ' SER . 48.3 mt-10 -46.09 -52.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 316' ' ' GLU . 24.8 p -38.14 123.15 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 165.94 145.28 4.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.31 8.28 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.6 p -101.42 -44.59 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 m -174.79 175.25 2.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.0 p -82.27 -56.82 3.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.0 p -47.22 -29.38 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.44 -63.2 4.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.6 p -69.86 -55.06 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.827 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.3 m -44.5 -61.18 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.01 121.8 3.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -136.97 127.71 27.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m -44.62 158.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 287' ' ' LEU . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 234' ' ' LEU . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 233' ' ' THR . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.432 ' HG3' HG21 ' A' ' 251' ' ' VAL . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 239' ' ' GLN . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 260' ' ' ALA . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.754 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.509 ' HG2' ' CE1' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.509 ' CE1' ' HG2' ' A' ' 272' ' ' LYS . 45.9 m170 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 287' ' ' LEU . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' HIS . . . . . 0.64 ' ND1' HG13 ' A' ' 285' ' ' VAL . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.64 HG13 ' ND1' ' A' ' 284' ' ' HIS . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.518 ' HB1' HG11 ' A' ' 296' ' ' VAL . . . -90.6 148.06 37.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.1 Cg_endo -69.83 -174.15 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.298 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.434 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.6 pp -90.92 -22.77 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -83.45 -29.59 32.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 293' ' ' PRO . 1.5 p -39.45 -49.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -95.98 -62.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -50.11 153.29 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.48 -179.93 5.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -73.49 127.9 88.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.561 0.696 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.84 6.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.309 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -124.95 34.57 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -38.44 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -53.56 -39.28 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.96 -56.15 2.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 t -42.34 -42.25 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 308' ' ' HIS . 8.7 tm0? -50.91 -39.73 55.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.5 p-80 -36.9 -35.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 308' ' ' HIS . 9.3 mt-10 -34.47 102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -103.05 133.19 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.26 38.95 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -96.52 -32.19 12.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -41.0 -45.0 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -45.05 -45.68 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.8 -41.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 317' ' ' SER . 7.3 tp10 -46.1 -44.28 15.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 316' ' ' GLU . 79.9 p -34.52 121.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -93.1 151.15 20.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -173.0 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.8 m -95.34 -57.46 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.1 p -140.69 177.86 7.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.1 m -102.71 -47.01 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 83.3 p -52.76 -44.12 66.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.1 -46.79 49.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.0 t -54.98 -59.46 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 79.3 p -53.95 -45.24 71.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 294' ' ' ILE . . . -52.61 -74.31 0.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -57.13 156.55 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t -45.82 151.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.509 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.785 ' HG2' HG22 ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 233' ' ' THR . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.403 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 239' ' ' GLN . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 260' ' ' ALA . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.785 HG22 ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.487 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.957 HD12 ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.522 ' HB2' HD11 ' A' ' 289' ' ' LEU . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 282' ' ' PHE . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 277' ' ' LEU . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -98.48 142.73 25.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.424 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.5 Cg_endo -69.75 -175.45 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.67 2.246 . . . . 0.0 112.348 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 218' ' ' GLY . 29.2 pt -89.62 -24.03 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -80.86 -21.4 63.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.2 p -42.76 -48.79 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.57 ' N ' HG13 ' A' ' 296' ' ' VAL . 17.4 m-85 -94.37 -40.82 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.37 124.72 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.01 138.87 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -173.78 140.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLN . . . . . 0.483 ' NE2' ' OD2' ' A' ' 305' ' ' ASP . 13.4 tt0 -172.41 108.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -37.56 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 306' ' ' SER . 12.1 mptt -46.16 -37.98 7.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.498 ' O ' ' NE2' ' A' ' 307' ' ' GLN . 5.6 m-20 -39.21 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 304' ' ' LYS . 38.6 t -47.25 -42.68 20.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 308' ' ' HIS . 1.4 pm0 -39.48 -30.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.601 ' N ' ' NE2' ' A' ' 307' ' ' GLN . 64.0 t-80 -39.42 -38.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 54.1 tt0 -36.31 103.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -73.62 130.97 82.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 172.63 12.33 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.84 -33.4 14.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -43.07 -41.02 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -41.83 -41.03 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.24 -40.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 317' ' ' SER . 56.8 mm-40 -46.37 -46.27 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 316' ' ' GLU . 11.1 t -37.55 122.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.83 16.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -173.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.701 2.267 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 11.0 t -100.28 -57.95 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 m -174.12 177.39 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.1 t -77.37 -43.64 32.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 56.2 p -52.4 -47.67 66.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.88 -43.71 64.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 m -47.98 -54.76 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 56.9 m -71.99 -45.64 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.848 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.85 130.95 7.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -141.02 138.75 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t -50.74 153.98 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.578 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.557 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.69 ' CE1' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.601 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.557 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.578 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -98.91 130.06 28.4 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 141.67 45.94 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 36.7 pt -48.5 -19.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.119 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.43 56.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.473 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 7.7 p -39.03 -34.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.456 ' HE2' HG21 ' A' ' 223' ' ' VAL . 11.9 m-85 -96.88 -40.76 8.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 63.2 135.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.74 157.23 19.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -172.65 134.83 0.75 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.89 61.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -93.07 81.36 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -82.63 -42.18 18.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -40.22 -41.53 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.421 ' OD1' ' C ' ' A' ' 305' ' ' ASP . 1.6 t0 -39.39 -58.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 92.8 p -41.95 -42.81 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 308' ' ' HIS . 38.1 tp60 -38.35 -40.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 309' ' ' GLU . 22.4 p-80 -36.8 -44.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 308' ' ' HIS . 2.2 pp20? -45.27 142.07 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.89 141.18 14.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.638 0.732 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.82 4.27 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.93 -36.42 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -46.54 -40.64 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -42.37 -32.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -45.68 -41.08 9.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 317' ' ' SER . 17.3 pt-20 -45.16 -35.62 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 316' ' ' GLU . 13.7 m -42.47 120.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 167.83 82.6 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 147.99 64.26 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.74 2.294 . . . . 0.0 112.328 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.1 p -99.15 -58.52 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 7.0 t -144.79 174.82 10.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.5 p -77.29 -44.21 30.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -88.52 -49.83 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -42.94 6.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 40.2 t -45.47 -48.96 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.1 m -62.1 -55.09 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.26 4.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -75.25 172.12 12.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t -51.57 153.51 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.791 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.514 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' HD12 ' A' ' 248' ' ' LEU . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.688 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 265' ' ' LEU . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 242' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 239' ' ' GLN . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 260' ' ' ALA . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 247' ' ' SER . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 224' ' ' ILE . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.688 HD21 ' CE1' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 287' ' ' LEU . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.462 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.514 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.791 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -95.81 140.98 22.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.83 177.52 5.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.69 2.26 . . . . 0.0 112.346 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.0 pt -85.35 -20.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.35 -12.0 65.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 293' ' ' PRO . 3.1 p -46.76 -52.26 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 111.124 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' N ' HG13 ' A' ' 296' ' ' VAL . 6.2 m-85 -96.21 -58.6 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.5 154.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.49 177.83 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 129.23 87.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.56 0.695 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 148.22 64.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.49 43.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -96.01 -42.4 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 19.9 pttt -40.9 -42.25 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 t70 -39.04 -53.18 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.9 t -50.73 -62.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.4 mm100 -51.99 -43.21 63.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 309' ' ' GLU . 2.3 t60 -36.99 -40.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 308' ' ' HIS . 6.9 tm-20 -34.55 107.24 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -107.41 151.72 41.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -177.88 2.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.66 -40.34 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 312' ' ' ALA . 31.6 mt-10 -38.34 -45.69 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -53.08 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -42.64 -45.38 4.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 14.8 tt0 -45.55 -47.13 14.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 48.0 t -34.93 114.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -133.8 174.54 20.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 178.69 4.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 18.2 t -97.34 -58.13 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 5.0 m -146.02 172.63 13.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 99.9 p -90.55 -43.85 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 91.9 p -51.19 -43.61 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.26 -51.21 28.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.5 p -55.55 -48.68 74.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.0 m -72.93 -60.4 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 294' ' ' ILE . . . -91.59 58.07 3.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.506 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -55.13 164.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t -65.82 157.16 31.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.401 ' CG ' HG23 ' A' ' 222' ' ' THR . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.401 HG23 ' CG ' ' A' ' 221' ' ' LYS . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.555 HG12 ' CB ' ' A' ' 292' ' ' ALA . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.622 ' HG2' HG22 ' A' ' 259' ' ' THR . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 258' ' ' ILE . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 238' ' ' ILE . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 233' ' ' THR . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.64 ' HG3' HG21 ' A' ' 251' ' ' VAL . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' A' ' 248' ' ' LEU . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.785 ' CE1' HD21 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 242' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 260' ' ' ALA . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.629 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 227' ' ' LYS . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.497 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.478 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.762 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -86.59 130.74 47.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.74 139.92 41.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 218' ' ' GLY . 17.7 pt -48.31 -26.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.76 -37.04 92.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.5 p -39.38 -48.24 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.104 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.575 ' N ' HG13 ' A' ' 296' ' ' VAL . 10.3 m-85 -94.84 -50.67 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -41.78 141.41 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -126.15 167.68 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -41.13 131.44 2.0 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.582 0.706 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 88.39 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -98.8 42.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -99.43 -39.44 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -52.82 -43.74 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.11 -54.61 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.7 t -45.12 -46.22 11.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 18.2 tm0? -41.33 -41.38 1.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 309' ' ' GLU . 7.3 p-80 -36.96 -39.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 308' ' ' HIS . 26.5 tt0 -34.45 100.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.63 150.3 19.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.573 0.702 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.99 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.621 2.214 . . . . 0.0 112.352 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -80.96 -39.27 26.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -44.8 -46.12 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -38.03 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.7 -39.07 1.0 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.23 -45.27 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.1 t -39.53 123.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.95 94.37 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.39 68.8 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.295 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 t -102.22 -57.51 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 t -171.15 147.84 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.9 p -87.23 -44.19 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.4 t -45.57 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.29 -53.05 36.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 13.5 t -44.55 -54.48 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.1 m -60.29 -55.78 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 84.85 -39.88 2.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 164.62 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t -52.82 160.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.445 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 248' ' ' LEU . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 242' ' ' PHE . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.791 HD12 ' H ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.524 HD21 ' CE1' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.735 ' HB2' HD11 ' A' ' 287' ' ' LEU . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -86.62 142.21 34.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -176.24 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.648 2.232 . . . . 0.0 112.314 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.446 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.5 pp -90.39 -18.05 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -85.82 -24.8 40.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.522 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 297' ' ' PHE . 13.7 p -38.91 -42.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.456 ' N ' HG13 ' A' ' 296' ' ' VAL . 11.9 m-85 -96.96 -48.04 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.22 -176.53 54.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -136.35 167.42 21.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -111.67 141.37 24.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.601 0.715 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -172.6 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.326 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -126.48 42.19 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -50.58 -41.56 54.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -40.22 -43.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.3 -43.49 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 67.8 m -44.03 -40.53 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.9 mm-40 -39.03 -42.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 307' ' ' GLN . 1.5 t-80 -36.86 -43.27 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -39.63 150.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -107.2 156.2 37.99 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.19 22.87 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.243 . . . . 0.0 112.388 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.72 -43.84 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.076 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -38.75 -43.7 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -39.77 -46.85 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.6 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 44.2 tp10 -45.88 -41.66 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 3.8 t -34.57 -63.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 317' ' ' SER . . . 35.22 87.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 140.93 43.96 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 91.0 p -102.95 -55.49 2.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 77.8 p -72.96 161.38 30.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.958 0.409 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.489 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 248' ' ' LEU . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.434 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.55 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.75 ' HB2' HD21 ' A' ' 287' ' ' LEU . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 277' ' ' LEU . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 259' ' ' THR . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 258' ' ' ILE . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.482 HG21 HD11 ' A' ' 238' ' ' ILE . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 233' ' ' THR . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.489 ' O ' HD12 ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.543 ' CE1' HD21 ' A' ' 277' ' ' LEU . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.4 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 226' ' ' ALA . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.603 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.603 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.403 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.543 HD21 ' CE1' ' A' ' 245' ' ' PHE . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.887 ' HB2' HD21 ' A' ' 287' ' ' LEU . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.92 0.391 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.508 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 234' ' ' LEU . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.452 ' N ' HG22 ' A' ' 233' ' ' THR . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.529 ' HB2' HG11 ' A' ' 251' ' ' VAL . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.402 ' HB2' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.722 ' HB2' HD12 ' A' ' 265' ' ' LEU . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.436 HD22 ' CG1' ' A' ' 262' ' ' VAL . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 239' ' ' GLN . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 227' ' ' LYS . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.47 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 248' ' ' LEU . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 247' ' ' SER . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.582 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 277' ' ' LEU . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.508 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.911 0.386 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.571 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 259' ' ' THR . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 233' ' ' THR . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.403 HG23 ' CE1' ' A' ' 242' ' ' PHE . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 251' ' ' VAL . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 238' ' ' ILE . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.407 HD22 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 239' ' ' GLN . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 227' ' ' LYS . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.538 ' HG2' HD12 ' A' ' 268' ' ' LEU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 267' ' ' PRO . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.767 ' HB2' HD21 ' A' ' 287' ' ' LEU . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 277' ' ' LEU . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.571 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.607 HG12 ' HB3' ' A' ' 292' ' ' ALA . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.468 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.902 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 258' ' ' ILE . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 238' ' ' ILE . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.691 ' HG3' HG21 ' A' ' 251' ' ' VAL . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' A' ' 277' ' ' LEU . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.677 HD22 ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 239' ' ' GLN . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 259' ' ' THR . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.576 ' N ' HD12 ' A' ' 258' ' ' ILE . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 261' ' ' ILE . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.677 ' CG1' HD22 ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.492 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.443 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.757 ' HB2' HD11 ' A' ' 287' ' ' LEU . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.536 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 17.2 m-70 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.468 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.902 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.581 HG12 ' CB ' ' A' ' 292' ' ' ALA . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.485 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 259' ' ' THR . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.501 ' N ' HG22 ' A' ' 233' ' ' THR . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.687 ' HG3' HG21 ' A' ' 251' ' ' VAL . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.794 ' CE1' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 239' ' ' GLN . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 227' ' ' LYS . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.435 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.619 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.794 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.881 ' HB2' HD21 ' A' ' 287' ' ' LEU . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.881 HD21 ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 277' ' ' LEU . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.485 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.581 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.881 0.372 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.551 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.495 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 258' ' ' ILE . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 233' ' ' THR . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 242' ' ' PHE . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.698 ' HG3' HG21 ' A' ' 251' ' ' VAL . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 248' ' ' LEU . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.693 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.698 HG21 ' HG3' ' A' ' 239' ' ' GLN . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 267' ' ' PRO . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 287' ' ' LEU . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.618 ' ND1' HG13 ' A' ' 285' ' ' VAL . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.618 HG13 ' ND1' ' A' ' 284' ' ' HIS . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 282' ' ' PHE . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.495 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.926 0.393 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 233' ' ' THR . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.47 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 233' ' ' THR . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' A' ' 251' ' ' VAL . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.803 ' HB2' HD12 ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.559 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 239' ' ' GLN . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 227' ' ' LYS . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 248' ' ' LEU . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.458 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.699 ' HB2' HD11 ' A' ' 289' ' ' LEU . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.71 ' HB2' HD21 ' A' ' 287' ' ' LEU . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 277' ' ' LEU . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.511 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.954 0.407 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.678 ' HG2' HG22 ' A' ' 259' ' ' THR . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 258' ' ' ILE . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.549 ' N ' HG22 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.43 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 251' ' ' VAL . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 248' ' ' LEU . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 248' ' ' LEU . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.511 HH21 HD21 ' A' ' 252' ' ' LEU . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 239' ' ' GLN . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.511 HD21 HH21 ' A' ' 250' ' ' ARG . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 255' ' ' GLU . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.758 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.678 HG22 ' HG2' ' A' ' 227' ' ' LYS . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.432 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 282' ' ' PHE . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.504 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.775 ' HD3' HG22 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 258' ' ' ILE . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.594 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 238' ' ' ILE . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 233' ' ' THR . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 233' ' ' THR . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.592 ' HG3' HG21 ' A' ' 251' ' ' VAL . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 260' ' ' ALA . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.775 HG22 ' HD3' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.664 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.77 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.444 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.594 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 277' ' ' LEU . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.504 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.945 0.402 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 292' ' ' ALA . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.512 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 259' ' ' THR . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 2.0 t30 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 233' ' ' THR . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' ' 242' ' ' PHE . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.554 ' O ' HD12 ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.504 ' CE1' HD21 ' A' ' 277' ' ' LEU . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 227' ' ' LYS . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 261' ' ' ILE . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.539 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.546 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 32.3 m-70 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 282' ' ' PHE . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.99 0.424 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HB3' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.502 ' N ' HG22 ' A' ' 233' ' ' THR . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 248' ' ' LEU . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.663 ' CE1' HD21 ' A' ' 277' ' ' LEU . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.739 ' HB3' HD12 ' A' ' 265' ' ' LEU . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.672 HD22 ' CG1' ' A' ' 262' ' ' VAL . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.534 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.609 HD12 ' H ' ' A' ' 229' ' ' LEU . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.739 HD12 ' HB3' ' A' ' 247' ' ' SER . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.432 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 245' ' ' PHE . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.902 ' HB2' HD21 ' A' ' 287' ' ' LEU . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.602 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.891 0.377 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 259' ' ' THR . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.455 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.49 HG21 HD11 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.452 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' A' ' 251' ' ' VAL . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.69 ' HB2' HD11 ' A' ' 248' ' ' LEU . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 242' ' ' PHE . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' A' ' 239' ' ' GLN . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 227' ' ' LYS . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.439 HG23 ' CD2' ' A' ' 225' ' ' LEU . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.456 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.411 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.494 HD21 ' CE1' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HB2' HD21 ' A' ' 287' ' ' LEU . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.546 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 18.5 m-70 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.455 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.506 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.531 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 224' ' ' ILE . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.456 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.774 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 233' ' ' THR . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 242' ' ' PHE . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.614 ' O ' HD12 ' A' ' 248' ' ' LEU . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.606 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.774 HD12 ' H ' ' A' ' 229' ' ' LEU . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.457 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.609 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 289' ' ' LEU . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.606 HD21 ' CE1' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 287' ' ' LEU . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.631 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.631 HG13 ' ND1' ' A' ' 284' ' ' HIS . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 282' ' ' PHE . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 277' ' ' LEU . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.531 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.887 0.375 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 287' ' ' LEU . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 234' ' ' LEU . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 233' ' ' THR . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.432 ' HG3' HG21 ' A' ' 251' ' ' VAL . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 239' ' ' GLN . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 260' ' ' ALA . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.754 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 9.9 m-70 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 287' ' ' LEU . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.64 ' ND1' HG13 ' A' ' 285' ' ' VAL . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.64 HG13 ' ND1' ' A' ' 284' ' ' HIS . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.965 0.412 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.509 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.785 ' HG2' HG22 ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 233' ' ' THR . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.403 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 239' ' ' GLN . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 260' ' ' ALA . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.785 HG22 ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.487 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.957 HD12 ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.522 ' HB2' HD11 ' A' ' 289' ' ' LEU . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 282' ' ' PHE . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 277' ' ' LEU . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 220' ' ' SER . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.89 0.376 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.578 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.557 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.69 ' CE1' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.601 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 33.8 m-70 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.557 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.578 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.955 0.407 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.791 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.514 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.455 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' HD12 ' A' ' 248' ' ' LEU . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.688 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 265' ' ' LEU . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 242' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 239' ' ' GLN . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 260' ' ' ALA . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 247' ' ' SER . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 224' ' ' ILE . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.688 HD21 ' CE1' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 287' ' ' LEU . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . 0.517 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 22.6 m-70 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.462 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.514 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.791 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.939 0.399 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.401 ' CG ' HG23 ' A' ' 222' ' ' THR . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.401 HG23 ' CG ' ' A' ' 221' ' ' LYS . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.555 HG12 ' CB ' ' A' ' 292' ' ' ALA . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.622 ' HG2' HG22 ' A' ' 259' ' ' THR . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 258' ' ' ILE . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 238' ' ' ILE . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 233' ' ' THR . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.64 ' HG3' HG21 ' A' ' 251' ' ' VAL . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' A' ' 248' ' ' LEU . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.785 ' CE1' HD21 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 242' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 260' ' ' ALA . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.629 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 227' ' ' LYS . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.497 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.478 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.762 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.908 0.385 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.445 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 248' ' ' LEU . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 242' ' ' PHE . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.791 HD12 ' H ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.524 HD21 ' CE1' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.735 ' HB2' HD11 ' A' ' 287' ' ' LEU . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.1 t -105.62 -43.9 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' ILE . 3.2 m -63.25 -38.32 90.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.06 -40.55 3.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.2 t -41.14 -46.84 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 43.2 p -75.96 -57.0 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.844 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 142.4 -48.18 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -144.04 165.1 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.876 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.8 m -65.17 141.61 58.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.04 -11.07 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 64.2 p -103.81 -30.02 10.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.565 HG21 ' HE2' ' A' ' 297' ' ' PHE . 61.9 t -101.03 124.44 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.489 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 19.0 mt -127.84 145.32 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 292' ' ' ALA . 5.4 mp -105.53 160.34 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -128.71 121.91 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -111.4 162.9 14.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 70.75 52.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 70.8 mt -110.41 136.35 20.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.63 51.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.74 -17.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -75.8 -30.87 57.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.485 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 4.3 m -50.14 156.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.167 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 91.6 mt -141.82 151.41 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.459 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -45.59 -58.91 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -50.39 -54.39 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.448 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -44.69 -51.78 8.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 31.0 mm -60.76 -53.51 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -44.81 -58.65 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' THR . 10.5 tm-20 -59.02 -61.1 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' GLU . 92.3 m -34.53 -44.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 248' ' ' LEU . 4.9 m-85 -80.59 -42.92 21.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.0 p -52.05 -19.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -59.1 -37.3 76.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 277' ' ' LEU . 47.9 m-85 -79.67 -44.69 20.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -166.83 167.46 39.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -56.87 146.99 24.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.873 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 264' ' ' PHE . 70.3 mt -115.71 160.1 20.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -102.6 -69.56 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -119.58 158.98 25.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 83.2 t -152.84 113.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.2 mt -128.88 116.13 18.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.7 tp -132.99 98.44 15.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 149.2 66.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.69 2.26 . . . . 0.0 112.322 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.01 -41.64 41.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.67 -30.52 65.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 108.03 1.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.465 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 259' ' ' THR . 2.3 pp -38.91 -43.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 258' ' ' ILE . 44.2 p -40.36 141.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.09 134.68 45.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -103.4 128.6 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.74 121.51 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.144 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.72 136.97 38.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 248' ' ' LEU . 16.2 m-85 -103.94 139.97 38.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.42 -23.4 61.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.434 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 8.8 tp10 -128.48 136.9 29.8 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -37.96 8.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.329 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.55 -49.22 76.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.85 -45.13 94.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -50.84 -52.18 43.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -59.76 -43.95 94.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.847 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 25.1 tttp -51.2 -49.67 60.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.63 86.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.097 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.55 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.0 t80 -47.31 -60.74 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -62.56 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 8.2 m-70 -57.28 -70.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 245' ' ' PHE . 18.9 mt -53.35 -41.05 65.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -44.62 140.65 2.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 69.99 25.49 4.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 t -128.57 155.5 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -105.56 133.02 50.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.75 ' HB2' HD21 ' A' ' 287' ' ' LEU . 25.7 t80 -69.63 -73.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.583 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.4 m170 -110.41 -71.76 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -124.96 -18.42 5.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.856 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.06 152.18 44.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.657 0.741 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 133.5 25.7 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 282' ' ' PHE . 38.4 mt -81.16 126.52 31.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.42 100.58 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 277' ' ' LEU . 67.2 mt -81.53 131.5 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -132.89 120.49 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.4 m95 -51.3 142.37 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 225' ' ' LEU . . . -84.69 142.72 39.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.584 0.707 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.512 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.6 Cg_endo -69.77 154.79 67.28 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.679 2.253 . . . . 0.0 112.337 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' A' ' 214' ' ' SER . 15.5 pt -62.56 -23.94 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -89.63 -10.97 64.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 297' ' ' PHE . 12.7 p -39.18 -48.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.573 ' N ' HG13 ' A' ' 296' ' ' VAL . 15.8 m-85 -91.56 -38.38 12.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 98.14 -163.73 21.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 149.46 46.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 301' ' ' PRO . . . -110.47 157.65 37.64 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 300' ' ' ALA . 53.3 Cg_endo -69.77 155.81 64.95 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.346 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -107.87 -175.09 2.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -62.67 -48.57 78.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.69 -42.14 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.16 -49.4 2.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.2 t -47.97 -45.86 31.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -44.64 -44.14 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -37.65 -46.98 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -44.12 151.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -111.71 153.07 44.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.551 0.691 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 179.79 3.43 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.323 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.47 -27.41 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.76 -42.28 75.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -44.15 -23.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.75 71.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.107 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.41 -47.48 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 15.3 t -38.55 120.61 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.06 174.42 31.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -178.86 2.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.01 -45.44 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.9 p -149.67 176.07 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.521 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.1 t -101.7 -60.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 0.0 110.894 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.0 m -70.19 -46.31 64.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.797 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.25 -41.66 3.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 m -54.59 -48.74 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.7 p -72.83 -47.64 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.826 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.98 128.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -135.92 122.63 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 55.0 m -51.0 150.98 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -104.18 -18.81 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 p -107.21 18.53 21.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.2 t -141.04 111.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.567 ' CG1' ' CZ3' ' A' ' 291' ' ' TRP . 40.9 mt -117.68 148.39 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 12.5 mt -119.11 133.24 55.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 259' ' ' THR . . . -114.31 123.26 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.075 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 259' ' ' THR . 27.0 mttp -116.24 164.08 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.65 52.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 258' ' ' ILE . 59.6 mt -108.79 139.32 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.619 0.724 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.4 Cg_endo -69.8 141.04 43.99 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.0 112.329 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.11 -21.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -69.68 -35.33 73.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.482 HG21 HD11 ' A' ' 238' ' ' ILE . 5.4 m -48.28 148.78 1.74 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.64 152.5 50.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -43.3 -58.39 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.81 -52.3 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.491 ' CA ' ' OE1' ' A' ' 237' ' ' GLU . 0.0 OUTLIER -45.78 -49.44 15.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 233' ' ' THR . 26.2 mm -64.99 -50.0 77.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.489 ' O ' HD12 ' A' ' 248' ' ' LEU . 27.1 tt0 -51.14 -53.51 33.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -54.44 33.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 29.8 m -40.81 -46.58 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.7 m-85 -78.95 -44.68 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 246' ' ' GLY . 43.6 p -44.16 -39.77 4.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.825 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -38.68 -42.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.543 ' CE1' HD21 ' A' ' 277' ' ' LEU . 60.2 m-85 -69.95 -41.07 75.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 243' ' ' SER . . . -178.25 171.78 44.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 58.8 m -51.65 146.03 8.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 239' ' ' GLN . 17.6 mt -114.77 145.13 42.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.26 -79.97 1.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.536 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -119.51 147.69 44.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.85 113.37 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.23 114.89 21.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.1 tp -133.88 98.53 14.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.22 57.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.23 -40.06 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.44 -29.58 60.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.38 123.21 5.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.455 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.4 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.3 pt -52.72 -39.68 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.118 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 226' ' ' ALA . 1.5 m -46.25 149.6 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -131.4 150.91 51.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.86 132.35 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 82.4 t -134.89 130.44 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -115.51 97.09 5.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.603 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 22.3 m-85 -64.89 143.41 57.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.13 -29.66 66.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 16.6 tp10 -121.14 139.1 28.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 0.0 110.906 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.0 3.84 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.44 -48.19 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.15 -43.17 99.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.603 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -59.34 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -51.85 -55.19 21.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 39.1 tttp -46.96 -61.37 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.25 -41.04 75.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 9.1 t80 -53.39 -46.73 69.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -62.71 -52.82 61.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.403 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 53.4 m-70 -57.08 -64.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.543 HD21 ' CE1' ' A' ' 245' ' ' PHE . 41.0 mt -51.42 -41.74 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -48.02 147.42 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 54.22 40.33 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.948 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.6 t -126.96 -176.29 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -127.48 127.08 43.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.887 ' HB2' HD21 ' A' ' 287' ' ' LEU . 28.4 t80 -75.6 -62.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.485 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.9 m170 -123.94 -75.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -128.89 -8.62 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 23.5 m -115.05 153.02 47.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.673 0.749 . . . . 0.0 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 134.51 28.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.732 2.288 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -87.12 125.21 34.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -111.98 100.75 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.8 131.45 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -138.48 121.29 16.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ3' ' CG1' ' A' ' 224' ' ' ILE . 57.0 m95 -53.0 146.76 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.898 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -100.29 142.76 25.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.74 178.8 4.2 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 0.0 112.353 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 294' ' ' ILE . 0.2 OUTLIER -85.51 -14.33 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.94 -36.94 45.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 297' ' ' PHE . 12.5 p -39.14 -50.08 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.591 ' N ' HG13 ' A' ' 296' ' ' VAL . 31.0 m-85 -96.06 -62.72 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.32 161.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.3 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -50.64 138.17 23.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.572 0.701 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -175.59 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.34 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -109.68 45.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -57.86 -41.54 82.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -40.25 -37.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.23 -46.42 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 35.1 t -47.54 -38.46 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 1.1 tm0? -40.7 -40.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 309' ' ' GLU . 6.8 t-80 -37.32 -44.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 308' ' ' HIS . 41.9 tt0 -34.69 119.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -101.99 142.87 25.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.55 34.13 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 0.0 112.282 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.03 -39.99 9.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -40.51 -49.37 2.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.51 -42.16 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.16 2.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -47.16 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t 55.58 42.2 29.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -40.74 148.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -174.71 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 3.6 t -103.0 -56.85 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.3 m -133.61 175.76 9.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.4 p -98.73 -30.12 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.5 m -95.79 -66.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -42.91 -41.79 4.7 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 75.5 p -52.53 -48.05 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.81 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.7 t -54.11 -55.25 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.5 82.48 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.35 144.92 51.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.7 m -63.78 147.76 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -105.44 -19.68 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 p -92.37 -28.85 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.196 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.7 t -96.17 138.4 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.508 HG12 ' CE3' ' A' ' 291' ' ' TRP . 19.5 mt -138.01 146.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 261' ' ' ILE . 17.2 mt -112.81 123.38 50.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.99 125.22 42.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.5 mttt -119.49 161.65 20.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.33 53.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.573 ' H ' HD12 ' A' ' 258' ' ' ILE . 35.2 mt -114.75 132.76 22.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.71 139.72 41.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.714 2.276 . . . . 0.0 112.332 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.99 -20.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.42 -36.77 93.04 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 234' ' ' LEU . 72.6 m -46.62 155.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 111.124 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.452 ' N ' HG22 ' A' ' 233' ' ' THR . 92.3 mt -140.61 137.61 33.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -36.4 -49.63 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.98 99.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 234' ' ' LEU . 6.6 mm-40 -54.81 -53.11 59.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.8 mm -59.68 -61.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.084 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.529 ' HB2' HG11 ' A' ' 251' ' ' VAL . 34.1 tt0 -39.99 -56.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.64 -58.17 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 22.6 m -41.07 -58.49 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -62.99 -45.33 92.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.402 ' HB2' HD12 ' A' ' 248' ' ' LEU . 8.0 t -48.41 -36.35 14.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -48.67 -44.27 37.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.2 m-85 -68.09 -50.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -159.71 -166.55 18.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.534 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.722 ' HB2' HD12 ' A' ' 265' ' ' LEU . 3.1 p -69.5 167.34 16.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 0.0 110.835 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.436 HD22 ' CG1' ' A' ' 262' ' ' VAL . 66.4 mt -140.47 174.13 10.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -143.02 -94.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -84.48 110.28 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 239' ' ' GLN . 78.9 t -118.5 103.24 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.08 121.37 34.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.8 tp -133.76 98.49 14.7 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.598 0.714 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 149.05 66.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 7.4 pt-20 -76.51 -39.81 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.42 -33.02 79.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.21 111.89 1.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.573 HD12 ' H ' ' A' ' 229' ' ' LEU . 20.3 pt -43.46 -36.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 227' ' ' LYS . 29.9 p -44.82 138.23 3.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.26 121.18 30.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.47 HG12 ' CD2' ' A' ' 225' ' ' LEU . 10.6 mt -90.7 123.87 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 248' ' ' LEU . 67.0 t -129.95 135.87 60.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.05 125.7 48.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 31.5 m-85 -91.84 149.73 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 247' ' ' SER . 34.3 mt -77.11 -24.81 51.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 27.6 tt0 -125.87 139.18 33.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.7 Cg_endo -69.75 -41.68 4.07 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.41 -47.1 87.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.05 -47.52 82.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.49 -47.63 63.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.12 -48.47 81.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 5.7 ttpm? -48.85 -58.29 5.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.48 55.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.15 -55.28 3.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -55.75 -56.21 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 31.8 m-70 -54.49 -66.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.8 mt -45.23 -48.71 12.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.71 145.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 62.32 25.51 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.1 t -124.17 157.55 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -108.83 127.41 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.582 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.1 t80 -69.84 -74.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 282' ' ' PHE . 22.7 m170 -116.02 -70.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.824 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -125.38 -20.73 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 33.7 m -111.41 152.13 43.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.565 0.697 . . . . 0.0 111.126 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 135.51 30.64 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.5 mt -79.34 118.8 21.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -112.34 100.74 9.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 277' ' ' LEU . 28.6 mt -87.93 145.95 25.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 291' ' ' TRP . 4.6 mm-40 -147.51 109.99 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.508 ' CE3' HG12 ' A' ' 224' ' ' ILE . 74.8 m95 -37.48 150.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -100.76 142.35 24.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.613 0.72 . . . . 0.0 111.107 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.2 Cg_endo -69.71 -174.87 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.383 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 25.2 pt -91.41 -14.62 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.47 -22.67 28.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 293' ' ' PRO . 4.0 p -40.61 -36.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -96.93 -49.09 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 49.66 -167.89 0.27 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.49 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -151.63 178.63 9.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -158.28 147.28 14.57 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -172.43 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.693 2.262 . . . . 0.0 112.304 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -115.22 74.54 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 -19.52 18.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -62.1 -29.19 70.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -49.04 -33.7 11.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 34.5 m -89.18 -65.79 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -38.89 -31.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -42.28 -67.15 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.804 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -146.01 163.05 36.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -150.56 157.6 36.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.557 0.694 . . . . 0.0 110.954 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.74 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -26.37 14.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -51.07 -38.64 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 3.2 ptmm? -57.26 -39.84 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.71 -44.41 96.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 10.7 mt-10 -47.1 -64.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 63.1 p 34.49 43.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -46.61 139.56 7.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.03 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 46.2 m -99.66 -57.11 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.872 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 m -91.91 177.74 6.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 97.3 p -107.2 -49.55 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 94.7 p -88.06 -43.99 11.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.22 -56.15 25.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -42.24 -46.59 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.877 0.37 . . . . 0.0 110.838 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.1 t -47.96 -57.42 5.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.93 117.41 4.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.437 ' NH2' ' O ' ' A' ' 291' ' ' TRP . 35.7 mtp180 -143.77 169.95 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 292' ' ' ALA . 2.9 t -64.88 156.18 31.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -111.27 -23.3 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -97.64 7.58 46.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 292' ' ' ALA . 96.6 t -129.36 119.2 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.571 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 27.0 mt -126.59 144.48 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 7.4 mt -109.69 149.35 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -124.65 113.26 17.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 259' ' ' THR . 53.0 mttt -106.4 166.04 10.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 67.79 54.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 42.9 mt -111.66 138.29 21.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.64 0.733 . . . . 0.0 110.944 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.75 139.33 40.02 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.356 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.82 -24.07 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.29 86.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.0 m -50.96 163.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 0.0 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 233' ' ' THR . 56.5 mt -151.26 158.71 44.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -51.78 -49.56 62.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.33 77.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.05 -57.29 11.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.403 HG23 ' CE1' ' A' ' 242' ' ' PHE . 24.1 mm -60.79 -56.81 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 251' ' ' VAL . 12.2 tt0 -42.49 -52.33 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.94 -60.09 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 6.5 m -39.54 -38.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.403 ' CE1' HG23 ' A' ' 238' ' ' ILE . 9.2 m-85 -81.28 -41.91 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.4 p -51.08 -32.36 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -46.45 -31.0 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.737 ' CE1' HD21 ' A' ' 277' ' ' LEU . 53.6 m-85 -84.83 -44.24 13.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.58 165.13 38.38 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.5 m -52.4 154.5 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.407 HD22 ' CG1' ' A' ' 262' ' ' VAL . 47.0 mt -123.75 146.42 48.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -93.17 -67.79 1.09 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.47 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -121.49 148.44 44.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 239' ' ' GLN . 49.4 t -147.52 117.07 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.8 mt -128.65 119.25 24.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 260' ' ' ALA . 7.7 tp -134.53 98.51 13.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.643 0.735 . . . . 0.0 110.918 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 150.1 67.9 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.616 2.211 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.63 -43.66 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -60.14 -23.09 59.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -124.9 114.74 2.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 13.3 pt -48.41 -38.75 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.596 HG22 ' HG2' ' A' ' 227' ' ' LYS . 39.5 p -47.14 146.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.86 134.48 44.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.054 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.28 134.13 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 248' ' ' LEU . 93.0 t -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.498 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.7 tt0 -119.36 117.81 29.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 34.0 m-85 -84.36 133.25 34.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.9 -27.33 68.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.47 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 29.5 tt0 -124.34 139.23 32.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.675 0.75 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.538 ' HG2' HD12 ' A' ' 268' ' ' LEU . 53.7 Cg_endo -69.75 -40.05 5.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 267' ' ' PRO . 8.5 mp -62.49 -46.61 87.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.01 -46.38 87.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.1 -46.51 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.155 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -60.59 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 27.9 ttpt -51.13 -55.89 15.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.29 92.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 34.1 t80 -49.26 -45.48 44.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -66.39 -48.39 70.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 56.7 m-70 -60.91 -66.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.737 HD21 ' CE1' ' A' ' 245' ' ' PHE . 15.2 mt -50.7 -42.78 57.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.11 146.12 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 56.3 37.84 29.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 5.7 t -128.77 165.47 20.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -112.69 133.69 54.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.767 ' HB2' HD21 ' A' ' 287' ' ' LEU . 42.8 t80 -78.72 -73.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.509 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 22.4 m170 -118.29 -71.99 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.13 -15.95 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.832 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.475 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 21.3 m -115.75 153.12 47.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 139.17 39.74 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.709 2.273 . . . . 0.0 112.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 282' ' ' PHE . 62.6 mt -85.7 125.73 33.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -112.33 100.68 8.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 277' ' ' LEU . 47.2 mt -90.0 126.24 35.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -130.85 121.38 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.571 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 39.6 m95 -49.49 150.79 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -113.03 143.42 29.11 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 111.122 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.69 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.79 158.11 58.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.646 2.23 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.89 -18.02 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.78 -21.76 70.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 293' ' ' PRO . 9.4 p -43.29 -45.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.512 ' N ' HG13 ' A' ' 296' ' ' VAL . 8.4 m-85 -92.21 -37.63 12.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.96 175.76 47.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.517 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.35 176.84 9.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.796 0.331 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -127.12 144.57 50.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.567 0.699 . . . . 0.0 111.08 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 124.37 11.03 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -73.61 136.43 43.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -79.8 -43.21 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -48.37 -41.03 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -44.63 -37.68 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 m -69.32 -41.84 76.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -48.85 -50.03 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 309' ' ' GLU . 14.8 t60 -43.93 -32.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 21.8 tp10 -36.03 127.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.49 122.35 43.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 145.42 57.11 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.658 2.239 . . . . 0.0 112.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.9 -19.85 19.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -48.21 -40.87 25.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -51.4 -46.17 62.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.45 -46.82 73.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -45.66 -43.23 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.1 t -44.04 103.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -151.98 -164.09 12.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.457 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 152.88 69.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.627 2.218 . . . . 0.0 112.342 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 321' ' ' SER . 3.4 m -103.08 -56.73 2.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 320' ' ' SER . 32.2 t -34.91 147.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.2 p -107.52 -50.71 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.2 m -44.8 -46.9 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -56.65 -70.81 0.86 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 74.4 p -42.87 -53.3 4.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.886 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -49.28 -39.47 30.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.815 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -63.78 -112.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -99.9 171.72 7.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.9 t -85.62 149.48 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -104.04 -15.06 15.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.4 p -95.88 -16.95 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.607 HG12 ' HB3' ' A' ' 292' ' ' ALA . 86.5 t -113.33 119.26 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.468 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 8.8 mt -120.9 138.29 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.902 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 84.1 mt -104.04 120.0 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.61 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 225' ' ' LEU . 0.1 OUTLIER -137.77 165.61 26.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.3 OUTLIER 65.12 53.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 258' ' ' ILE . 25.1 mt -112.63 142.51 27.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.47 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 146.65 60.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.671 2.247 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -54.16 -21.35 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.97 -28.21 70.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.511 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 238' ' ' ILE . 3.7 m -54.09 148.16 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.824 0.345 . . . . 0.0 111.147 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.6 155.16 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.408 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -47.76 -41.33 22.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.115 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.47 -50.59 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.49 -53.14 24.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 242' ' ' PHE . 27.6 mm -61.85 -64.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.691 ' HG3' HG21 ' A' ' 251' ' ' VAL . 22.1 tt0 -36.38 -48.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -68.15 -55.46 12.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 43.4 m -45.99 -49.64 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.3 m-85 -73.4 -44.71 57.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 t -51.83 -29.61 20.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -45.93 -34.88 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.496 ' CE1' HD21 ' A' ' 277' ' ' LEU . 63.1 m-85 -78.97 -44.7 21.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.07 168.48 41.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 9.1 m -55.3 130.98 44.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.677 HD22 ' CG1' ' A' ' 262' ' ' VAL . 13.3 mt -98.66 161.14 13.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.46 -105.93 2.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.477 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -80.71 118.94 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 239' ' ' GLN . 54.9 t -120.2 109.47 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.59 109.8 14.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.4 tp -133.32 98.57 15.26 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.6 Cg_endo -69.82 151.37 68.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.27 -40.35 27.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.48 -16.04 60.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -132.16 116.28 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 259' ' ' THR . 2.6 pp -49.89 -27.83 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.576 ' N ' HD12 ' A' ' 258' ' ' ILE . 42.2 p -54.09 140.72 30.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.83 141.03 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.092 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 261' ' ' ILE . 5.0 mp -114.73 129.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.677 ' CG1' HD22 ' A' ' 248' ' ' LEU . 81.1 t -130.94 131.0 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.596 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.3 tt0 -116.42 97.55 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.492 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -65.51 141.21 58.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.12 -24.72 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.443 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 10.5 tp10 -126.47 137.93 31.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -42.87 3.07 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.37 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.4 mt -59.47 -51.42 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -60.46 -45.21 94.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -53.38 -44.78 68.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.077 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -61.88 -49.89 74.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -50.05 -58.73 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.79 -51.46 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -42.59 -50.87 5.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -60.94 -52.91 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -52.69 -66.32 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.9 mt -47.75 -46.97 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -44.36 139.71 2.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 62.01 33.77 17.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.7 t -130.9 156.13 45.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -101.55 120.86 40.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.757 ' HB2' HD11 ' A' ' 287' ' ' LEU . 3.7 t80 -70.55 -72.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.662 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.1 m170 -112.78 -74.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.536 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 17.2 m-70 -125.82 -12.64 6.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.47 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 16.0 m -121.2 153.26 58.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 0.0 111.118 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 129.37 17.55 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 282' ' ' PHE . 62.4 mt -73.74 126.76 31.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -112.33 101.3 9.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.13 136.96 33.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.97 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.16 123.47 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.468 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 55.6 m95 -52.62 132.42 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.965 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.902 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -90.63 140.52 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.471 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.6 Cg_endo -69.69 146.41 60.53 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 35.9 pt -58.86 -15.48 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -73.42 -26.86 69.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 297' ' ' PHE . 7.0 p -49.33 -44.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 111.117 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.596 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 6.4 m-85 -96.41 -45.09 6.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.69 24.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.542 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -154.56 156.36 36.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.34 . . . . 0.0 111.137 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -48.6 143.86 7.35 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.574 0.702 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -169.19 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -123.82 43.92 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.98 -54.03 4.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -46.63 -31.56 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.65 -39.75 51.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.7 m -45.98 -33.24 3.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -83.21 -47.58 11.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -39.92 -32.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 310' ' ' GLN . 18.8 mm-40 -38.63 123.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 309' ' ' GLU . 8.5 pt20 -33.96 96.96 0.11 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 0.0 110.894 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.429 ' N ' ' O ' ' A' ' 309' ' ' GLU . 54.0 Cg_endo -69.71 165.42 30.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.59 -45.35 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -53.07 -50.54 64.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -41.13 -52.81 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.2 -43.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 317' ' ' SER . 19.6 tt0 -51.68 -46.81 63.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 316' ' ' GLU . 28.3 t -34.88 124.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.24 178.97 36.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 164.06 35.97 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.66 2.24 . . . . 0.0 112.329 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 53.2 p -101.66 -44.21 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.0 m 49.48 46.19 23.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 217' ' ' SER . 23.3 m -65.4 -46.54 79.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.7 p -81.02 -48.47 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -55.55 -64.65 4.19 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.5 m -55.48 -52.73 62.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 213' ' ' SER . 28.9 t -47.82 -56.94 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -42.4 -64.74 1.48 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -53.78 156.6 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 38.2 m -44.57 154.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER -108.51 -14.15 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 42.0 p -114.26 20.22 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.581 HG12 ' CB ' ' A' ' 292' ' ' ALA . 88.1 t -147.21 129.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.485 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 10.3 mt -132.87 147.94 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 16.2 mt -109.33 125.09 51.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.75 140.84 34.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.635 ' HG2' HG22 ' A' ' 259' ' ' THR . 63.5 mttt -138.46 170.47 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.79 50.49 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 44.7 mt -109.16 142.25 25.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.75 138.68 38.41 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.41 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -67.57 -35.7 86.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.6 m -44.7 163.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 111.138 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.501 ' N ' HG22 ' A' ' 233' ' ' THR . 64.7 mt -150.6 142.88 24.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.59 -36.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.084 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -69.5 -49.51 54.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -52.18 -54.03 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.75 -58.58 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.687 ' HG3' HG21 ' A' ' 251' ' ' VAL . 23.8 tt0 -43.67 -56.15 3.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.68 -59.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 64.6 m -40.07 -50.28 2.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.148 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 27.3 m-85 -72.43 -48.53 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.0 t -49.54 -33.75 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -43.35 -38.97 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.794 ' CE1' HD21 ' A' ' 277' ' ' LEU . 68.0 m-85 -71.5 -49.36 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -158.95 169.39 35.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.5 m -61.37 123.3 17.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.869 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 264' ' ' PHE . 20.7 mt -94.51 163.59 13.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -109.37 -77.34 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -112.76 147.08 37.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 239' ' ' GLN . 78.2 t -143.48 124.7 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 47.2 mt -132.94 106.25 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.0 tp -124.66 98.48 37.24 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.933 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 148.79 65.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.31 -45.26 26.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.91 -30.39 56.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.42 2.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.489 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 23.3 pt -45.88 -28.25 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.0 111.162 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.635 HG22 ' HG2' ' A' ' 227' ' ' LYS . 61.7 p -50.07 139.67 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -131.92 124.36 29.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.9 mt -96.28 128.68 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.64 140.31 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 30.4 tt0 -126.47 112.02 15.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 248' ' ' LEU . 27.6 m-85 -81.26 151.32 28.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.79 -5.84 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.435 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -142.82 137.81 15.44 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.668 0.746 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.8 -39.23 6.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.671 2.248 . . . . 0.0 112.341 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 62.9 mt -63.21 -51.07 67.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -40.76 96.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.77 70.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -58.07 -49.44 76.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -50.27 -55.59 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.09 77.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.619 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 8.1 t80 -48.15 -45.84 33.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.0 mtp85 -62.24 -47.84 82.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -63.13 -72.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.794 HD21 ' CE1' ' A' ' 245' ' ' PHE . 30.8 mt -45.75 -26.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.44 137.29 55.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 70.83 32.3 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 m -139.37 169.67 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.06 143.52 45.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.881 ' HB2' HD21 ' A' ' 287' ' ' LEU . 10.5 t80 -78.55 -72.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.733 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.4 m170 -108.46 -73.05 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -128.39 -7.18 5.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 13.4 m -119.32 153.8 53.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.644 0.735 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 127.6 14.81 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.881 HD21 ' HB2' ' A' ' 282' ' ' PHE . 58.3 mt -72.03 120.71 18.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.7 101.58 11.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 277' ' ' LEU . 40.4 mt -94.33 142.56 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -147.69 108.55 4.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.485 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 53.8 m95 -38.82 146.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.952 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.581 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -96.91 143.52 26.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.594 0.711 . . . . 0.0 111.07 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.616 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.75 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 12.0 pt -91.17 -16.5 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -84.25 -16.99 65.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 293' ' ' PRO . 2.7 p -51.0 -53.98 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 263' ' ' GLU . 12.9 m-85 -93.88 -40.66 10.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.88 132.98 0.91 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -174.59 149.54 1.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.063 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -131.79 143.87 50.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 175.54 7.99 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.93 67.28 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -87.5 -43.04 12.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -40.38 -41.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -40.55 -42.99 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 23.6 t -50.17 -49.18 53.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -45.69 -38.74 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 309' ' ' GLU . 59.1 t-80 -39.16 -39.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.814 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 308' ' ' HIS . 16.2 tt0 -35.09 100.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -96.72 135.92 21.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.587 0.708 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 164.9 32.81 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.73 -19.37 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -59.53 -39.74 84.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 6.9 ptmt -47.93 -33.58 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.65 -38.53 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 317' ' ' SER . 6.3 tp10 -49.04 -45.82 43.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 316' ' ' GLU . 83.2 p -38.0 132.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.412 ' HA2' ' HD2' ' A' ' 319' ' ' PRO . . . -174.31 106.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HD2' ' HA2' ' A' ' 318' ' ' GLY . 53.6 Cg_endo -69.79 -179.19 2.75 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.665 2.243 . . . . 0.0 112.344 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 74.7 m -100.97 -58.49 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 52.6 m 57.42 41.79 25.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.5 p -97.66 -57.11 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 215' ' ' GLY . 2.5 m -59.52 -55.13 38.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.23 -45.43 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.507 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.0 t -44.03 -62.26 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.809 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.7 p -51.08 -48.27 61.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.38 73.72 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -68.87 144.94 54.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 292' ' ' ALA . 24.1 m -45.25 156.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.438 ' O ' ' CZ3' ' A' ' 291' ' ' TRP . 0.0 OUTLIER -109.92 -20.61 12.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p -94.72 -27.48 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.551 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.7 t -94.63 133.43 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.156 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.495 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 18.1 mt -134.8 138.96 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.66 122.72 46.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.0 49.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -124.08 164.78 18.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.2 OUTLIER 70.49 52.66 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 258' ' ' ILE . 53.3 mt -110.4 138.07 20.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.617 0.723 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.3 Cg_endo -69.79 131.65 21.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.36 -34.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.11 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.5 -40.2 61.62 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.2 m -41.82 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 233' ' ' THR . 92.4 mt -141.67 138.75 32.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 234' ' ' LEU . . . -37.02 -49.95 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.47 77.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -49.01 -55.96 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 242' ' ' PHE . 36.5 mm -60.66 -52.7 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.698 ' HG3' HG21 ' A' ' 251' ' ' VAL . 20.3 tt0 -46.22 -56.42 5.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.36 -51.84 57.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.1 m -44.61 -47.22 10.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 248' ' ' LEU . 7.6 m-85 -77.63 -51.58 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 51.8 p -41.9 -36.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -38.96 -51.96 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.83 -49.1 76.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.5 148.83 15.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 12.0 m -46.31 128.06 9.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.693 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 56.8 mt -90.95 140.32 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -78.29 -52.87 5.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -140.64 150.63 43.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.698 HG21 ' HG3' ' A' ' 239' ' ' GLN . 68.9 t -141.93 129.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -144.87 116.71 8.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.3 tp -134.24 98.49 14.03 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.606 0.717 . . . . 0.0 110.946 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.88 66.01 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.276 . . . . 0.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -74.49 -45.69 44.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -55.02 -33.85 57.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.48 114.23 2.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 229' ' ' LEU . 26.0 pt -46.88 -33.16 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 62.7 p -45.77 126.04 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.05 123.04 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.15 128.39 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.05 140.98 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.588 ' OE1' ' CE2' ' A' ' 297' ' ' PHE . 25.1 tt0 -128.72 114.35 16.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.693 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 25.6 m-85 -83.8 159.52 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 68.0 mt -86.86 -32.54 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 267' ' ' PRO . 2.6 tp10 -114.97 133.88 22.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 266' ' ' GLU . 53.6 Cg_endo -69.76 -27.44 26.48 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.673 2.248 . . . . 0.0 112.377 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.1 mt -71.87 -49.96 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.21 -42.32 93.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -59.25 -48.12 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -58.03 -48.84 78.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.572 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 12.6 ttmt -50.59 -55.42 16.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.27 -45.4 84.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 6.5 t80 -49.46 -49.26 46.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -60.27 -54.24 48.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 36.6 m-70 -61.92 -67.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 56.4 mt -47.83 -27.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -67.86 143.85 55.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.053 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 62.07 39.04 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.0 m -133.36 -178.73 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -128.24 135.19 49.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 287' ' ' LEU . 24.0 t80 -79.54 -63.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.7 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 15.6 m170 -121.89 -73.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.618 ' ND1' HG13 ' A' ' 285' ' ' VAL . 7.0 p80 -125.9 -23.79 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.618 HG13 ' ND1' ' A' ' 284' ' ' HIS . 33.7 m -104.96 152.66 39.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.618 0.723 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 146.49 60.76 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.353 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 282' ' ' PHE . 27.6 mt -95.47 122.26 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -112.22 100.64 8.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.94 141.42 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -145.47 117.05 8.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.495 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 67.8 m95 -43.09 149.12 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -97.77 142.75 25.05 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.569 0.699 . . . . 0.0 111.148 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.559 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.72 -176.74 1.57 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.328 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.4 pt -91.23 -14.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.7 -18.45 44.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 293' ' ' PRO . 5.6 p -48.62 -43.18 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 111.114 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.588 ' CE2' ' OE1' ' A' ' 263' ' ' GLU . 10.6 m-85 -94.46 -54.78 3.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.93 -174.65 19.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -158.15 168.82 26.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -151.71 138.3 11.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.551 0.691 . . . . 0.0 111.087 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.61 37.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -123.19 82.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.72 -27.37 14.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -57.94 -42.3 84.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.895 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -42.36 -44.85 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.0 t -67.61 -46.19 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 308' ' ' HIS . 14.5 mm100 -39.58 -43.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.3 t-160 -36.94 -42.93 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -39.21 158.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.13 151.23 68.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 112.65 3.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.744 2.296 . . . . 0.0 112.333 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -97.89 -39.53 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 312' ' ' ALA . 14.1 pt-20 -37.86 -43.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -39.43 -56.45 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.66 52.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.5 tt0 -45.27 -47.72 12.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 316' ' ' GLU . 10.5 t -35.56 129.11 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.35 144.97 9.0 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 103.84 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.345 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 321' ' ' SER . 26.5 p -103.21 -57.94 1.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 320' ' ' SER . 1.7 t -35.11 146.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.447 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 60.3 p -87.3 -47.18 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.895 0.379 . . . . 0.0 110.888 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 215' ' ' GLY . 61.7 m -79.39 -42.29 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -35.63 -55.24 1.05 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 88.1 p -42.2 -47.98 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -81.83 -59.63 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 45.16 50.78 9.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -153.65 135.22 14.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.842 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.6 m -66.88 143.33 56.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 3.7 mppt? -104.45 1.62 30.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 54.6 p -118.13 -27.77 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 297' ' ' PHE . 62.1 t -96.58 118.97 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 37.6 mt -116.92 147.59 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.085 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 36.0 mt -111.93 119.74 39.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.49 132.98 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 259' ' ' THR . 45.3 mttm -128.49 161.53 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.58 50.96 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.3 mt -107.63 142.86 26.08 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.634 0.73 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.75 138.54 38.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.13 -21.04 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -70.03 -32.31 69.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.1 m -46.87 159.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.842 0.354 . . . . 0.0 111.146 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 233' ' ' THR . 67.4 mt -149.15 145.44 27.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.47 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -40.32 -45.48 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.144 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.08 79.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -53.73 -59.65 4.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 233' ' ' THR . 28.2 mm -59.2 -50.63 79.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' A' ' 251' ' ' VAL . 35.2 tt0 -48.79 -59.35 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -62.59 -57.49 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 53.2 m -40.24 -53.54 2.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.23 -49.54 64.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.1 p -44.47 -36.26 2.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -46.92 -38.79 11.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' A' ' 277' ' ' LEU . 56.7 m-85 -75.43 -47.66 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.9 165.84 36.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.803 ' HB2' HD12 ' A' ' 265' ' ' LEU . 82.0 p -46.51 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 87.6 mt -139.26 137.6 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.559 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -91.53 -67.62 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -125.76 150.14 47.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 239' ' ' GLN . 93.7 t -138.67 105.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 mt -115.13 113.57 24.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.7 tp -134.27 98.41 14.04 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.647 0.737 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 148.93 66.19 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 112.323 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.35 -39.37 47.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.16 -27.08 71.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.5 118.06 3.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 20.7 pt -48.09 -35.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 227' ' ' LYS . 81.1 p -44.45 139.19 2.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.704 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -134.34 114.85 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 225' ' ' LEU . 11.5 mt -86.54 133.73 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 248' ' ' LEU . 92.1 t -138.83 119.5 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.44 ' C ' ' OE1' ' A' ' 263' ' ' GLU . 0.0 OUTLIER -99.04 135.33 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -102.47 149.75 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.803 HD12 ' HB2' ' A' ' 247' ' ' SER . 32.7 mt -83.43 -12.42 56.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -136.86 132.72 18.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -34.47 14.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.0 mt -65.47 -52.08 55.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.18 -42.99 99.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -62.34 -43.6 98.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 61.3 tttt -53.79 -54.93 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -58.72 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.1 t80 -46.1 -47.79 17.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -60.06 -56.65 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.855 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.458 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 49.9 m-70 -53.62 -61.68 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.699 ' HB2' HD11 ' A' ' 289' ' ' LEU . 43.8 mt -55.39 -41.29 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -46.1 141.5 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 57.66 32.08 21.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 1.8 t -124.96 171.62 10.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.88 139.59 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.71 ' HB2' HD21 ' A' ' 287' ' ' LEU . 18.0 t80 -89.14 -69.77 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.691 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 17.8 m170 -119.93 -72.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -124.97 -23.44 4.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 21.9 m -109.64 153.03 43.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.668 2.246 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' A' ' 282' ' ' PHE . 39.9 mt -75.5 121.06 21.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.99 100.79 9.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 277' ' ' LEU . 59.2 mt -88.74 135.31 33.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.69 119.12 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.516 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.2 m95 -52.96 148.0 8.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.511 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -99.33 151.8 37.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.569 0.699 . . . . 0.0 111.111 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.555 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.0 Cg_endo -69.78 -179.52 2.97 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.646 2.231 . . . . 0.0 112.367 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.37 -14.78 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.63 -28.34 22.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.527 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 293' ' ' PRO . 2.6 p -40.02 -39.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 223' ' ' VAL . 10.3 m-85 -96.66 -62.15 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -56.67 -176.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -162.7 147.4 11.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -38.73 143.68 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 111.085 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 127.34 14.45 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.242 . . . . 0.0 112.353 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.27 41.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.82 -60.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -42.42 -38.41 1.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -52.15 -43.48 64.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 36.0 m -45.58 -28.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -95.72 -33.8 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 310' ' ' GLN . 7.2 m170 -39.61 -51.89 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 3.5 pt-20 -34.49 94.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 308' ' ' HIS . 4.5 tt0 -130.53 124.77 21.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.582 0.706 . . . . 0.0 110.948 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 106.05 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -87.35 -26.43 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -44.12 -41.23 5.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -67.63 -49.01 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.7 -41.92 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.37 -53.98 9.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 36.4 t -38.06 122.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.96 91.81 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.47 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 133.09 24.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.694 2.263 . . . . 0.0 112.346 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 31.9 m -100.59 -48.36 4.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 40.8 t -44.25 106.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.503 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 84.2 p -62.93 -47.6 82.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 215' ' ' GLY . 14.7 m -72.67 -52.9 13.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 214' ' ' SER . . . -37.71 -48.65 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 t -47.41 -62.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.7 m -64.51 -59.71 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.18 110.77 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 51.3 mmt-85 -78.47 128.01 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 292' ' ' ALA . 13.7 m -42.26 162.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.844 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.22 -20.47 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.93 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.6 p -93.77 -29.55 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 292' ' ' ALA . 70.6 t -92.8 113.2 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 32.6 mt -116.96 138.85 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 10.9 mt -110.19 123.8 50.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.86 132.73 51.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.678 ' HG2' HG22 ' A' ' 259' ' ' THR . 75.4 mttt -125.7 165.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.45 52.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.758 ' H ' HD12 ' A' ' 258' ' ' ILE . 62.3 mt -112.19 136.83 21.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.622 0.725 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.2 Cg_endo -69.69 133.06 24.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.4 -33.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -53.9 -41.55 67.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.477 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 234' ' ' LEU . 18.4 m -45.69 163.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.133 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.549 ' N ' HG22 ' A' ' 233' ' ' THR . 78.6 mt -148.69 153.91 38.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.43 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -48.95 -42.81 38.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -63.5 -47.54 81.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -52.21 -61.62 2.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 28.6 mm -53.6 -59.47 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.617 ' HG3' HG21 ' A' ' 251' ' ' VAL . 29.5 tt0 -37.22 -56.18 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 241' ' ' THR . 3.3 tt0 -64.32 -58.74 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 240' ' ' GLU . 60.8 m -34.76 -54.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.163 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 248' ' ' LEU . 47.4 m-85 -71.93 -48.78 42.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 248' ' ' LEU . 11.1 t -44.48 -39.13 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -40.47 -50.04 2.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.421 ' CE1' HD21 ' A' ' 277' ' ' LEU . 43.2 m-85 -60.86 -43.31 98.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -174.21 156.78 24.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.0 m -41.13 144.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 110.863 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.8 mt -116.67 160.12 21.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.906 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -103.78 -89.19 2.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.472 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.511 HH21 HD21 ' A' ' 252' ' ' LEU . 12.1 mmm180 -98.9 143.64 28.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.341 . . . . 0.0 110.867 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 239' ' ' GLN . 57.4 t -145.13 114.66 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.511 HD21 HH21 ' A' ' 250' ' ' ARG . 15.0 mt -132.3 121.43 23.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -134.69 98.65 13.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.611 0.72 . . . . 0.0 110.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 148.77 65.79 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 0.0 112.391 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 255' ' ' GLU . 1.4 pm0 -76.61 -33.84 58.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.58 -36.31 92.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.55 117.53 3.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.455 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.758 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.2 pt -47.25 -33.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.678 HG22 ' HG2' ' A' ' 227' ' ' LYS . 56.7 p -50.06 128.36 18.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -116.95 129.49 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.082 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.89 129.85 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.09 128.6 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -115.22 108.09 16.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 19.4 m-85 -70.05 140.67 52.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.6 -30.01 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.1 tp10 -121.34 139.9 30.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.631 0.729 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.5 Cg_endo -69.75 -43.66 2.54 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.697 2.264 . . . . 0.0 112.324 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.1 mt -60.19 -44.16 95.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.15 -47.01 84.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.13 -52.35 44.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -57.08 -46.0 82.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 57.3 tttt -53.05 -61.11 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.67 -47.47 79.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.2 t80 -48.12 -44.48 31.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -63.91 -56.8 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.423 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 58.8 m-70 -52.89 -58.3 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.8 mt -57.56 -48.28 79.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -37.02 132.39 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 69.53 46.24 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.8 m -142.27 169.08 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -116.93 140.16 49.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.873 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.716 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 21.0 t80 -80.94 -65.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.716 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 12.8 m170 -118.04 -74.84 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.432 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -127.25 -10.91 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.471 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 31.5 m -117.86 153.18 50.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 111.097 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 147.16 62.41 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.656 2.237 . . . . 0.0 112.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 282' ' ' PHE . 46.4 mt -96.75 127.95 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -112.46 100.68 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.39 140.86 29.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.96 121.08 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 84.4 m95 -55.29 148.59 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -105.83 144.82 29.66 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.533 ' HG2' HG13 ' A' ' 296' ' ' VAL . 54.2 Cg_endo -69.78 -172.48 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.6 pp -91.63 -22.79 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.97 -37.56 92.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 297' ' ' PHE . 3.0 m -39.77 -55.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.549 ' H ' HG23 ' A' ' 296' ' ' VAL . 20.4 m-85 -95.59 -29.28 14.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -69.21 -0.52 22.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -84.19 114.46 21.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -163.62 149.41 9.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 173.88 10.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -126.95 96.71 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -98.83 -40.84 7.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -41.11 -35.53 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.38 -58.97 1.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 56.5 p -64.72 -36.88 85.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.464 ' HA ' ' NE2' ' A' ' 307' ' ' GLN . 5.6 tp60 -55.62 -27.89 52.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 307' ' ' GLN . 7.1 m170 -36.83 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -163.4 -179.34 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -131.57 151.52 78.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.604 0.716 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 105.02 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -95.03 -20.66 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -49.0 -38.6 23.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 315' ' ' ALA . 13.7 ptmt -43.33 -31.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.421 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -62.31 -44.97 95.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.082 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' SER . 21.9 tt0 -45.29 -46.74 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 316' ' ' GLU . 14.8 m -34.97 122.98 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.49 145.52 9.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.03 39.41 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 32.4 m -101.74 -57.81 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.83 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.5 t -165.61 176.74 7.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 28.7 t -69.82 -44.07 70.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.0 m -58.65 -43.21 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -40.93 -47.21 4.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 m -60.16 -49.91 75.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 44.2 t -54.33 -44.85 72.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.02 127.53 5.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -169.51 152.58 4.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 292' ' ' ALA . 8.2 t -50.67 150.76 2.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -107.59 -40.24 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.2 p -96.04 25.39 4.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.142 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -138.87 124.92 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.504 HG12 ' CE3' ' A' ' 291' ' ' TRP . 34.9 mt -128.83 142.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 261' ' ' ILE . 27.9 mt -110.16 121.54 45.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.21 128.15 37.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.775 ' HD3' HG22 ' A' ' 259' ' ' THR . 15.7 mmtp -118.49 153.31 34.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 74.9 54.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 258' ' ' ILE . 79.6 mt -108.7 135.49 20.06 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.621 0.724 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.594 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 53.7 Cg_endo -69.77 132.27 22.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.31 -30.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.33 90.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.533 HG21 HD11 ' A' ' 238' ' ' ILE . 5.2 m -48.71 163.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 111.143 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 233' ' ' THR . 60.1 mt -151.72 151.08 30.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -39.48 -50.98 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.57 69.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.09 -57.94 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 233' ' ' THR . 32.9 mm -53.37 -64.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.592 ' HG3' HG21 ' A' ' 251' ' ' VAL . 9.5 tt0 -38.5 -50.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.58 -56.21 17.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 89.8 m -44.45 -52.58 7.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -71.71 -40.13 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 28.8 t -49.85 -41.64 45.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -38.92 -41.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.627 ' CE1' HD21 ' A' ' 277' ' ' LEU . 57.4 m-85 -72.21 -49.09 38.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.936 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.1 166.52 39.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.7 m -56.03 140.37 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 110.915 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.77 HD21 ' CZ ' ' A' ' 264' ' ' PHE . 18.4 mt -110.05 162.46 14.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.73 -97.48 2.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -88.46 121.72 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.3 t -123.16 108.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 16.2 mt -128.14 118.68 23.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 260' ' ' ALA . 12.7 tp -134.93 98.48 13.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.592 0.71 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.73 148.21 64.77 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.695 2.263 . . . . 0.0 112.353 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -73.7 -44.34 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.8 -36.56 50.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.79 122.93 5.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 229' ' ' LEU . 15.2 pt -52.51 -35.78 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 111.111 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.775 HG22 ' HD3' ' A' ' 227' ' ' LYS . 37.3 p -42.38 137.23 2.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.568 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -125.54 127.11 45.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 225' ' ' LEU . 23.0 mt -99.69 116.17 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.664 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.9 t -121.99 131.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -119.42 102.12 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.77 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 13.4 m-85 -68.84 158.92 33.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 53.3 mt -86.09 -31.15 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.01 133.87 22.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -35.88 11.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.374 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.26 -49.56 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.87 -42.54 94.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.02 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 65.6 mtt-85 -62.21 -47.73 83.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 17.8 ttpt -52.11 -59.64 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.45 -45.94 66.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -49.34 -53.23 23.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 272' ' ' LYS . 95.2 mtm-85 -54.85 -49.38 71.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.444 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 59.7 m-70 -61.43 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 245' ' ' PHE . 46.0 mt -51.03 -27.36 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.41 140.28 58.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.093 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.87 44.01 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 m -139.96 -179.27 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -127.02 144.22 51.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.68 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 18.2 t80 -89.6 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.68 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 11.1 m170 -121.43 -72.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.846 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.594 ' CE1' ' HB3' ' A' ' 230' ' ' PRO . 5.3 p80 -127.23 -14.34 5.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 16.9 m -115.95 154.26 48.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.46 66.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.8 mt -98.32 118.32 34.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -112.35 100.61 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 277' ' ' LEU . 97.7 mt -83.81 144.89 28.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -147.71 105.18 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.504 ' CE3' HG12 ' A' ' 224' ' ' ILE . 97.3 m95 -38.82 153.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -100.97 143.47 26.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.553 0.692 . . . . 0.0 111.131 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 13.3 pt -91.71 -26.59 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.089 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -76.98 -27.15 60.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.531 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.7 p -39.44 -46.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.531 ' N ' HG13 ' A' ' 296' ' ' VAL . 12.6 m-85 -96.1 -58.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 46.36 -173.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.0 172.38 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -142.73 128.48 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.618 0.723 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.05 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.708 2.272 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.68 43.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -91.32 -56.55 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -46.88 -35.07 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -41.68 -40.73 2.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.9 t -39.33 -40.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 309' ' ' GLU . 3.8 tp-100 -71.71 -45.6 61.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 30.1 t60 -37.09 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 307' ' ' GLN . 7.0 tp10 -35.03 105.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -99.72 131.95 23.81 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.55 40.59 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -94.94 -30.28 14.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -39.73 -42.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.54 -46.64 70.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -49.32 -40.64 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.092 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.448 ' C ' ' OE1' ' A' ' 316' ' ' GLU . 9.9 tm-20 -45.38 -43.0 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 89.7 p -40.33 103.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.7 166.24 36.64 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 162.05 43.57 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 24.3 m -103.18 -58.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.819 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.1 t -167.83 177.99 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -59.43 -57.44 12.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.5 m -45.95 -41.65 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -48.18 -64.96 2.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 20.9 t -54.25 -55.38 28.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.5 t -43.42 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -89.79 81.29 1.44 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -74.11 176.5 6.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.8 t -93.88 141.22 28.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.22 -16.75 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.9 p -94.27 11.31 30.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 292' ' ' ALA . 97.0 t -144.35 130.63 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.512 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 13.2 mt -134.94 144.31 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 39.6 mt -106.03 116.42 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 136.96 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.535 ' HG2' HG22 ' A' ' 259' ' ' THR . 28.1 mttp -132.75 160.79 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 2.0 t30 73.99 53.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.4 mt -113.09 139.03 22.53 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.79 140.33 42.29 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.662 2.242 . . . . 0.0 112.356 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.49 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.82 -33.15 81.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 234' ' ' LEU . 6.7 m -55.07 160.66 1.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 233' ' ' THR . 52.4 mt -151.29 153.57 35.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -43.58 -50.18 7.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.69 -56.17 22.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -45.53 -59.73 2.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.514 HG23 ' CE1' ' A' ' 242' ' ' PHE . 26.4 mm -58.27 -60.3 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.554 ' O ' HD12 ' A' ' 248' ' ' LEU . 14.3 tt0 -39.57 -46.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -71.82 -58.84 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 97.4 m -39.42 -59.33 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.542 ' CE2' ' CD1' ' A' ' 277' ' ' LEU . 38.8 m-85 -62.24 -41.5 98.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.6 t -52.15 -35.61 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -42.55 -46.49 4.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.504 ' CE1' HD21 ' A' ' 277' ' ' LEU . 75.2 m-85 -67.61 -45.39 75.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -170.91 163.01 36.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 74.7 m -47.22 150.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 239' ' ' GLN . 27.2 mt -117.98 161.9 19.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.07 -92.48 2.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -100.64 127.13 47.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.6 114.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.59 113.18 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 260' ' ' ALA . 4.4 tp -132.99 98.43 15.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 110.929 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.9 Cg_endo -69.79 148.77 65.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.331 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -75.6 -44.63 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -61.75 -21.51 60.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -125.96 115.43 2.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 12.8 pt -49.23 -36.26 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.535 HG22 ' HG2' ' A' ' 227' ' ' LYS . 40.5 p -47.03 139.86 5.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -132.1 120.59 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 261' ' ' ILE . 4.6 mp -91.86 121.49 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.113 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 68.0 t -122.64 135.53 62.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.61 112.22 16.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.539 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 26.2 m-85 -78.46 156.31 29.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 85.9 mt -81.58 -21.73 38.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.468 ' CG ' ' HB2' ' A' ' 269' ' ' GLU . 11.5 pt-20 -134.3 137.22 27.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -20.72 34.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.638 2.226 . . . . 0.0 112.333 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.22 -61.34 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 266' ' ' GLU . 54.9 mm-40 -60.08 -40.48 89.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -57.06 -52.62 64.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -55.57 -46.46 77.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 19.9 tttp -53.3 -57.12 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.95 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.83 -48.49 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.113 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 17.0 t80 -49.14 -48.52 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -59.01 -45.18 91.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.546 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 71.5 m-70 -70.89 -70.32 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.542 ' CD1' ' CE2' ' A' ' 242' ' ' PHE . 39.9 mt -43.14 -24.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -66.28 148.79 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 54.23 37.76 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.3 m -135.82 158.72 43.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -106.35 126.6 52.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.726 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 13.0 t80 -68.39 -68.03 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.726 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.8 m170 -115.53 -73.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 32.3 m-70 -130.56 -0.82 4.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 15.5 m -128.1 153.72 78.58 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.608 0.718 . . . . 0.0 111.141 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 141.22 44.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.686 2.258 . . . . 0.0 112.368 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 282' ' ' PHE . 49.3 mt -92.11 122.84 34.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -112.34 101.12 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 140.28 29.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -137.08 107.09 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 46.4 m95 -40.18 135.58 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 223' ' ' VAL . . . -93.64 140.7 23.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.577 0.703 . . . . 0.0 111.086 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.554 ' O ' HG22 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.74 -172.11 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.97 -14.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -77.31 -31.86 50.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 293' ' ' PRO . 2.8 m -41.13 -53.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.132 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.526 ' H ' HG23 ' A' ' 296' ' ' VAL . 32.3 m-85 -93.54 -36.56 12.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.95 0.01 40.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.07 162.2 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -159.75 148.85 14.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.575 0.702 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.55 54.69 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.72 2.28 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -133.63 85.98 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -98.22 -37.97 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -42.13 -42.9 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -40.12 -52.15 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 37.4 t -55.21 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.07 -44.37 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -40.37 -65.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -69.23 117.67 11.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -142.7 143.8 27.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 108.7 2.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.369 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.22 -35.63 13.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 312' ' ' ALA . 15.9 tt0 -38.26 -47.54 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -41.35 -45.26 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -38.64 -60.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -61.2 -50.47 72.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.5 t 71.69 41.45 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 60.08 146.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 162.23 42.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 22.3 m -61.86 -56.05 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 80.2 p -174.05 171.25 3.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.456 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.3 m -51.61 -57.59 8.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 110.87 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.3 m -55.14 -43.54 74.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -59.93 -52.36 53.38 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 33.1 m -42.22 -53.25 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 0.0 110.881 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.8 t -48.09 -40.86 24.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 62.09 91.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -136.58 162.56 32.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.4 m -86.89 153.94 21.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.798 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -106.44 -24.44 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.4 p -102.48 22.43 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HB3' ' A' ' 292' ' ' ALA . 87.1 t -141.62 109.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 52.4 mt -115.06 144.83 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 14.6 mt -110.47 143.7 40.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -126.17 132.14 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -127.88 162.42 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 71.94 52.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.609 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.2 mt -110.96 138.63 21.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.467 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.6 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.52 -32.18 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.05 -39.77 80.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.451 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.4 m -43.35 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.141 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.502 ' N ' HG22 ' A' ' 233' ' ' THR . 56.2 mt -153.33 151.13 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -42.54 -49.14 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.72 -46.56 89.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -51.72 -57.67 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 19.7 mm -60.36 -54.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.7 tt0 -45.71 -54.65 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.1 -53.9 38.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 39.9 m -45.2 -48.42 12.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 248' ' ' LEU . 8.7 m-85 -74.02 -47.41 37.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 57.0 p -42.48 -36.12 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -42.81 -40.9 3.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.663 ' CE1' HD21 ' A' ' 277' ' ' LEU . 85.1 m-85 -77.47 -46.16 23.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.22 157.69 30.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.739 ' HB3' HD12 ' A' ' 265' ' ' LEU . 1.1 t -46.34 155.25 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.672 HD22 ' CG1' ' A' ' 262' ' ' VAL . 93.5 mt -123.53 136.87 54.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.534 ' HA2' HD21 ' A' ' 265' ' ' LEU . . . -86.5 -100.2 0.79 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 118.7 29.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.868 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.7 t -115.39 115.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.03 118.12 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 260' ' ' ALA . 6.6 tp -134.97 98.71 12.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.579 0.704 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.48 65.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.34 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.31 -43.41 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -58.49 -28.76 62.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.72 116.3 2.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.609 HD12 ' H ' ' A' ' 229' ' ' LEU . 32.8 pt -48.19 -31.8 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 67.8 p -48.32 136.76 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -127.52 139.97 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.063 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.8 137.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.2 t -137.5 128.01 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.59 86.21 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 8.2 m-85 -51.07 155.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.739 HD12 ' HB3' ' A' ' 247' ' ' SER . 94.7 mt -80.47 -27.4 37.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.432 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.6 tp10 -124.21 137.32 28.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.653 0.74 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.69 -37.21 9.64 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.706 2.271 . . . . 0.0 112.352 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.57 -50.76 68.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -43.59 96.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.22 -49.76 63.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -61.13 -46.82 88.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 75.4 tttt -48.89 -47.66 43.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.14 -43.24 67.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.482 ' CD2' ' CE2' ' A' ' 291' ' ' TRP . 5.1 t80 -46.71 -38.66 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -51.76 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.57 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 27.3 m-70 -50.45 -54.9 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 245' ' ' PHE . 19.0 mt -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -36.79 136.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.125 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 64.88 46.82 2.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.7 p -139.79 -179.84 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.7 mtmt -130.27 136.8 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.902 ' HB2' HD21 ' A' ' 287' ' ' LEU . 30.2 t80 -77.54 -74.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.712 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.5 m170 -108.67 -72.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -131.77 -2.48 3.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.467 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 11.0 m -120.8 154.02 57.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 134.23 27.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.69 2.26 . . . . 0.0 112.356 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.902 HD21 ' HB2' ' A' ' 282' ' ' PHE . 35.7 mt -86.06 122.29 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -112.52 100.76 9.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 21.4 mt -97.09 140.1 32.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.3 123.36 14.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.482 ' CE2' ' CD2' ' A' ' 274' ' ' PHE . 95.5 m95 -50.22 139.69 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.602 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -90.93 145.8 32.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 0.0 111.102 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.583 ' HG2' HG13 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.77 -174.76 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.27 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 21.8 pt -90.58 -16.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.59 -35.33 51.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.715 HG23 ' H ' ' A' ' 297' ' ' PHE . 2.7 m -39.9 -61.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.715 ' H ' HG23 ' A' ' 296' ' ' VAL . 26.8 m-85 -96.75 -30.36 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -67.85 -0.82 15.14 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -81.32 112.37 18.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.344 . . . . 0.0 111.053 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -174.95 143.89 0.8 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.563 0.697 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 85.96 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.381 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -124.66 95.41 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -96.86 -39.66 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -42.93 -46.67 5.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.875 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.33 -39.34 4.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.4 t -51.45 -37.69 50.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.3 mm-40 -72.13 -49.95 31.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 307' ' ' GLN . 14.3 m170 -36.97 -38.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -40.03 110.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -98.2 135.47 21.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 115.62 4.18 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.353 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -98.07 -36.29 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -39.12 -42.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.94 -55.62 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.67 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 317' ' ' SER . 30.6 tt0 -46.7 -46.67 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.66 110.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 154.9 -173.94 33.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 135.96 31.93 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 59.5 p -101.41 -58.23 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 10.2 t -80.6 165.89 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 10.6 m -49.2 -47.48 46.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.1 m -56.76 -49.88 73.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.71 -40.13 6.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.8 t -62.33 -49.67 74.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.814 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.2 m -45.11 -51.73 9.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.75 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -156.07 155.86 33.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.841 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.5 t -66.37 141.74 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -97.71 -31.59 12.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 39.5 p -88.71 22.31 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 292' ' ' ALA . 64.5 t -141.38 119.12 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.55 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 26.4 mt -121.06 148.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 26.5 mt -124.59 117.14 23.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.3 138.43 31.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 259' ' ' THR . 25.5 mttp -130.63 154.06 48.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.62 49.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 47.7 mt -102.55 139.46 20.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.455 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.7 Cg_endo -69.76 133.34 25.33 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.327 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.22 -24.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 230' ' ' PRO . . . -60.32 -40.69 97.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.49 HG21 HD11 ' A' ' 238' ' ' ILE . 5.1 m -50.56 157.7 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.792 0.329 . . . . 0.0 111.19 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 63.9 mt -145.44 153.17 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.452 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -44.67 -42.08 7.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.94 -48.99 66.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.25 -58.39 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 233' ' ' THR . 28.0 mm -54.2 -62.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.606 ' HG3' HG21 ' A' ' 251' ' ' VAL . 11.4 tt0 -41.13 -57.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -59.19 -60.82 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 91.9 m -38.59 -53.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.69 ' HB2' HD11 ' A' ' 248' ' ' LEU . 9.8 m-85 -69.8 -42.14 74.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 5.8 t -49.78 -42.2 46.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -38.88 -47.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.494 ' CE1' HD21 ' A' ' 277' ' ' LEU . 55.9 m-85 -65.61 -50.41 65.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -163.64 156.63 28.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 51.8 m -48.7 134.38 16.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.69 HD11 ' HB2' ' A' ' 242' ' ' PHE . 33.3 mt -102.77 173.87 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -125.63 -95.51 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.471 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -87.74 127.77 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.606 HG21 ' HG3' ' A' ' 239' ' ' GLN . 91.3 t -130.66 114.89 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.132 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.32 117.56 21.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.4 tp -133.76 98.34 14.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.37 66.68 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 8.3 pt-20 -76.52 -37.29 56.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.84 -36.41 91.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.509 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -122.79 115.87 2.83 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -45.03 -31.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.129 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 227' ' ' LYS . 9.4 p -44.43 123.38 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -115.0 118.76 34.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.439 HG23 ' CD2' ' A' ' 225' ' ' LEU . 5.3 mp -88.43 139.3 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.455 ' CG1' HD22 ' A' ' 248' ' ' LEU . 98.2 t -139.09 138.21 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.132 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.434 ' OE1' ' CZ ' ' A' ' 297' ' ' PHE . 35.1 tt0 -122.5 91.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.46 151.56 19.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.53 -38.57 26.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.456 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 6.1 tp10 -111.86 138.99 21.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.661 0.743 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 54.0 Cg_endo -69.68 -44.07 2.35 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 0.0 112.365 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.69 -53.25 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.02 -37.6 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.41 75.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -61.51 -45.16 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.411 ' HG2' ' NE2' ' A' ' 276' ' ' HIS . 35.9 tttm -53.52 -58.71 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.71 83.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -48.51 -56.48 8.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 17.4 mtm180 -53.08 -56.75 13.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.411 ' NE2' ' HG2' ' A' ' 272' ' ' LYS . 36.0 m-70 -50.33 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.494 HD21 ' CE1' ' A' ' 245' ' ' PHE . 48.1 mt -52.97 -32.44 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -57.9 138.61 55.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 62.47 44.61 6.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 67.5 m -143.24 149.95 38.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.853 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -95.19 127.95 41.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HB2' HD21 ' A' ' 287' ' ' LEU . 29.9 t80 -71.93 -68.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.606 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.3 m170 -120.9 -60.54 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.546 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 18.5 m-70 -134.98 -32.97 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.455 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.3 m -100.63 152.89 37.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.132 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 135.71 31.08 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.712 2.274 . . . . 0.0 112.318 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.0 mt -82.09 123.18 28.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -112.46 100.42 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.54 140.43 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -139.46 118.38 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.55 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 36.8 m95 -53.11 132.88 38.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.506 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -85.08 140.34 36.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 111.069 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 296' ' ' VAL . 54.5 Cg_endo -69.74 -176.32 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.28 . . . . 0.0 112.344 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 295' ' ' GLY . 21.0 pt -86.39 -27.13 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 294' ' ' ILE . . . -75.9 -25.34 67.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 293' ' ' PRO . 12.0 p -40.95 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 111.1 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.483 ' N ' HG13 ' A' ' 296' ' ' VAL . 9.9 m-85 -96.85 -49.76 4.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 58.96 -176.8 2.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -141.36 153.7 45.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -175.02 154.62 1.74 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . 0.445 ' OE1' ' CG ' ' A' ' 305' ' ' ASP . 1.0 OUTLIER -122.85 86.65 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -88.77 -34.43 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.07 -38.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.445 ' CG ' ' OE1' ' A' ' 302' ' ' GLN . 7.8 m-20 -39.34 -47.85 1.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.3 t -48.77 -45.09 39.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -39.43 -38.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' A' ' 309' ' ' GLU . 29.6 m170 -36.83 -41.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 308' ' ' HIS . 18.4 pt-20 -34.54 139.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -123.91 149.77 60.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.916 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 139.49 40.54 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.3 -42.48 7.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 314' ' ' LYS . 10.1 pt-20 -42.3 -40.42 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 313' ' ' GLU . 0.1 OUTLIER -42.34 -45.63 4.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.49 -41.52 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 317' ' ' SER . 25.0 mm-40 -47.22 -45.48 23.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 316' ' ' GLU . 2.9 m -34.53 123.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.49 20.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 162.82 40.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.718 2.279 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 26.1 p -102.78 -41.73 6.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.6 m -55.29 157.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 89.1 p -77.23 -50.28 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 -45.88 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.858 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -48.3 7.68 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 27.7 m -49.8 -54.97 15.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.2 m -58.76 -47.7 83.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 60.62 56.97 21.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -95.08 146.96 23.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 292' ' ' ALA . 10.7 t -52.6 149.26 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -111.71 -17.24 13.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.865 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.6 p -92.99 -29.52 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.62 125.71 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.531 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 21.9 mt -123.16 152.18 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 224' ' ' ILE . 51.1 mt -113.17 120.14 40.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -99.53 135.69 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -130.07 160.35 33.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.456 ' ND2' ' HG2' ' A' ' 286' ' ' PRO . 27.1 t30 73.97 52.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.774 ' H ' HD12 ' A' ' 258' ' ' ILE . 36.3 mt -108.69 137.09 19.94 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 110.894 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.2 Cg_endo -69.71 135.76 31.39 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.37 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.84 -33.73 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.64 -37.5 83.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 234' ' ' LEU . 9.4 m -41.56 164.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 233' ' ' THR . 58.5 mt -150.91 145.81 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.955 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.421 ' HA ' HD23 ' A' ' 253' ' ' LEU . . . -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.48 96.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -51.83 -59.79 3.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 242' ' ' PHE . 32.4 mm -56.59 -54.5 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.614 ' O ' HD12 ' A' ' 248' ' ' LEU . 26.5 tt0 -43.15 -57.42 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -63.54 -52.77 59.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 93.3 m -42.38 -56.52 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.109 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 248' ' ' LEU . 23.6 m-85 -69.72 -42.81 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.3 t -45.41 -39.17 6.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -38.66 -49.99 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.606 ' CE1' HD21 ' A' ' 277' ' ' LEU . 59.3 m-85 -64.63 -45.86 85.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.49 157.39 27.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.2 m -47.51 130.95 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 242' ' ' PHE . 28.0 mt -96.22 164.26 12.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -108.72 -101.85 2.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.489 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -87.15 120.63 28.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 96.4 t -122.34 115.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 mt -129.76 115.3 17.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 260' ' ' ALA . 8.8 tp -133.36 98.5 15.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.79 148.46 64.92 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -75.31 -44.0 47.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.66 52.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.05 121.47 4.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.774 HD12 ' H ' ' A' ' 229' ' ' LEU . 28.8 pt -49.89 -34.71 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 111.122 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.457 ' N ' HG13 ' A' ' 258' ' ' ILE . 48.2 p -44.3 140.59 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.632 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -130.41 132.89 45.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.17 132.5 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.609 ' CG1' HD22 ' A' ' 248' ' ' LEU . 64.9 t -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.157 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -124.31 88.08 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 248' ' ' LEU . 10.6 m-85 -57.27 135.29 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.59 -35.48 81.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.27 135.51 21.8 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.667 0.746 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -37.02 9.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -49.32 76.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -64.49 -41.07 96.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.75 -51.95 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -61.56 -45.33 94.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.42 -57.6 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -56.72 -48.44 77.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 289' ' ' LEU . 0.8 OUTLIER -44.25 -54.17 5.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 52.3 mmm-85 -58.05 -57.1 14.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -48.24 -59.9 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.606 HD21 ' CE1' ' A' ' 245' ' ' PHE . 39.0 mt -58.13 -37.94 75.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -43.45 124.38 3.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 73.12 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.4 p -127.19 154.49 44.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.04 126.0 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.946 ' HB2' HD11 ' A' ' 287' ' ' LEU . 8.5 t80 -71.04 -59.52 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.746 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 10.7 m170 -122.28 -74.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.631 ' ND1' HG13 ' A' ' 285' ' ' VAL . 6.6 p80 -125.9 -21.54 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.631 HG13 ' ND1' ' A' ' 284' ' ' HIS . 19.6 m -111.64 151.97 43.74 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.645 0.736 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . 0.456 ' HG2' ' ND2' ' A' ' 228' ' ' ASN . 53.7 Cg_endo -69.77 145.45 57.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.328 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 282' ' ' PHE . 47.7 mt -95.69 134.68 38.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -112.37 100.4 8.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 277' ' ' LEU . 93.4 mt -86.57 140.18 30.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -146.5 115.79 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.531 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 33.7 m95 -44.79 150.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 296' ' ' VAL . . . -104.22 137.23 19.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 111.08 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.765 ' HG2' HG13 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.78 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.237 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 8.9 pt -92.01 -22.72 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.75 70.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.531 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.765 HG13 ' HG2' ' A' ' 293' ' ' PRO . 35.0 m -39.01 -52.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.614 ' N ' HG23 ' A' ' 296' ' ' VAL . 18.5 m-85 -97.0 -42.75 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 91.37 150.25 24.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.2 23.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -164.65 135.29 3.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.555 0.693 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 118.64 5.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -106.34 40.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -99.19 -54.43 2.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 6.2 ptmt -54.69 -31.89 58.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 9.9 t70 -45.06 -48.53 11.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.4 t -76.73 -51.31 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 308' ' ' HIS . 47.1 tt0 -39.73 -33.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.3 p-80 -36.8 -35.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 308' ' ' HIS . 4.1 pt-20 -34.45 102.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . 0.477 ' NE2' ' HE3' ' A' ' 314' ' ' LYS . 34.3 tt0 -108.88 135.17 20.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.47 69.15 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.728 2.285 . . . . 0.0 112.289 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.76 -30.83 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -45.86 -29.92 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.477 ' HE3' ' NE2' ' A' ' 310' ' ' GLN . 0.1 OUTLIER -49.25 -36.96 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 314' ' ' LYS . . . -46.87 -40.12 13.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 317' ' ' SER . 48.3 mt-10 -46.09 -52.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 316' ' ' GLU . 24.8 p -38.14 123.15 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 165.94 145.28 4.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.31 8.28 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.6 p -101.42 -44.59 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 m -174.79 175.25 2.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.46 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 78.0 p -82.27 -56.82 3.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.0 p -47.22 -29.38 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.44 -63.2 4.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.6 p -69.86 -55.06 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.827 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 16.3 m -44.5 -61.18 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.01 121.8 3.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -136.97 127.71 27.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 292' ' ' ALA . 3.2 m -44.62 158.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 2.3 mppt? -111.74 -33.95 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.9 p -105.51 28.18 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.0 t -139.26 114.33 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 47.1 mt -117.51 141.87 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 64.6 mt -113.8 117.17 30.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.48 43.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.084 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -118.75 169.66 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.34 55.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 287' ' ' LEU . 65.1 mt -107.2 138.01 19.75 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.641 0.734 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 284' ' ' HIS . 54.3 Cg_endo -69.68 136.16 32.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 0.0 112.377 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.42 -30.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.63 95.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 234' ' ' LEU . 12.1 m -43.64 158.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.122 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 233' ' ' THR . 68.1 mt -147.51 155.59 42.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -48.1 -53.41 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.5 -48.8 78.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -47.56 -61.23 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.2 mm -56.96 -51.51 67.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.432 ' HG3' HG21 ' A' ' 251' ' ' VAL . 18.2 tt0 -46.63 -57.66 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.53 -57.83 8.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 99.8 m -37.84 -52.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 238' ' ' ILE . 13.3 m-85 -74.61 -49.74 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.1 t -45.28 -35.42 3.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 244' ' ' ARG . 11.2 mtp-105 -38.56 -49.74 1.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -64.03 -50.87 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.47 35.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 50.7 m -52.53 147.81 7.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.855 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 264' ' ' PHE . 17.2 mt -114.68 147.31 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -87.3 -60.71 1.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -136.06 155.52 50.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 239' ' ' GLN . 89.5 t -148.37 111.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.4 mt -121.97 116.39 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 260' ' ' ALA . 14.3 tp -133.58 98.39 15.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.65 65.41 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.624 2.216 . . . . 0.0 112.375 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.63 -42.02 52.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.46 -33.25 61.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.11 120.7 4.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 17.4 pt -50.63 -40.77 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 1.7 m -44.42 151.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.754 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -135.79 146.5 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.48 132.03 63.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.27 137.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -126.75 95.55 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 11.8 m-85 -66.06 147.31 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 77.5 mt -73.57 -31.74 63.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -114.77 136.36 22.48 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.635 0.731 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -36.19 11.44 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.335 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 28.9 mt -64.42 -47.49 78.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.966 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -45.32 87.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -51.79 -51.15 58.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -59.8 -46.05 90.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.592 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 16.9 ttmt -50.66 -54.96 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.14 98.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.489 ' CD2' ' CZ2' ' A' ' 291' ' ' TRP . 1.4 t80 -47.71 -67.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.8 ptm180 -52.27 -51.6 57.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 9.9 m-70 -48.93 -73.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 278' ' ' ALA . 32.9 mt -48.77 -46.65 41.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.38 147.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 56.19 44.65 24.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.5 t -143.81 173.2 11.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -121.51 139.35 53.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 287' ' ' LEU . 30.9 t80 -78.6 -59.93 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.562 ' CE1' ' CE2' ' A' ' 282' ' ' PHE . 20.1 m170 -123.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.64 ' ND1' HG13 ' A' ' 285' ' ' VAL . 5.3 p80 -125.24 -21.4 4.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.64 HG13 ' ND1' ' A' ' 284' ' ' HIS . 20.1 m -106.44 152.18 40.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.2 56.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 0.0 112.361 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 282' ' ' PHE . 76.2 mt -99.88 125.08 45.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -112.48 100.51 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -88.99 134.59 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.07 125.89 19.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.489 ' CZ2' ' CD2' ' A' ' 274' ' ' PHE . 90.3 m95 -54.8 144.93 20.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.518 ' HB1' HG11 ' A' ' 296' ' ' VAL . . . -90.6 148.06 37.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.1 Cg_endo -69.83 -174.15 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.678 2.252 . . . . 0.0 112.298 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.434 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.6 pp -90.92 -22.77 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -83.45 -29.59 32.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 293' ' ' PRO . 1.5 p -39.45 -49.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -95.98 -62.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.95 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -50.11 153.29 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -133.48 -179.93 5.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -73.49 127.9 88.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.561 0.696 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.84 6.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.309 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -124.95 34.57 4.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -38.44 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -53.56 -39.28 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.96 -56.15 2.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 t -42.34 -42.25 3.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 308' ' ' HIS . 8.7 tm0? -50.91 -39.73 55.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 309' ' ' GLU . 5.5 p-80 -36.9 -35.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 308' ' ' HIS . 9.3 mt-10 -34.47 102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -103.05 133.19 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.26 38.95 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -96.52 -32.19 12.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -41.0 -45.0 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -45.05 -45.68 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -39.8 -41.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 317' ' ' SER . 7.3 tp10 -46.1 -44.28 15.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 316' ' ' GLU . 79.9 p -34.52 121.11 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -93.1 151.15 20.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.493 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -173.0 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.8 m -95.34 -57.46 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.1 p -140.69 177.86 7.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.1 m -102.71 -47.01 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 83.3 p -52.76 -44.12 66.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.827 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -70.1 -46.79 49.2 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.0 t -54.98 -59.46 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 79.3 p -53.95 -45.24 71.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 294' ' ' ILE . . . -52.61 -74.31 0.31 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -57.13 156.55 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 292' ' ' ALA . 6.7 t -45.82 151.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -111.73 -27.01 8.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -109.64 19.65 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 95.8 t -135.77 121.51 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.509 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 15.7 mt -124.53 149.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.9 121.79 43.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -97.45 135.48 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.785 ' HG2' HG22 ' A' ' 259' ' ' THR . 72.8 mttt -132.78 162.37 31.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.473 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER 72.9 47.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 258' ' ' ILE . 38.8 mt -107.46 138.39 19.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.621 0.724 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 54.0 Cg_endo -69.77 135.13 29.66 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.31 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.61 -30.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.24 91.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 234' ' ' LEU . 7.2 m -49.08 164.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.842 0.353 . . . . 0.0 111.137 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 233' ' ' THR . 61.2 mt -151.43 156.1 39.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.403 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -47.12 -46.7 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.26 -49.64 76.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -48.97 -61.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 23.8 mm -51.09 -63.15 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 29.8 tt0 -38.68 -50.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -64.8 -58.16 6.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 19.2 m -44.14 -50.75 8.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.23 -49.08 65.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.1 t -46.28 -38.76 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -41.2 -39.56 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.48 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.0 m-85 -74.8 -46.42 36.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -165.36 -153.84 7.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.513 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 265' ' ' LEU . 22.9 p -79.31 166.36 22.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 66.8 mt -138.48 149.34 45.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -106.47 -104.36 2.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -84.3 119.64 25.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 110.812 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 239' ' ' GLN . 89.9 t -121.25 112.58 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.9 mt -130.92 119.89 22.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 260' ' ' ALA . 5.5 tp -134.93 98.52 13.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.595 0.712 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.75 65.63 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -76.4 -44.32 36.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -59.32 -27.5 63.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -123.46 107.17 1.05 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.454 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 229' ' ' LEU . 29.0 pt -42.95 -36.97 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.891 0.376 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.785 HG22 ' HG2' ' A' ' 227' ' ' LYS . 46.3 p -47.32 135.04 10.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -122.05 143.47 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 16.9 mt -114.63 127.32 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.487 ' CG1' HD22 ' A' ' 248' ' ' LEU . 62.3 t -131.21 138.01 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -125.17 93.31 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 45.8 m-85 -57.2 153.85 11.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.957 HD12 ' HB2' ' A' ' 247' ' ' SER . 95.8 mt -77.56 -36.25 52.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 20.9 tt0 -115.01 141.79 27.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.65 0.738 . . . . 0.0 110.868 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 54.0 Cg_endo -69.71 -43.2 2.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.367 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.27 -54.05 51.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 21.7 pt-20 -61.33 -41.52 97.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -52.38 -48.89 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -62.19 -49.69 74.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -47.23 -58.71 3.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.48 -50.22 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -50.38 -57.07 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -46.83 -49.74 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -65.12 -72.62 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.522 ' HB2' HD11 ' A' ' 289' ' ' LEU . 59.2 mt -39.39 -54.6 1.87 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -39.65 143.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 56.22 40.41 30.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 277' ' ' LEU . 3.6 t -136.91 166.98 22.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -110.34 135.19 51.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 27.5 t80 -84.23 -73.62 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.533 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.9 m170 -116.54 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -128.45 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 228' ' ' ASN . 34.4 m -108.82 152.52 42.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.609 0.719 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 133.96 26.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.615 2.21 . . . . 0.0 112.343 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 282' ' ' PHE . 32.6 mt -74.2 125.33 28.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.36 100.55 8.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 277' ' ' LEU . 62.6 mt -91.82 138.49 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -142.21 108.98 5.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 69.7 m95 -43.89 148.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 220' ' ' SER . . . -98.48 142.73 25.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 0.0 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.424 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.5 Cg_endo -69.75 -175.45 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.67 2.246 . . . . 0.0 112.348 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 218' ' ' GLY . 29.2 pt -89.62 -24.03 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -80.86 -21.4 63.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.523 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.2 p -42.76 -48.79 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.57 ' N ' HG13 ' A' ' 296' ' ' VAL . 17.4 m-85 -94.37 -40.82 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -40.37 124.72 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -175.01 138.87 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -173.78 140.62 0.82 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -172.41 108.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.96 -37.56 11.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 306' ' ' SER . 12.1 mptt -46.16 -37.98 7.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.498 ' O ' ' NE2' ' A' ' 307' ' ' GLN . 5.6 m-20 -39.21 -25.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 304' ' ' LYS . 38.6 t -47.25 -42.68 20.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 308' ' ' HIS . 1.4 pm0 -39.48 -30.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.601 ' N ' ' NE2' ' A' ' 307' ' ' GLN . 64.0 t-80 -39.42 -38.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 308' ' ' HIS . 54.1 tt0 -36.31 103.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -73.62 130.97 82.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 172.63 12.33 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -92.84 -33.4 14.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -43.07 -41.02 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -41.83 -41.03 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.24 -40.85 1.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.074 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 317' ' ' SER . 56.8 mm-40 -46.37 -46.27 18.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 316' ' ' GLU . 11.1 t -37.55 122.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -140.88 145.83 16.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -173.15 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.701 2.267 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 11.0 t -100.28 -57.95 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 m -174.12 177.39 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.1 t -77.37 -43.64 32.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 56.2 p -52.4 -47.67 66.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.88 -43.71 64.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 m -47.98 -54.76 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 56.9 m -71.99 -45.64 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.848 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 101.85 130.95 7.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -141.02 138.75 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 3.3 t -50.74 153.98 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -109.62 -23.32 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.9 p -94.41 -30.03 14.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.578 HG12 ' CB ' ' A' ' 292' ' ' ALA . 65.0 t -94.19 125.73 46.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.557 HG12 ' CZ3' ' A' ' 291' ' ' TRP . 31.9 mt -129.03 138.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 45.5 mt -105.69 123.87 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -101.96 124.28 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -112.44 169.06 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.3 m120 64.65 55.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 258' ' ' ILE . 45.8 mt -114.73 130.53 24.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.573 0.701 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 136.68 33.55 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.64 2.227 . . . . 0.0 112.368 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.95 -35.68 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -50.88 -39.5 40.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 m -45.62 155.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.114 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 89.1 mt -144.22 146.33 32.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.89 -46.57 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.06 92.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -53.74 -59.28 4.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.518 HG23 ' CE1' ' A' ' 242' ' ' PHE . 29.9 mm -57.83 -54.34 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.492 ' O ' ' CD1' ' A' ' 248' ' ' LEU . 23.2 tt0 -44.15 -58.53 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.53 -58.81 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 88.6 m -38.92 -54.25 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.177 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 238' ' ' ILE . 11.0 m-85 -69.01 -45.6 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.0 t -48.48 -36.64 15.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -40.13 -46.12 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.69 ' CE1' HD21 ' A' ' 277' ' ' LEU . 74.2 m-85 -69.14 -48.54 62.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -164.84 163.15 36.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -53.0 142.58 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.872 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 239' ' ' GLN . 45.7 mt -109.28 171.76 7.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -121.3 -92.13 1.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.451 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.64 118.41 31.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 78.1 t -120.37 100.7 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.184 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.1 mt -116.73 115.75 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.7 tp -132.4 98.26 16.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.715 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 148.61 65.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.736 2.29 . . . . 0.0 112.333 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -76.64 -41.19 46.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -56.37 -32.78 60.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.16 124.65 5.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 229' ' ' LEU . 14.4 pt -55.16 -34.1 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 77.1 p -52.0 138.61 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.601 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -120.95 148.27 44.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.081 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 225' ' ' LEU . 50.3 mt -116.09 117.4 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.23 133.89 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -118.96 96.84 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 270' ' ' ALA . 16.5 m-85 -67.54 136.27 54.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.818 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.2 mt -64.04 -31.46 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -118.07 134.03 23.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.632 0.73 . . . . 0.0 110.903 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -35.73 12.04 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.309 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.0 -50.24 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -63.34 -43.03 98.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 264' ' ' PHE . . . -53.08 -50.26 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.04 -46.9 87.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 40.6 tttm -51.98 -52.85 47.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.32 82.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 2.7 t80 -47.18 -43.42 21.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.8 mmt-85 -65.8 -57.63 7.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 53.1 m-70 -52.99 -61.03 2.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 245' ' ' PHE . 49.4 mt -54.23 -52.74 60.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.55 145.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 62.75 39.01 11.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.4 t -139.25 154.82 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -104.94 136.36 44.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 283' ' ' HIS . 54.1 t80 -79.31 -71.4 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.524 ' CD2' ' CE2' ' A' ' 282' ' ' PHE . 25.5 m170 -113.37 -63.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 33.8 m-70 -131.48 -31.47 1.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.87 152.69 38.52 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.673 0.749 . . . . 0.0 111.087 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 149.61 66.95 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 61.8 mt -92.99 124.18 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -112.64 100.78 8.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.7 mt -89.07 138.73 31.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -143.35 123.01 13.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.557 ' CZ3' HG12 ' A' ' 224' ' ' ILE . 58.8 m95 -47.39 147.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.578 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -98.91 130.06 28.4 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.696 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 141.67 45.94 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.377 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 36.7 pt -48.5 -19.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.119 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -74.2 -33.43 56.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.473 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 7.7 p -39.03 -34.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.456 ' HE2' HG21 ' A' ' 223' ' ' VAL . 11.9 m-85 -96.88 -40.76 8.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 63.2 135.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.74 157.23 19.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -172.65 134.83 0.75 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.89 61.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -93.07 81.36 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -82.63 -42.18 18.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -40.22 -41.53 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.941 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.421 ' OD1' ' C ' ' A' ' 305' ' ' ASP . 1.6 t0 -39.39 -58.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 92.8 p -41.95 -42.81 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 308' ' ' HIS . 38.1 tp60 -38.35 -40.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 309' ' ' GLU . 22.4 p-80 -36.8 -44.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 308' ' ' HIS . 2.2 pp20? -45.27 142.07 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -148.89 141.18 14.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.638 0.732 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 115.82 4.27 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.93 -36.42 10.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -46.54 -40.64 13.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -42.37 -32.29 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -45.68 -41.08 9.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 317' ' ' SER . 17.3 pt-20 -45.16 -35.62 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 316' ' ' GLU . 13.7 m -42.47 120.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 167.83 82.6 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 147.99 64.26 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.74 2.294 . . . . 0.0 112.328 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.1 p -99.15 -58.52 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 7.0 t -144.79 174.82 10.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 96.5 p -77.29 -44.21 30.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -88.52 -49.83 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.85 -42.94 6.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 40.2 t -45.47 -48.96 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.885 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.1 m -62.1 -55.09 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.26 4.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -75.25 172.12 12.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 292' ' ' ALA . 23.1 t -51.57 153.51 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -111.5 -37.91 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 70.5 p -94.7 17.11 14.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.791 HG12 ' CB ' ' A' ' 292' ' ' ALA . 62.5 t -135.96 126.4 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.514 HG12 ' CE3' ' A' ' 291' ' ' TRP . 11.9 mt -138.63 143.0 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.8 mm? -98.99 161.82 13.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.3 102.95 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -103.48 162.93 12.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.455 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 71.53 50.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.47 HD21 ' CD2' ' A' ' 287' ' ' LEU . 46.0 mt -110.31 138.74 20.97 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.462 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.9 Cg_endo -69.69 134.64 28.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.724 2.282 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.23 94.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 234' ' ' LEU . 10.2 m -40.35 160.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 111.134 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.458 ' N ' HG22 ' A' ' 233' ' ' THR . 91.2 mt -145.57 150.17 35.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -46.89 -44.78 19.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.68 91.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -52.8 -59.42 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.32 -57.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' HD12 ' A' ' 248' ' ' LEU . 16.0 tt0 -41.22 -57.46 2.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.47 -53.31 56.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 56.1 m -44.07 -51.74 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 248' ' ' LEU . 6.3 m-85 -72.26 -36.99 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.3 t -55.59 -38.09 68.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 244' ' ' ARG . 1.5 mmp_? -39.85 -40.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.688 ' CE1' HD21 ' A' ' 277' ' ' LEU . 66.2 m-85 -74.63 -43.55 54.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -175.63 158.35 25.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.471 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 265' ' ' LEU . 22.9 m -41.02 147.63 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 110.856 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 242' ' ' PHE . 19.9 mt -117.43 162.32 18.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -105.74 -111.33 3.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 -83.36 123.67 29.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 239' ' ' GLN . 92.0 t -121.26 103.82 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.7 114.96 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 260' ' ' ALA . 9.7 tp -132.84 98.47 16.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 148.56 65.27 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.698 2.265 . . . . 0.0 112.352 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -76.75 -40.62 47.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.28 -34.82 68.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.493 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -121.25 123.69 5.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 16.8 pt -50.84 -37.34 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.108 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 32.3 p -42.82 139.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -129.86 127.23 39.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.057 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.25 129.9 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.9 t -132.51 128.87 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.34 97.49 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -62.85 143.06 57.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 247' ' ' SER . 92.1 mt -73.6 -32.91 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 77.9 tt0 -120.32 139.41 28.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 266' ' ' GLU . 53.8 Cg_endo -69.77 -40.77 4.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.96 -45.57 94.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.82 -42.45 90.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 224' ' ' ILE . . . -52.79 -49.93 64.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -62.46 -48.94 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.896 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 276' ' ' HIS . 72.6 tttt -49.48 -52.3 30.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.73 64.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -40.41 -41.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 278' ' ' ALA . 1.4 ttt180 -78.05 -65.04 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 272' ' ' LYS . 25.8 m-70 -37.44 -54.54 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.688 HD21 ' CE1' ' A' ' 245' ' ' PHE . 28.7 mt -61.52 -47.05 87.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 275' ' ' ARG . . . -36.6 148.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 57.79 42.63 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 2.2 t -144.52 150.87 38.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -103.81 132.8 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 287' ' ' LEU . 22.1 t80 -67.57 -75.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.671 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 13.1 m170 -112.76 -59.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . 0.517 ' CD2' ' HB3' ' A' ' 283' ' ' HIS . 22.6 m-70 -134.22 -32.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.462 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 27.2 m -99.73 153.11 37.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 133.31 25.16 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 282' ' ' PHE . 19.6 mt -79.55 124.51 28.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -112.42 100.22 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 23.7 mt -87.41 130.72 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -130.96 118.6 20.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.514 ' CE3' HG12 ' A' ' 224' ' ' ILE . 79.2 m95 -47.7 152.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.791 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -95.81 140.98 22.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 111.075 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.3 Cg_endo -69.83 177.52 5.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.69 2.26 . . . . 0.0 112.346 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 23.0 pt -85.35 -20.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -88.35 -12.0 65.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 293' ' ' PRO . 3.1 p -46.76 -52.26 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 111.124 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' N ' HG13 ' A' ' 296' ' ' VAL . 6.2 m-85 -96.21 -58.6 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 297' ' ' PHE . . . -36.5 154.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.49 177.83 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 129.23 87.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.56 0.695 . . . . 0.0 111.071 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 148.22 64.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.49 43.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -96.01 -42.4 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 305' ' ' ASP . 19.9 pttt -40.9 -42.25 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 t70 -39.04 -53.18 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.9 t -50.73 -62.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.4 mm100 -51.99 -43.21 63.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 309' ' ' GLU . 2.3 t60 -36.99 -40.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 308' ' ' HIS . 6.9 tm-20 -34.55 107.24 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -107.41 151.72 41.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -177.88 2.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 313' ' ' GLU . . . -92.66 -40.34 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 312' ' ' ALA . 31.6 mt-10 -38.34 -45.69 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -53.08 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -42.64 -45.38 4.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 14.8 tt0 -45.55 -47.13 14.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 48.0 t -34.93 114.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -133.8 174.54 20.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 178.69 4.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.328 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 18.2 t -97.34 -58.13 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 5.0 m -146.02 172.63 13.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.484 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 99.9 p -90.55 -43.85 9.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 91.9 p -51.19 -43.61 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -69.26 -51.21 28.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.5 p -55.55 -48.68 74.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.0 m -72.93 -60.4 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 294' ' ' ILE . . . -91.59 58.07 3.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.506 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -55.13 164.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 292' ' ' ALA . 2.6 t -65.82 157.16 31.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.401 ' CG ' HG23 ' A' ' 222' ' ' THR . 12.0 pttt -112.13 -23.56 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.401 HG23 ' CG ' ' A' ' 221' ' ' LYS . 60.1 p -120.43 28.56 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.555 HG12 ' CB ' ' A' ' 292' ' ' ALA . 60.6 t -144.84 118.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.46 143.8 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 292' ' ' ALA . 86.9 mt -106.1 116.55 32.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -91.16 129.78 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.622 ' HG2' HG22 ' A' ' 259' ' ' THR . 86.6 mttt -124.59 164.61 19.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.25 50.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 258' ' ' ILE . 46.6 mt -109.13 136.29 20.12 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.468 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.0 Cg_endo -69.79 135.62 30.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.64 2.226 . . . . 0.0 112.346 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -43.59 -29.23 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.73 96.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.513 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.492 HG21 HD11 ' A' ' 238' ' ' ILE . 6.9 m -44.42 162.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.11 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 52.5 mt -148.82 148.59 30.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -41.55 -43.25 2.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.88 81.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.31 -54.73 27.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 233' ' ' THR . 47.5 mm -55.97 -58.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.64 ' HG3' HG21 ' A' ' 251' ' ' VAL . 38.3 tt0 -42.47 -52.98 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 241' ' ' THR . 6.0 tp10 -63.97 -60.64 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 240' ' ' GLU . 55.9 m -35.56 -58.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' A' ' 248' ' ' LEU . 45.6 m-85 -69.71 -47.49 62.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -42.02 -40.67 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -39.23 -53.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.785 ' CE1' HD21 ' A' ' 277' ' ' LEU . 49.6 m-85 -61.07 -48.19 82.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -162.75 159.77 32.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.527 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.0 m -56.03 134.63 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.841 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 242' ' ' PHE . 84.3 mt -103.84 150.91 23.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -93.79 -63.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -122.82 154.37 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.64 HG21 ' HG3' ' A' ' 239' ' ' GLN . 95.1 t -152.72 108.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.4 mt -119.09 117.81 29.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 260' ' ' ALA . 11.0 tp -134.84 98.45 13.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.711 . . . . 0.0 110.926 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 53.5 Cg_endo -69.76 148.7 65.67 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -73.41 -44.71 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -52.69 -37.2 50.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -120.21 121.69 4.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.629 HD12 ' H ' ' A' ' 229' ' ' LEU . 16.5 pt -51.95 -32.27 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.622 HG22 ' HG2' ' A' ' 227' ' ' LYS . 36.3 p -47.69 134.49 12.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.707 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -124.24 125.73 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.112 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 225' ' ' LEU . 15.2 mt -94.59 122.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.4 t -123.59 137.8 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -122.37 99.05 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.497 ' CZ ' HD21 ' A' ' 248' ' ' LEU . 14.8 m-85 -67.15 142.2 57.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 73.6 mt -72.38 -27.13 62.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -118.46 133.57 23.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.655 0.741 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 268' ' ' LEU . 53.1 Cg_endo -69.85 -45.49 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.478 ' CD2' ' HG2' ' A' ' 267' ' ' PRO . 3.2 mm? -59.52 -43.47 93.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -65.76 -45.57 82.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.99 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -62.62 -45.42 92.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -53.42 -57.07 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.75 -53.14 60.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 278' ' ' ALA . 3.0 t80 -42.69 -45.8 4.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.78 -55.73 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -57.46 -62.62 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 245' ' ' PHE . 51.6 mt -49.63 -47.76 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 274' ' ' PHE . . . -38.27 137.65 0.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 64.87 44.6 3.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.4 p -140.53 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -109.46 141.63 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.663 ' CE2' ' CG ' ' A' ' 283' ' ' HIS . 26.3 t80 -84.86 -72.61 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.663 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 9.0 m170 -110.7 -74.87 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -125.31 -12.79 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 34.1 m -118.97 152.36 51.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.625 0.726 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 143.89 52.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.707 2.271 . . . . 0.0 112.315 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 282' ' ' PHE . 34.2 mt -89.6 126.7 35.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.44 100.65 8.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.85 132.64 35.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -135.37 119.77 17.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -44.64 128.3 6.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.762 ' HB2' ' HG ' ' A' ' 225' ' ' LEU . . . -86.59 130.74 47.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 296' ' ' VAL . 53.8 Cg_endo -69.74 139.92 41.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.713 2.276 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 218' ' ' GLY . 17.7 pt -48.31 -26.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.76 -37.04 92.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 297' ' ' PHE . 11.5 p -39.38 -48.24 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.104 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.575 ' N ' HG13 ' A' ' 296' ' ' VAL . 10.3 m-85 -94.84 -50.67 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -41.78 141.41 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -126.15 167.68 15.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -41.13 131.44 2.0 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.582 0.706 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 88.39 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -98.8 42.62 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 303' ' ' LYS . 0.0 OUTLIER -99.43 -39.44 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -52.82 -43.74 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.11 -54.61 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.7 t -45.12 -46.22 11.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 18.2 tm0? -41.33 -41.38 1.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 309' ' ' GLU . 7.3 p-80 -36.96 -39.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 308' ' ' HIS . 26.5 tt0 -34.45 100.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.63 150.3 19.21 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.573 0.702 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.99 1.59 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.621 2.214 . . . . 0.0 112.352 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -80.96 -39.27 26.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -44.8 -46.12 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -38.03 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -40.7 -39.07 1.0 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.23 -45.27 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.1 t -39.53 123.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 147.95 94.37 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.39 68.8 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.295 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 27.4 t -102.22 -57.51 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.9 t -171.15 147.84 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 25.9 p -87.23 -44.19 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.4 t -45.57 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.29 -53.05 36.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 13.5 t -44.55 -54.48 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.1 m -60.29 -55.78 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 84.85 -39.88 2.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 164.62 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.1 t -52.82 160.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -111.53 -26.65 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.6 p -95.19 -30.0 14.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.765 HG12 ' CB ' ' A' ' 292' ' ' ALA . 61.2 t -93.09 127.68 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.158 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.5 mt -130.32 149.2 33.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 261' ' ' ILE . 91.5 mt -112.59 139.96 47.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.67 128.35 54.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.141 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -124.21 165.91 16.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER 70.74 48.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 258' ' ' ILE . 52.8 mt -108.89 132.43 21.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.465 ' HD3' ' CG2' ' A' ' 285' ' ' VAL . 53.5 Cg_endo -69.78 138.19 37.17 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.337 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -42.05 -29.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -56.71 -41.04 89.83 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 234' ' ' LEU . 17.2 m -44.36 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 111.136 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.477 ' N ' HG22 ' A' ' 233' ' ' THR . 78.0 mt -147.35 146.32 29.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.445 ' N ' HD23 ' A' ' 253' ' ' LEU . . . -41.29 -45.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.3 77.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -47.75 -54.22 12.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.64 -60.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 248' ' ' LEU . 13.6 tt0 -39.25 -49.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.25 -49.63 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 90.6 m -45.87 -50.75 14.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 248' ' ' LEU . 16.0 m-85 -78.46 -42.04 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.6 t -45.53 -44.97 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -38.95 -46.45 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 277' ' ' LEU . 38.6 m-85 -65.32 -44.52 87.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.22 157.21 25.92 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 10.9 m -44.3 141.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.943 0.401 . . . . 0.0 110.867 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 242' ' ' PHE . 38.0 mt -111.74 157.31 20.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 265' ' ' LEU . . . -97.24 -88.07 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -111.12 137.65 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 89.4 t -128.71 106.3 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 24.7 mt -114.59 113.14 23.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 260' ' ' ALA . 10.9 tp -134.07 98.57 14.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.731 . . . . 0.0 110.904 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 253' ' ' LEU . 52.9 Cg_endo -69.81 148.57 65.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 256' ' ' GLY . 6.9 pt-20 -74.75 -37.26 62.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 255' ' ' GLU . . . -60.31 -36.01 89.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -119.95 121.2 4.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.532 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.791 HD12 ' H ' ' A' ' 229' ' ' LEU . 17.2 pt -50.04 -32.86 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 72.3 p -45.8 134.2 7.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 253' ' ' LEU . . . -123.9 122.82 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.083 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 225' ' ' LEU . 28.8 mt -93.56 131.11 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 88.7 t -134.42 124.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.39 93.65 4.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 8.5 m-85 -58.05 148.07 27.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 249' ' ' GLY . 70.8 mt -77.0 -35.28 57.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.45 ' CD ' ' HD2' ' A' ' 267' ' ' PRO . 7.5 tp10 -112.21 138.49 21.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.663 0.744 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.45 ' HD2' ' CD ' ' A' ' 266' ' ' GLU . 53.3 Cg_endo -69.76 -50.25 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.34 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.06 -42.14 93.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -62.11 -48.01 82.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 264' ' ' PHE . . . -54.0 -48.3 70.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.76 -59.43 4.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -54.83 -49.42 71.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -47.03 -49.51 21.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.866 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -57.92 -57.19 13.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -54.56 -62.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.524 HD21 ' CE1' ' A' ' 245' ' ' PHE . 56.9 mt -51.15 -45.75 61.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.96 138.47 1.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 62.41 47.34 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 p -136.03 -178.87 5.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -129.22 133.82 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.735 ' HB2' HD11 ' A' ' 287' ' ' LEU . 28.8 t80 -78.77 -60.84 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' HIS . . . . . 0.599 ' CG ' ' CE2' ' A' ' 282' ' ' PHE . 20.8 m170 -124.01 -76.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -126.13 -14.51 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.465 ' CG2' ' HD3' ' A' ' 230' ' ' PRO . 33.4 m -112.59 152.6 44.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 111.094 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 138.35 37.43 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 282' ' ' PHE . 31.6 mt -88.75 128.9 35.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.21 100.83 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 44.0 mt -93.12 129.64 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -135.18 131.26 36.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -52.42 138.46 27.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.765 ' CB ' HG12 ' A' ' 223' ' ' VAL . . . -86.62 142.21 34.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.528 0.68 . . . . 0.0 111.117 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -176.24 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.648 2.232 . . . . 0.0 112.314 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.446 ' C ' HD12 ' A' ' 294' ' ' ILE . 2.5 pp -90.39 -18.05 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -85.82 -24.8 40.44 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.522 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 297' ' ' PHE . 13.7 p -38.91 -42.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.948 0.404 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.456 ' N ' HG13 ' A' ' 296' ' ' VAL . 11.9 m-85 -96.96 -48.04 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.22 -176.53 54.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -136.35 167.42 21.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -111.67 141.37 24.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.601 0.715 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -172.6 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.326 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -126.48 42.19 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -50.58 -41.56 54.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -40.22 -43.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.3 -43.49 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 67.8 m -44.03 -40.53 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 308' ' ' HIS . 15.9 mm-40 -39.03 -42.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 307' ' ' GLN . 1.5 t-80 -36.86 -43.27 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -39.63 150.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -107.2 156.2 37.99 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 132.19 22.87 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.664 2.243 . . . . 0.0 112.388 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -97.72 -43.84 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.076 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -38.75 -43.7 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -39.77 -46.85 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.6 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 317' ' ' SER . 44.2 tp10 -45.88 -41.66 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 316' ' ' GLU . 3.8 t -34.57 -63.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 317' ' ' SER . . . 35.22 87.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 140.93 43.96 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.357 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 91.0 p -102.95 -55.49 2.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 77.8 p -72.96 161.38 30.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.971 . . . . . . . . 0 0 . 1 stop_ save_